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The potential involvement of the PH domain of IRS-1 in the stimulation of glucose 
uptake by insulin has been investigated. Exogenous IRS-1 PH domain - produced 
using a GST fusion protein system - was introduced into permeabilized 3T3-L1 
adipocytes prior to insulin stimulation. The exogenous protein was able to partially 
block insulin-stimulated tyrosine phosphorylation of IRS-1, but only if the stimulation 
time with 100 nM insulin was reduced from 10 min to 2 min. However, insulin 
stimulation of PI 3-K activity and of glucose uptake - both events have been 
implicated to be downstream of IRS-1 phosphorylation - were not affected. The 
results are consistent with the view that the PH domain is involved in targeting IRS-1 
to the insulin receptor. However the nature of this process is not clear. Binding 
studies using either biotinylated IRS-1 PH domain or immobilized IRS-1 PH domain 
did not reveal a protein ligand for this structural domain.
Insulin stimulation of glucose uptake and of PKB activity appear to occur via PI 3-K. 
Evidence was obtained in support of the view that PKB is downstream of PI 3-K and 
involved in insulin-stimulated glucose uptake in 3T3-L1 adipocytes. First, activation 
of PKB is less sensitive to insulin stimulation than elevation of glucose uptake. Thus, 
the potential signal from PKB to increase transport activity may be amplified. 
Second, following insulin treatment, maximal stimulation of PKB activity occurs 
before that of glucose transport activity. Third, following the addition of wortmannin 
- an inhibitor of PI 3-K - to insulin-stimulated cells, PKB activity declines more 
rapidly than glucose uptake. Fourth, chronic treatment of cells with insulin down- 
regulates both cell surface GLUT4 and PKB activity. Further, in rat adipocytes, 
metformin can counteract the effects of prolonged insulin stimulation on both 
parameters.
The characteristics of insulin stimulation of PKB activity were also investigated in 
3T3-L1 adipocytes. First, measurements of PKB activity in subcellular fractions 
revealed that only the activity in the cytoplasm is stimulated by insulin. Second,
PP2A has a partial role to play in the deactivation of PKB. Thus, if okadaic acid - an 
inhibitor of PP2A - is present during insulin stimulation prior to wortmannin 
treatment, then the inhibition of PKB activity is partially blocked. Further, okadaic 
acid also reduces the rate at which wortmannin inhibits insulin-stimulated glucose 
uptake. However, it is likely that okadaic acid also acts on proteins other than PKB to 
cause this effect.
The expression of a constitutively active form of PKB in 3T3-L1 adipocytes leads to 
an elevation of basal glucose uptake (without an effect on the maximal insulin- 
stimulated response). The ATB-BMPA photolabel label was used to assess the 
relative contributions from GLUT1 and GLUT4. In the basal state, cell surface levels 
of both GLUT1 and GLUT4 are higher than those in control basal cells. In the 
insulin-stimulated state, only cell surface levels of GLUT1 are greater than those in 
control insulin-stimulated cells. Also, glucose transport and GLUT4 translocation are 
similarly increased by constitutively active PKB in basal cells, but to less than half the 
maximal insulin-stimulated response (38.9% and 37% respectively). Thus, it is likely 
that GLUT4 is the major contributor to the elevated glucose uptake induced by 
constitutively active PKB.
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Glucose is a major metabolic substrate. First, it is the starting point for the generation 
of ATP via glycolysis, the citric acid cycle and oxidative phosphorylation. Second, its 
conversion to glycogen allows it to act as an energy store. Third, it is involved in 
cellular biosynthesis via the generation of NADPH and ribose 5-phosphate in the 
pentose phosphate pathway. Levels of glucose in human blood are maintained 
between 80 and 120 mg per 100 ml (4.4 to 6.7 mM). One of the regulatory 
mechanisms involved is the control of glycogen metabolism in the liver by levels of 
hormones and glucose in the circulation: glucose can be released or taken up by the 
liver depending on the circumstances. One of the regulatory hormones that induce 
glycogen synthesis, insulin, can also act on muscle and adipose cells to encourage 
uptake of glucose via glucose transporters. These are integral membrane proteins that 
allow glucose to cross the plasma membrane.
The mechanism of insulin action involves altering the distribution of glucose 
transporters between intracellular membranes and the plasma membrane, such that 
there is an increase in the number of cell surface transporters. To have a greater 
understanding of insulin-stimulated glucose uptake, investigations are required in 
several key areas: the nature of the transporters that allow glucose transport; the nature 
of the intracellular compartments that contain glucose transporters; the mechanism of 
the subcellular trafficking of glucose transporters; the mechanism by which insulin 
stimulation leads to a change in the cellular distribution of glucose transporters. 
Studies of this kind will be of benefit in the treatment of non-insulin dependent 
diabetes mellitus (NIDDM), where a defect of the transporters or in the response to 
insulin stimulation may be responsible.
Insulin communicates with the cell by binding to and activating the transmembrane 
insulin receptor at the cell surface. Insulin receptor substrate-1 (IRS-1) is 
subsequently phosphorylated, enabling it to associate with and activate 
phosphoinositide 3-kinase (PI 3-K). Present at the the N-terminus of IRS-1 is the
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pleckstrin homology (PH) domain, which is not directly involved in the enzyme 
activation. The increased kinase activity of PI 3-K appears to lead to a rise in glucose 
uptake via translocation of glucose transporters, though the mechanism involved is not 
known. However, several downstream enzymes are known to be regulated by PI 3-K, 
one of them being protein kinase B (PKB). The studies described in this thesis have 
investigated the possible involvement of the IRS-1 PH domain and of PKB in insulin- 
regulated glucose uptake in adipocytes.
1.1 Facilitative Glucose Transporters
The presence of glucose transporters in the plasma membrane of adipocytes provide a 
means for the movement of glucose across the cell surface. They are important with 
regards to insulin-stimulated glucose uptake, since the rate at which glucose is 
transported by them represents the end-point of the action of insulin on the cell. 
Glucose transporters are integral membrane proteins that allow passive facilitated 
diffusion of glucose (reviewed by Gould and Holman, 1993). Thus, a glucose 
concentration gradient across the plasma membrane provides the driving force for 
glucose to enter or exit the cell via the transporter. The glucose transporter is specific 
for D-glucose and has kinetic properties that can be described by the Michaelis- 
Menten equation. Thus, transport is characterized by two values: Km, the 
concentration of glucose at which transport is half the maximal rate, Vmax. From a 
family of glucose transporters that has been identified in mammalian cells, the 
isoforms that exist in adipocytes are GLUT1, GLUT4 and GLUT5. Only GLUT1 and 
GLUT4 will be described in further detail, as GLUT5 is a fructose transporter.
1.1.1 GLUT1
A cDNA clone for GLUT1 was isolated by Mueckler et al (1985), using anti-serum 
raised against the purified transporter from erythrocytes. A cDNA library prepared 
from the HepG2 cell line (derived from a human hepatoma) was screened. The
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sequence of the cDNA clone reveals a polypeptide of 492 residues with a molecular 
weight of 54 kDa. A hydropathy plot of the amino acid sequence suggests the 
presence of 12 transmembrane domains. As tryptic digestion of the erythrocyte 
transporter occurs only on the cytoplasmic side of the membrane, the hydrophilic loop 
between the sixth and seventh transmembrane domains and the C-terminal tail were 
predicted to be located in the cytoplasm. The TV-glycosylation site was predicted to be 
at residue Asn-45, which follows the first transmembrane domain; thus, the N- 
terminal tail is likely to be cytosolic as well. A cDNA clone for GLUT1 was also 
isolated by Bimbaum et al (1986) from a cDNA library from rat brain. A polypeptide 
of 492 residues was also predicted, with 97.6% homology to the HepG2 transporter. 
Further, the tissue distribution of GLUT1 was investigated by blot hybridization of 
total RNA: the transporter was also detected in kidney and adipose tissue, but not in 
the liver.
Human erythrocytes have also been used to determine the kinetics of glucose transport 
for GLUT1 (Lowe and Walmsley, 1986). Using D-[14C]glucose, transport was 
determined in terms of net flux, where the influx or efflux of labelled sugar into a 
sugar-free comparment was measured. The value of the Km for the efflux of glucose 
was determined to be greater than that for its influx. Thus, at 0 °C, the former is 12- 
fold greater than the latter, whereas at 20 °C it is 3-fold. Thus, the GLUT1 transporter 
is kinetically asymmetrical. It was proposed that this property allows GLUT1 to 
effectively act like a unidirectional transporter under conditions of low extracellular 
glucose and high glucose demand (Gould and Holman, 1993).
1.1.2 GLUT4
A cDNA clone for GLUT4 was isolated by five independent groups in 1989. This 
was achieved by screening cDNA libraries from rat skeletal muscle (Bimbaum, 1989, 
and Charron et al., 1989), human skeletal muscle (Fukumoto et al., 1989), rat 
adipocyte and heart (James et al., 1989) and mouse 3T3-L1 adipocytes (Kaestner et 
al., 1989) with GLUT1 cDNA. The sequence reveals a polypeptide of 509 residues
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(510 for mouse GLUT4) with a molecular weight of 55 kDa. The amino acid 
sequence is about 65% identical to that of GLUT1. Similarity is greatest within the 
predicted transmembrane domains, apart from the third from the N-terminus. 
Differences are more apparent in the predicted cytoplasmic domains for the N- and C- 
terminal tails and for the central cytoplasmic loop. The putative 7V-glycosylation site 
in the exofacial loop following the first transmembrane domain is also present at 
residue Asn-57. The tissue distribution of GLUT4 was also investigated by Northern 
blot analysis of total RNA from rat tissue using GLUT4 cDNA as the probe 
(Bimbaum, 1989, Charron et al., 1989, and James et al., 1989). RNA for this isoform 
is abundant in insulin-responsive heart, skeletal muscle and adipose tissue. This 
observation was confirmed by immunoblotting with a monoclonal antibody for 
GLUT4 (James et al., 1989). The expression of GLUT4 following differentiation of 
mouse 3T3-L1 fibroblasts into adipocytes was also observed (James et al., 1989, and 
Kaestner et al., 1989). mRNA for the isoform does not appear until 3 days after 
induction of differentiation.
The cloning of GLUT1 and GLUT4 allowed kinetic studies to be performed in 
Xenopus oocytes expressing glucose transporters (Keller et al., 1989). Transport of 3- 
O-methyl-D-glucose was determined under equilibrium exchange conditions, where 
the concentration of unlabelled sugar inside the cell is the same as that of external H- 
labelled sugar. From their studies, the Km for GLUT4 is 1.8 mM, which is lower than 
that for GLUT1, in which the Km is 21.3 mM. In similar studies by Nishimura et al. 
(1993), cell surface transporters were also quantitated by photolabelling with 2-N-A- 
(1 -azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(D-mannos-4-yloxy)-2-propylamine (ATB- 
BMPA) (Introduction 1.2.2). It was determined that the Km is 26.2 and 4.3 mM for 
GLUT1 and GLUT4 respectively, whereas the turnover number (Vmax/Number of 
transporters) is about 20 000 min'1 for both isoforms. It has been suggested that the 
relatively low value for the Km of GLUT4, compared with that of GLUT1, allows the 
former to transport glucose at close to its Vmax under physiological conditions (Gould 
and Holman, 1993).
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Studies on transport via GLUT4 have been performed using rat adipocytes (Whitesell 
and Gliemann, 1979). When transport of 3-0-methyl-D-glucose was measured under 
equilibrium exchange conditions, insulin stimulation was found to increase Vmax by 
about 6-fold without a significant change in the Km. The net influx of 3-O-methyl-D- 
glucose into a sugar-free cell was also determined, with a Km of 2.5 to 5 mM. This 
value is similar to that obtained under equilibrium exchange conditions (Km of 3.1-3.5 
mM), indicating that the transporter exhibits symmetrical kinetic properties. The study 
led to the question as to whether the increase in Vmax is due to an increase in the 
number of cell surface transporters, or to an increase in the turnover number of the 
transporters.
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1.2 Insulin-stimulated Translocation of Glucose 
Transporters
The regulation of glucose uptake by insulin occurs via the alteration of the distribution 
of glucose transporters in the cell. To understand how signalling from the insulin 
receptor leads to this cellular effect, knowledge is required of: the relative roles of 
GLUT1 and GLUT4; the membrane compartments that contain these transporter 
isoforms; the mechanisms involved in the movement of the transporters between these 
comparments. The locus (or loci) of insulin action in this subcellular trafficking 
system for glucose transporters thus forms (or form) the end-point (or end-points) of 
the insulin signalling pathway.
1.2.1 Subcellular Localization of Glucose Transporters
The translocation of GLUT4 from the microsome fraction to the plasma membrane 
following insulin stimulation of rat adipocytes was discovered in 1980 by two 
independent groups. Studies by Cushman and Wardzala (1980) were based on the use 
of cytochalasin B, which is a competitive inhibitor of D-glucose transport. Plasma 
membrane and microsome fractions were prepared from homogenized rat adipocytes. 
Following insulin stimulation, they found that the number of D-glucose-inhibitable 
cytochalasin B-binding sites increased in the former and decreased in the latter. 
Suzuki and Kono (1980) measured the cytochalasin B-sensitive glucose transport 
activity of transporters reconstituted into a cell-free system. Crude microsomal 
fractions were further fractionated by sucrose density gradient centrifugation. 
Fractions were then either subjected to an assay of marker enzymes, or they were 
reconstituted into liposomes prior to assay of transport activity. Fractions 
corresponding to the peaks for 5’-nucleotidase (a plasma membrane marker) and 
UDPGakN-acetylglucosamine galactosyltransferase (representing an intracellular 
membrane compartment) were also found to contain the peaks for transport activity. 
Upon insulin stimulation, there appeared to be an increase in activity associated with
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the plasma membrane and a decrease in that found in the intracellular membrane 
fraction.
The characterization of subcellular membrane fractions isolated from rat adipocytes 
by differential ultracentrifugation has been described by Simpson et al. (1983). Four 
fractions termed the plasma membrane, the high density microsome (HDM), the low 
density microsome (LDM), and mitochondria and nuclei were obtained, each enriched 
with marker proteins for the plasma membrane, endoplasmic reticulum, Golgi 
apparatus and mitochondria respectively. The levels of D-glucose-inhibitable 
cytochalasin B-binding sites per mg protein are greatest in the LDM. Insulin 
stimulation decreases the levels present in this fraction, together with a concomitant 
increase in the HDM and plasma membrane. GLUT1 and GLUT4 were later 
identified as the transporters in the LDM fraction of rat adipocytes (Zorzano et al., 
1989). An antibody raised against GLUT4 was conjugated to protein A agarose and 
used to immunoadsorb the LDM fraction. From immunoblotting studies, it was found 
that 80% of GLUT4-containing vesicles were adsorbed, while more than 90% of 
GLUT 1-containing vesicles remained in the supernatant. Following insulin 
stimulation, both isoforms were found to increase in number in the plasma membrane 
and decrease in the LDM. It was concluded that insulin-stimulated glucose transport 
occurs via the tranlocation of the two transporter isoforms from two or more 
intracellular pools. This conclusion was supported by Piper et al. (1991). 
Homogenates from 3T3-L1 adipocytes were spun to remove the crude plasma 
membrane fraction, before fractionation by sucrose density gradient centrifugation. 
Immunoblotting of fractions showed that the peak for GLUT4 occurs at a denser 
fraction than that for GLUT1; both peaks decrease following insulin stimulation. 
Also, cells labelled with antibodies against GLUT1 and GLUT4, before observation 
by confocal immunfluorescence microscopy, revealed distinct populations of both 
isoforms.
The subcellular distribution of GLUT4 was also investigated by immunoelectron 
microscopy of brown adipose tissue (Slot et al., 1991). In basal cells, most of the 
GLUT4 transporters are present in tubulo-vesicular structures, either in the trans-
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Golgi reticulum (TGR) or throughout the cytoplasm. In insulin-stimulated cells, there 
is an increase in GLUT4 at the plasma membrane (from 1% total cell number to 40%), 
with a concomitant decrease in the tubulo-vesicular structures. Further, the 
transporter is also present in coated pits and vesicles following insulin stimulation. 
Immunolabelling of albumin to detect early endosomes demonstrated that GLUT4 is 
present in these structures in insulin-treated cells. The early endosomes were also 
found in association with tubulo-vesicular structures containing GLUT4, where 
separation of the two proteins appeared to occur between the two compartments. Late 
endosomes were defined by the appearance of albumin and cathepsin D: these contain 
little GLUT4. The increase in GLUT4 in the coated pits and early endosomes in the 
insulin-stimulated state was seen as an indication that recycling from the plasma 
membrane occurs during insulin stimulation. Further, the accumulation of GLUT4 in 
these structures suggested that insulin acts by increasing the exocytosis of GLUT4, 
rather than by decreasing its endocytosis.
The co-localization of GLUT1 with endosomal-TGR markers supports the idea that 
the transporter is part of a recycling pathway between this compartment and the 
plasma membrane (Tanner and Lienhard, 1989). GLUT1 and receptors for transferrin 
and insulin-like growth factor II (IGF-II) all translocate to the plasma membrane upon 
insulin stimulation of 3T3-L1 adipocytes. Binding and immunoblotting studies 
showed an increase in these proteins in the crude plasma membrane fraction (1.5-fold, 
1.2-fold and 2.5-4.5-fold respectively) and their decrease in the microsomal fraction. 
GLUT 1-containing vesicles were prepared by mixing the microsomal fraction with 
Staphylococcus aureus cells conjugated to an anti-GLUTl antibody. Binding studies 
revealed that the content of tranferrin receptors were similar in microsomal 
membranes and GLUT1 vesicles under basal and insulin-stimulated conditions. Also, 
immunoadsorption of GLUT1 vesicles extracted similar percentages of GLUT1 and 
IGF-II receptors from the microsomal membrane. This was also observed when IGF- 
II-containing vesicles were prepared instead. However, these markers do not appear 
to co-localize with GLUT4 in the same vesicles (Zorzano et al., 1989). Vesicles 
prepared by immunoadsorption of the LDM fraction from rat adipocytes with anti-
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GLUT4 were immunoblotted with an antibody against the IGF-II receptor. Little 
depletion of this receptor from the LDM was observed.
Taken together, these studies indicate the recycling of GLUT1 and GLUT4 between 
intracellular membranes and the plasma membrane. While insulin stimulation appears 
to cause the translocation of GLUT1, transferrin receptors and IGF-II receptors from 
the same intracellular compartment, it appears that GLUT4 is translocated from a 
distinct pool. This is based on two observations. First, GLUT4 can be isolated in 
vesicles that do not contain these other proteins. Second, the insulin-stimulated 
increase in cell surface GLUT4 is much greater than that for GLUT1 and the 
endosomal-TGR markers.
1.2.2 Kinetic Studies of GLUT4 Translocation
In order to assess the relative roles of GLUT1 and GLUT4 in insulin-stimulated 
glucose uptake, it is necessary to be able to quantitate the levels of both transporters in 
the plasma membrane, before and after insulin stimulation. Further, in order to 
determine the kinetics of the movement of glucose transporters between membrane 
compartments, a method of tagging these transporters is required. The ATB-BMPA 
photolabel was developed for these purposes (Clark and Holman, 1990). This 
compound is composed of two D-mannose groups linked to 2-propylamine via their 
C-4 hydroxy groups. The photolabile ATB group is attached to the bridge between 
the two sugar groups. The D-mannose groups interact with the transporter, where 
upon irradiation with 300 nm light, the label is incorporated into the transporter. As 
ATB-BMPA is membrane impermeable, then only cell surface transporters are 
detected.
The quantification of cell surface GLUT1 and GLUT4 by ATB-BMPA photolabelling 
was first undertaken in 3T3-L1 adipocytes (Calderhead et al., 1990). Immunoblotting 
of cell lysate with antibodies against each isoform revealed GLUT1 to be the more 
dominant of the two transporters (4:1). After photolabelling of cells with ATB-
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BMP A, tagged transporters were immunoprecipitated and resolved on a sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gel. Following 
insulin stimulation, the ratio of GLUT1 to GLUT4 in the plasma membrane decreased 
from 4.6 to 1.6. However, the fold-increase was 6.5 and 17.1 for GLUT1 and GLUT4 
respectively. The affinity of the transporters for the probe was not considered to be 
changed by insulin treatment, since there was no change in its dissociation constant 
for the inhibition of 2-deoxy-D-glucose transport. Insulin stimulation was found to 
increase 2-deoxy-D-glucose transport by 21-fold. As GLUT1 was still the 
predominant transporter under insulin-stimulated conditions, it was concluded that 
translocation would only account for the rise in transport if GLUT4 had a higher 
intrinsic activity. Similar experiments were performed using rat adipocytes (Holman 
et al., 1990). Under basal conditions, it was determined that the level of GLUT4 
transporters in the plasma membrane was about twice that of GLUT1. Upon insulin 
stimulation, there was a 5- and 15-20-fold increase in cell surface GLUT1 and GLUT4 
respectively, leading to GLUT4 as 90% of both transporters. Insulin-stimulated 3-0- 
methyl-D-glucose transport was found to be 20-30-fold greater than in basal cells. As 
this increase was similar to that for GLUT4 translocation, it was similarly concluded 
that the intrinsic activity of GLUT4 was greater than that for GLUT1. Further, unlike 
3T3-L1 adipocytes, GLUT1 is not a major contributor to transport activity in rat 
adipocytes.
ATB-BMPA was used in further studies to compare changes in glucose transport 
activity with levels of cell surface transporters in rat adipocytes (Clark et al., 1991). 
Following insulin stimulation, transport of 3-O-methyl-D-glucose increases with a 
half-time of 3.2 min, but with a time lag of 47.1 s. However, the appearance of 
GLUT1 and GLUT4 at the cell surface occur with half-times of 2.32 and 2.17 min 
respectively and with no time lag. Transport activity and cell surface transporters 
were also determined following the removal of insulin from stimulated cells. The 
former declines with a half-time of 10.9 min, whereas the latter decreases with similar 
half-times of 11.7 and 12.3 min for GLUT1 and GLUT4 respectively. Similar studies 
were undertaken in 3T3-L1 adipocytes (Yang et al., 1992). Likewise, there is also a 
lag between the appearance of cell surface transporters and the increase in transport
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activity, while the decline in both parameters following insulin removal are similar. 
In subsequent studies, it was observed that the half-time for the appearance of cell 
surface GLUT4 is faster when determined by immunoblotting instead of ATB-BMPA 
photolabelling (Satoh et al., 1993). Thus, these data support the idea that transporters 
can exist in partially occluded or occluded vesicles in the plasma membrane. It was 
further postulated that these vesicles are associated with trafficking proteins and 
cannot participate in glucose transport.
The recycling of ATB-BMPA-labelled transporters between the plasma membrane 
and the LDM in rat adipocytes was demonstrated by Satoh et al. (1993). Cells 
stimulated to a steady state of glucose transport activity were treated with collagenase 
to remove the insulin present. Immunodetectable and labelled GLUT4 in the plasma 
membrane and transport activity all declined to below 20% of the original response 
with similar half-times. In the continuous presence of insulin, while cell surface 
immunodetectable GLUT4 and transport activity remained constant, labelled GLUT4 
declined with a half-time similar to that following collagenase treatment, but to a 
higher steady state level. Restimulation of collagenase-treated cells restored cell 
surface immunodetectable GLUT4, labelled GLUT4 and transport activity to steady 
state levels observed in cells continuously treated with insulin. The half-times for the 
first two were similar and slightly faster than that for the last. Thus, the data indicates 
that insulin affects the rate constant for the exocytosis (keX) of GLUT4, and not that for 
its endocytosis (ken). Values for these constants were calculated assuming that there 
are only two pools of GLUT4: the plasma membrane and the LDM. It was estimated 
that kex increases about 10-fold following insulin stimulation, whereas ken remains 
constant. These experiments were repeated again, but with measurements of GLUT4 
in the LDM instead. It was observed that labelled GLUT4 that had returned to the 
LDM from the plasma membrane following collagenase treatment, could be reduced 
following restimulation with insulin to a steady state level found in cells continuously 
treated with insulin. Thus, the data indicates that total cellular GLUT4 is involved in 
subcellular trafficking. Similar experiments were carried out in 3T3-L1 adipocytes 
(Yang and Holman, 1993). Basal and maximally insulin-stimulated cells were 
labelled with ATB-BMPA before further incubation at these steady states, during
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which the decline in labelled GLUT1 and GLUT4 in the plasma membrane was 
determined. In the insulin-stimulated state, both transporters share a similar value for 
keX and for ken- A steady state is reached where half the labelled transporters are 
present in the plasma membrane. In the basal state, ken for both transporters are 
similar, while ken in insulin-stimulated cells are about 30% slower. Further, in the 
basal state, labelled GLUT4 is internalized to a greater extent than GLUT1. Thus, 8% 
of original cell surface labelled transporter remain, compared with 21%. This 
observation is reflected in kex, where the value for GLUT1 is 3.5-times greater than 
that for GLUT4. Insulin stimulation was determined to raise GLUT1 and GLUT4 
exocytosis by 3-fold and 9-fold respectively.
In the two-pool model, the half-time for the insulin-stimulated appearance of cell 
surface GLUT4 should be the same as that for the internalization of cell surface 
GLUT4 during continuous insulin stimulation, as both depend on the same values for 
kex and ken- However, this is not observed experimentally (Satoh et al., 1993): the 
former has a faster half-time (2.7 min) than that for the latter (10.6 min). This data 
was found to be better explained by the computer simulation of a three-pool model 
(Holman et al., 1994). Here, there are two intracellular pools: the tubulo-vesicular 
system and the early endosomes. The former would allow the initial rapid 
translocation of GLUT4 without a major contribution from ken on the half-time for 
this process. The latter would account for the slower half-time for the recycling of 
GLUT4 in the presence of insulin.
From these studies with ATB-BMPA, it is now known that GLUT4, and not GLUT1, 
is the major insulin-responsive transporter isoform. This conclusion is based on the 
relatively large insulin-stimulated increase in cell surface GLUT4, compared with that 
of GLUT1, in adipocytes. The cause of this appears to be the insulin stimulation of a 
greater increase in keX for GLUT4 than that for GLUT1. Further, the translocation of 
GLUT4 is the major contributor to glucose transport activity. Subsequent studies 
have demonstrated that GLUT4 has a greater intrinsic activity (Turnover number/Km) 
than that of GLUT1 (Nishimura et al., 1993). The kinetic studies with ATB-BMPA 
labelled-transporters support previous biochemical and morphological studies in two
12
areas. First, the kinetic data also indicates that there is distinct pool of GLUT4 inside 
the cell, ready for rapid translocation to the cell surface. Second, the kinetic data is 
consistent with a role for GLUT4 exocytosis as the major mechanism of GLUT4 
translocation.
1.2.3 Targeting of GLUT4
In 3T3-L1 adipocytes, the rate of exocytosis of GLUT4 is lower in the basal state than 
in the insulin-stimulated state, whereas for GLUT1, the difference is not as great 
(Yang and Holman, 1993). This observation implies that there must be a sequence or 
structure present in the former that enables it to be retained in the cell more efficiently 
in the basal state. An approach to determine the sites in GLUT4 responsible for this 
property has been to observe the subcelluar distribution of chimeras of GLUT1 and 
GLUT4. Piper et al. (1992) expressed transporter constructs in CHO cells. Their 
subcellular distribution was detected by immunoelectron and immunofluorescence 
microscopy. Wild-type GLUT4 was detected mainly in intracellular tubulo-vesicles, 
while wild-type GLUT1 was found mainly in the plasma membrane. A chimera 
where the C-terminal 25 residues of GLUT4 were replaced with those of GLUT1 
showed the same intracellular localization as wild-type GLUT4. Likewise, 
exchanging the C-terminal 25 residues of GLUT1 with those of GLUT4 had no effect 
on its cell surface localization. However, when the N-terminal 41 residues of the 
latter chimera were replaced with those of GLUT4, intracellular localization was 
observed. Further studies (Piper et al., 1993) demonstrated that the deletion of 8 
amino acids from the N-terminus of GLUT4, or the deletion of residue phe-5, was 
sufficient to cause localization at the plasma membrane. The motif is PSGFGGI.
However, similar experiments by Czech et al. (1993) showed that the C-terminus of 
GLUT4 is important for intracellular sequestration. A hemagglutinin epitope was 
inserted into an exofacial loop of transporter constructs, which were then expressed in 
COS-7 cells. Tagged constructs were detected by immunofluorescence microscopy. 
A chimera where the C-terminal 30 residues of GLUT4 were substituted into GLUT1
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was detected intracellularly, but not at the cell surface. The converse chimera, where 
the 29 C-terminal residues of GLUT1 were substituted into GLUT4, was observed at 
the cell surface. Intracellular localization of the former was also observed in CHO 
cells. Further experiments in CHO and COS-7 cells by Corvera et al. (1994) 
demonstrated that the dileucine motif (residues leu-489 and leu-490) in GLUT4 was 
the critical component of C-terminal-mediated sequestration. Thus, its mutation to a 
double alanine in the chimera of GLUT1 substituted with the C-terminal 30 residues 
of GLUT4 led to levels at the cell surface similar to those of wild-type GLUT1.
It has been argued that the use of transfected CHO and COS-7 cells may not be 
adequate for investigating the targeting sequences of GLUT4 (Holman and Cushman, 
1994). First, they are unresponsive to insulin and thus may not possess the molecular 
mechanisms for sequestration of GLUT4. Second, expression of constructs at a high 
level may overcome the ability of the cell to maintain the transporters intracellularly. 
Further work was carried out on chimeras and mutants expressed in 3T3-L1 cells. 
Verhey et al. (1995) produced chimeric transporters with an epitope tag in the central 
cytoplasmic loop. These were expressed in 3T3-L1 adipocytes at levels that were less 
than 2-fold of that of endogenous GLUT4. Cell surface transporters were detected by 
immunofluorescence microscopy of plasma membrane sheets. A chimera of GLUT1 
substituted with the N-terminal 183 residues of GLUT4 was not present in the plasma 
membrane under basal conditions. Following insulin stimulation, there was only a 
slight increase in the levels of this chimera at the cell surface. However, for a chimera 
of GLUT1 substituted with the C-terminal 30 residues of GLUT4, insulin treatment 
led to levels in the plasma membrane that were equivalent to those obtained with cells 
expressing endogenous GLUT4 or tagged-GLUT4. This chimera was absent from the 
cell surface in the basal state. Contrary to previous data, mutation of the dileucine 
motif in the latter construct to a double alanine did not affect intracellular localization. 
Further experiments demonstrated that this mutation reduced the rate of 
internalization of the transporter following removal of insulin stimulation.
Marsh et al. (1995) expressed C-terminal epitope-tagged GLUT4 constructs in 3T3- 
L1 adipocytes. The distribution of transporters between the plasma membrane and the
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LDM was quantitated by immunoblotting. Expression levels were defined as low 
(similar to endogenous GLUT4) or high (4-fold the levels of endogenous GLUT4). 
Mutation of phe-5 to alanine led to accumulation of GLUT4 at the plasma membrane, 
giving a high ratio of cell surface to intracellular transporters (PM/LDM ratio). 
Insulin stimulation caused a further slight increase of this transporter at the cell 
surface. Mutation of the dileucine motif to a double alanine gave different results 
depending on the expression level. At low levels, the transporter had a similar 
PM/LDM ratio to that of endogenous or tagged- GLUT4, in both basal and insulin- 
stimulated states. At high levels, the ratio increased for basal cells, but was not as 
high as that for the phe-5 mutant. Additional transporters could be recruited to the 
cell surface upon insulin treatment.
As both groups had used different sets of transporter constructs in their experiments, it 
is difficult to make direct comparisons between their work. Verhey et al. (1995) 
concluded that the C- and N-terminus are important for intracellular sequestration, 
though the latter is not involved in targeting to an insulin-sensitive pool. Further, the 
dileucine motif appears to be important for the rate of internalization only. Marsh et 
al. (1995) inferred that as both N- and C-terminal mutants were still capable of 
insulin-stimulated translocation, other sequences must be involved in this process. 
Both agreed that the dileucine motif is not involved in intracellular sequestration. 
However, while these studies have identified sequences in GLUT4 that contribute to 
its intracellular sequestration, the cellular mechanisms involved in this process are not 
yet known.
1.2.4 Fusion of GLUT4 Vesicles at the Plasma Membrane
The exocytosis of GLUT4-containing vesicles to the plasma membrane has been 
compared to the fusion of neurotransmitter-containing vesicles at synaptic 
membranes. It has been proposed that the proteins involved in the latter process may 
also be involved in GLUT4 translocation (Holman and Cushman, 1994). The model 
is as follows. Present in the vesicular and plasma membranes are Soluble N-
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ethylmaleimide Sensitive Fusion (NSF) Attachment Protein Receptors (SNAREs) (v- 
SNARE for the former, t-SNARE for the latter). A complex is formed, consisting of 
these two proteins plus Soluble NSF Attachment Proteins (SNAPs). The binding of 
NSF protein to the assembly drives the fusion of the vesicle with the plasma 
membrane. The presence of these proteins in rat adipocytes and their ability to form 
complexes with each other in vitro was demonstrated by Timmers et al. (1996). 
Plasma membrane and GLUT4 vesicles were isolated from rat adipocytes, solubilized, 
and mixed with recombinant a-SNAP and wyc-epitope-tagged NSF plus ATP and 
EDTA. The resulting complex was immunoprecipitated with an anti-myc antibody, 
before elution of SNAREs with Mg2+. The proteins detected by immunoblotting were 
syntaxin 4 (a t-SNARE), VAMP2 and VAMP3 (v-SNAREs), and a-SNAP.
A functional role for the SNARE proteins in GLUT4 translocation was studied by 
Cheatham et al. (1996). Compounds were introduced into permeabilized 3T3-L1 
adipocytes prior to determination of insulin-stimulated GLUT4 translocation. These 
were: botulinum neurotoxin D (an endopeptidase specific for VAMPs 2 and 3); IgA 
protease (which cleaves VAMP2, but not VAMP3); glutathione 5-transferase (GST) 
fusion proteins of the soluble portion of syntaxin 4 or VAMP2. All were found to 
inhibit exocytosis of GLUT4 following insulin treatment, as determined by 
immunofluorescence microscopy of plasma membrane sheets. Similar studies were 
undertaken by Olson et al. (1997) in 3T3-L1 adipocytes infected with recombinant 
vaccinia virus. The expression of the cytoplasmic domains of syntaxin 4, VAMP2, or 
VAMP3, but not syntaxin 3, led to a reduction in insulin-stimulated GLUT4 
translocation, as determined by immunoblotting or immunofluorescence microscopy 
of plasma membrane sheets. Further, the presence of syntaxin 4 did not affect GLUT1 
translocation. Thus, both groups indicate that VAMP2 and syntaxin 4 could have a 
role to play in the docking and fusion of GLUT4 vesicles with the plasma membrane.
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1.3 Insulin Signalling
The recognition of the hormone insulin at the cell surface ultimately leads to the 
translocation of glucose transporters, especially GLUT4, to the plasma membrane. To 
have a greater understanding of insulin action, the signalling mechanisms that link 
these two events need to be determined. Several studies have mapped the molecular 
events that occur in the cell following the binding of insulin to its receptor. The 
discovery of insulin-regulated proteins, such as IRS-1 and PKB, warrant 
investigations into their potential role in insulin-stimulated glucose uptake and are the 
subject of studies described in this thesis. Some studies have demonstrated that the 
activation or inhibition of certain cellular proteins can influence glucose transport 
activity. These include G proteins, protein kinase C (PKC), and protein phosphatases 
1 and 2A (PP1 and PP2A). How these proteins are involved in the normal insulin- 
stimulated response remains to be determined.
1.3.1 The Insulin Receptor
The insulin receptor is a heterotetramer consisting of a pair of disulphide bond-linked 
a-subunits, each disulphide bond-linked to a p-subunit (reviewed by White and Kahn, 
1994). The a-subunit is extracellular and binds the ligand insulin. The P-subunit is a 
transmembrane protein which possesses insulin-regulatable tyrosine kinase activity. 
A cDNA clone for the human insulin receptor precursor was isolated by two 
independent groups in 1985. Ullrich et al. (1985) deduced a polypeptide consisting of 
an N-terminal 27 residue signal sequence, followed by a 719 residue a-subunit 
sequence, a 4 residue cleavage site and a 620 residue p-subunit sequence. Ebina et al. 
(1985) had identified a different isoform of the receptor precursor, where the a- 
subunit was found to consist of 731 residues. The a-subunit is hydrophilic with 15 
putative N-glycosylation sites and a region rich in cysteine residues. The P-subunit is 
composed of an N-terminal extracellular domain with four putative A-glycosylation 
sites and four cysteine residues, a hydrophobic transmembrane domain and a C-
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terminal cytosolic domain. The intracellular domain can be further subdivided into 
the juxtamembrane region, the kinase region and the C-terminal region.
The ability of insulin to stimulate tyrosine phosphorylation of the insulin receptor was 
described by Kasuga et al. (1982) in a cell-free system. Partially purified insulin 
receptor from solubilized rat membrane was incubated with or without insulin before 
the addition of [y- P]ATP. Insulin was found to induce the incorporation of 
phosphate into the p-subunit on its tyrosine residues, indicating autophosphorylation 
of the receptor. The role of putative autophosphorylation sites in the P-subunit were 
investigated by Murakami and Rosen (1991), where they mutated tyrosine residues to 
phenylalanine. The cDNA constructs were stably transfected into CHO cells. 
Mutation of tyr-1146, -1150 and -1151 in the kinase region impaired the insulin- 
stimulated kinase activity of the receptor. Whereas mutation of tyr-960 in the 
juxtamembrane region did not affect receptor kinase activity, it did reduce the 
sensitivity to stimulation of glucose uptake and thymidine incorporation. Mutation of 
tyr-953 in the juxtamembrane region and tyr-1316 and tyr-1322 in the C-terminal tail 
had no effect on the above parameters. Thus, autophosphorylation of the receptor is 
required for normal insulin-stimulated kinase activity and for the ability to effect 
downstream events in the cell.
The importance of tyrosine phosphorylation of the insulin receptor for the subsequent 
phosphorylation of substrate proteins was determined by Yonezawa et al. (1994), 
using CHO cells overexpressing wild-type and mutant insulin receptors. First, 
mutation of lys-1018 to arginine in the kinase region abolished both insulin-stimulated 
autophosphorylation and phosphorylation of the substrate proteins IRS-1 and She. 
Second, whilst mutation of tyr-960 to alanine attenuated phosphorylation of IRS-1 and 
She, the deletion of-the C-terminal 82 residues (containing tyr-1316 and tyr-1322) 
impaired She phosphorylation only. Thus, receptor tyrosine kinase activity and the 
autophosphorylation of certain tyrosine residues are both required in order for 
phosphorylation of endogenous substrates to occur.
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1.3.2 Substrates of the Insulin Receptor
1.3.2.1 IRS-1
The tyrosine phosphorylation of IRS-1 by the insulin receptor in vivo was first 
identified in the hepatoma cell line Fao by White et al. (1985). Cells previously 
labelled with P-orthophosphate were immunoprecipitated with anti-phosphotyrosine 
antibodies. Following insulin stimulation, a protein of 185 kDa was observed. The 
protein, termed ppl85, was later purified from rat liver (Rothenberg et al., 1991) with 
anti-phosphotyrosine. Purified ppl85 was subjected to tryptic digestion, after which, 
one of the fragments was used to raise an antibody specific for the protein. This work 
enabled the generation of cDNA probes for ppl85, which were used to identify cDNA 
clones for the protein (Sun et al., 1991). IRS-1 (ppl85) is a hydrophilic protein of 131 
kDa with potential phosphorylation sites: there are 35 for serine/threonine kinases 
(based on motifs for known kinases of this type) and at least 1 0  for tyrosine kinases 
(six possessing the YMXM motif, three with YXXM and one with EYYE). Another 
group (Keller et al., 1991 and 1993) were able to purify IRS-1 (ppl60) from mouse 
3T3-L1 cells and to clone its cDNA. The protein has a molecular weight of 131 kDa 
and is 97.6% identical to rat IRS-1; the number of residues are 1231 compared with 
1235 for rat. Two N-terminal domains in IRS-1 have also been identified. The first is 
the PH domain (Musacchio et al., 1993) at residues 13-115 of rat IRS-1. The second 
is the phosphotyrosine-binding (PTB) domain, a 156-residue domain in mouse IRS-1 
that is C-terminal to the PH domain (Sun et al., 1995).
The multiple phosphorylation of IRS-1 by the insulin receptor was observed in CHO 
cells expressing human insulin receptor and rat liver IRS-1 (Sun et al., 1992). Tryptic 
digestion of phosphorylated IRS-1 from basal cells revealed 12 fragments containing 
phosphoserine, four with phosphothreonine and one with phosphotyrosine. Following 
insulin stimulation, eight further phosphoserine and one further phosphothreonine 
were observed; also seen were at least six phosphotyrosines. The same study 
suggested direct phosphorylation of IRS-1 by the insulin receptor. Partially purified 
IRS-1 from Sf9 cells expressing its cDNA was incubated with [y-32P]ATP and Mn2+.
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The addition of partially purified activated insulin receptor from CHO cells led to an 
increase in phosphorylation of the protein on tyrosine residues only. Sun et al. (1991) 
suggested that IRS-1 functions as a multisite docking protein for other proteins 
involved in signal transduction. This was based on their observation that PI 3-K 
activity was present on IRS-1 immunoprecipitates following insulin stimulation of 
CHO cells expressing the insulin receptor. It was predicted that the src homology 2 
(SH2) domains (of which there are two) of the regulatory subunit (p85) of PI 3-K bind 
to the phosphotyrosine residues on IRS-1.
The mechanism of the activation of PI 3-K was investigated by Backer et al. (1992). 
Recombinant IRS-1 was incubated with p85 immunoprecipitates (containing the pi 10 
catalytic subunit) from quiescent CHO cells before assaying for PI 3-K activity. An 
increase in activity was observed if IRS-1 was phosphorylated beforehand. Activation 
seemed to occur via the phosphorylated YXXM motif, as phosphopeptides from IRS-1 
sequences were also capable of raising kinase activity if they contained this motif. 
Further, tryptic phosphopeptides containing tyr-608 or tyr-939 of IRS-1 were found to 
bind most strongly to the SH2 domains of p85 (Sun et al., 1993); both peptides 
contain the YMXM motif. Thus, activation of PI 3 -K appears to occur upon 
association of its SH2 domains with the phosphorylated YXXM motifs of IRS-1. 
Further, Rordorf-Kikolic et al. (1995) demonstrated the need for both SH2 domains of 
p85 for maximal activation of PI 3-K. A point mutation in either or both of the SH2 
domains to inhibit phosphopeptide binding was made. Activation of PI 3-K activity in 
the p85/pl 10 heterodimer by tyrosine-phosphorylated IRS-1 was found to be reduced 
by about 50% for a single mutation and by 100% for a double mutation.
The association of phosphotyrosine residues in IRS-1 with other signalling proteins 
also occurs (Figure 1.3.1) (reviewed by Keller and Lienhard, 1994). The first is Grb2, 
which possesses a single SH2 domain that is thought to bind to try-895 (YVNI). Grb2 
associates with Sos, a protein which causes GDP release from the G protein Ras. The 
second is the phosphotyrosine phosphatase Syp (SH-PTP2), which possesses two N- 
terminal SH2 domains, one of which is believed to bind to tyr-1172 (YIDL). The
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third is Nek, which has a single SH2 domain. Thus, the binding of an SH2 domain- 






Figure 1.3.1. The Interaction of Tyrosine-phosphorylated IRS-1 with SH2 
Domain-containing Proteins (Keller and Lienhard, 1994).
The importance of the serine/threonine phosphorylated state of IRS-1 was 
demonstrated by Tanti et al. (1994). Pre-treatment of 3T3-L1 adipocytes with okadaic 
acid prior to insulin stimulation led to a reduction in the tyrosine phosphorylation of 
IRS-1, but not of the insulin receptor, as determined by immunoblotting with anti- 
phosphotyrosine. Also, there was an observed decrease in the electrophoretic mobility 
of IRS-1 following okadaic acid treatment. This appeared to be due to an increase in 
serine/threonine phosphorylation, since cells labelled with [y- P]orthophosphate 
demonstrated an increase in phosphorylated IRS-1 that could not be immunoblotted or 
immunoprecipitated with anti-phosphotryosine. Further, when immunoprecipitated 
IRS-1 was incubated with purified insulin receptor, phosphorylation of the former was
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reduced if the cells had previously been treated with okadaic acid. Thus, 
serine/threonine phosphorylation of IRS-1 appears to modulate phosphorylation at the 
tyrosine residues.
1.3.2.2 IRS-2
The protein 4PS was purified and cloned from murine myeloid progenitor cells (Sun 
et al., 1995) and subsequently designated IRS-2 due to its similarity to IRS-1. The 
IRS-2 cDNA reveals a polypeptide of 145 kDa. In common with IRS-1 is the N- 
terminal PH domain (69% identical), followed by the PTB domain (75% identical). 
Though the C-terminus is 35% identical to that of IRS-1, about 20 putative tyrosine 
phosphorylation motifs are present: nine of these are YXXM, of which four are 
YMXM. IRS-2 was detected in insulin-stimulated murine liver by Tobe et al. (1995). 
Phosphotyrosine immunoblotting revealed a faint 190 kDa band, relative to that for 
IRS-1. Further, it was shown that IRS-2 phosphorylation is enhanced in IRS-1- 
deficient mice. Patti et al. (1995) were able to immunoprecipitate IRS-2 from murine 
muscle and liver, where upon insulin stimulation, they detected increased tyrosine 
phosphorylation and the binding of p85 with associated PI 3-K activity. Further, it 
was found that these effects are more noticeable in IRS-1-deficient mice, and that they 
are due to enhanced phosphorylation of IRS-2, as its expression level is unchanged. 
IRS-2 appears to be the major alternative substrate to IRS-1 in insulin-stimulated IRS- 
1-deficient mice in terms of activation of PI 3-K, since removal of IRS-2 from tissue 
homogenates virtually depletes phosphotyrosine-associated activity (Patti et al, 1995).
1.3.2.3 IRS-3
A 60 kDa protein (pp60) that binds PI 3-K following tyrosine phosphorylation, due to 
insulin stimulation of rat adipocytes, was identified by Lavan and Lienhard (1993). 
Following insulin stimulation, anti-phosphotyrosine immunoblotting showed the 
appearance of a band of 60 kDa. Further, anti-phosphotyrosine immunoblotting of 
p85 immunoprecipitates from insulin-stimulated cells showed the presence of a 60 
kDa protein. This protein was not observed in IRS-1 immunoprecipitates, indicating
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that its association with PI 3-K is not via IRS-1. Also, GST fusion proteins of the isl­
and C-terminal SH2 domains of PI 3-K were found to bind to tyrosine-phosphorylated 
pp60, indicating that association is via this domain.
The purification of pp60 and the cloning of its cDNA from a rat adipocyte cDNA 
library was later described by Lavan et al. (1997). The sequence reveals a polypeptide 
of 494 residues with a molecular weight of 55.3 kDa. As with IRS-1 and IRS-2, the 
protein has an N-terminal PH domain (50% and 45% identical respectively), followed 
by a PTB domain (48% and 53% identical respectively), followed by putative tyrosine 
phosphorylation sites (four with YXXM motifs). Thus, based on its similarity to IRS- 
1 and IRS-2, pp60 was designated IRS-3. A study by Kelly and Ruderman (1993), in 
which p85 immunoprecipitates from rat adipocyte membrane fractions were 
immunoblotted with anti-phosphotyrosine, revealed a 60 kDa band located 
predominantly in the plasma membrane. This is in contrast to a 185 kDa band found 
mainly in the LDM. Assuming this 60 kDa protein is IRS-3, then its plasma 
membrane localization indicates that it has a different role to play in insulin 
signalling.
1.3.2.4 She
The phosphorylation of the SH2 domain-containing protein She by the insulin 
receptor was described by Pronk et al. (1993). She immunoprecipitates from insulin- 
stimulated CHO cells overexpressing the insulin receptor were immunoblotted with 
anti-phosphotyrosine. Two bands of 52 and 46 kDa were observed, whereas Skolnik 
et al. (1993a) also detected a 6 6  kDa band. The association of tyrosine- 
phosphorylated She with Grb2 was demonstrated by Skolnik et al. (1993a). 
Immunoprecipitates of Grb2 from insulin-stimulated CHO cells (overexpressing the 
insulin receptor) that were immunoblotted with anti-Shc revealed the presence of the 
52 and 6 6  kDa bands of She. Skolnik et al. (1993a) also detected Grb2 on IRS-1 
immunoprecipitates from the same cell system following insulin stimulation. Thus, 
there is a convergence of signalling pathways towards Grb2.
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Grb2 was found to be able to bind to Sos, as determined by immunoblotting with anti- 
Sos of Grb2 immunoprecipitates from L6  myoblast cells overexpressing Grb2 
(Skolnik et al., 1993b). Further, IRS-1 and She were also detected in the 
immunoprecipitated complex following insulin stimulation. A role for Sos in 
promoting the exchange of bound GDP on the G protein Ras for GTP was shown by 
Baltensperger et al. (1993). COS-1 cells transfected with cDNAs for Sos and Ras
'X '}were radiolabelled with [y- PJorthophosphate: the amount of GTP-bound Ras present 
was 10-fold greater than if Sos cDNA was absent. It has been suggested that insulin 
stimulation activates Ras either by localizing cytosolic Grb2/Sos to membrane-bound 
Ras, or by increasing the intrinsic activity of Sos (Skolnik et al., 1993b).
1.3.3 Downstream of the Insulin Receptor Substrates
1.3.3.1 Phosphoinositide 3-Kinase
PI 3-K is a heterodimer of a p85 regulatory subunit and a pi 10 catalytic subunit 
(reviewed by Kapeller and Cantley, 1994). Two isoforms have been identified for 
each subunit: a  and p. The p85 subunit is composed of an N-terminal sre homology 3 
(SH3) domain, followed by a Bcr homology domain sandwiched between a pair of 
proline-rich sequences, followed by an inter-SH2 region that is sandwiched between 
two SH2 domains. The association of p85 with pi 10 occurs via the inter-SH2 region. 
In mouse 3T3-L1 adipocytes, insulin-stimulated PI 3-K activity is observed in p85a 
immunoprecipitates, but not in those of p85P; also, the latter is not detected by 
immunoblotting (Baltensperger et al., 1994).
The lipid kinase activity of PI 3-K leads to the phosphorylation of 
phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PI 4-P) and 
phosphatidylinositol 4,5-bisphosphate (PI 4 ,5 -P2) to form phosphatidylinositol 3- 
phosphate (PI 3-P), phosphatidylinositol 3,4-bisphosphate (PI 3 ,4 -P2) and 
phosphatidylinositol 3,4,5-trisphosphate (PI 3 ,4 ,5 -P3) respectively, as determined with 
p85 immunoprecipitates from rat adipocytes (Kelly and Ruderman, 1993). However,
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extracted lipids from rat adipocytes show that only PI 3 ,4 -P2 and PI 3 ,4 ,5 -P3 levels are 
elevated following insulin stimulation (Kelly and Ruderman, 1993).
Two inhibitors of PI 3-K have been used to determine the role of the kinase in insulin- 
stimulated glucose uptake: wortmannin and LY294002. Wortmannin is a membrane 
permeable fungal metabolite that inhibits the kinase activity of PI 3-K at nanomolar 
concentrations (IC50 -3 nM) by binding non-competitively and irreversibly to p i 10 (Ui 
et al., 1995). It is a relatively specific inhibitor, as it can block other kinases at 
concentrations greater than 1 pM (Ui et al., 1995). Clarke et al. (1994) demonstrated 
that the stimulation of glucose uptake by 100 nM insulin in 3T3-L1 adipocytes can be 
inhibited by wortmannin in a dose-dependent manner. Insulin-stimulated transport 
activity is reduced to basal levels with 1 pM wortmannin. The observed lack of 
transport activity is due to the inhibition of the translocation of GLUT1 and GLUT4 to 
the plasma membrane, as determined by ATB-BMPA photolabelling of cell surface 
transporters. In further experiments, the loss of cell surface transporters following the 
addition of wortmannin to insulin-stimulated 3T3-L1 adipocytes was determined by 
ATB-BMPA photolabelling (Yang et al., 1996). Estimation of the rate constants for 
the endocytosis and exocytosis of transporters revealed that wortmannin blocks the 
exocytotic pathway. LY294002 is another membrane permeable compound; it is a 
specific competitive inhibitor at the ATP-binding site of PI 3-K (IC50 ~1.4 pM) 
(Vlahos et al., 1994). Pre-treatment of 3T3-L1 adipocytes with this compound (100 
pM) prior to 100 nM insulin stimulation blocks the increase in glucose uptake. 
Further, this correlates with an absence of GLUT4 at the cell surface (Cheatham et al., 
1994).
An alternative method to block PI 3-K activity has been the transient expression by 
adenovirus of dominant negative p85a in 3T3-L1 adipocytes (Katagiri et al., 1997). 
Insulin action was affected in three ways. First, maximal insulin-stimulated PI 3-K 
activity in anti-phosphotyrosine immunoprecipitates was reduced to 6%. Second, 
maximal insulin-stimulated 2-deoxy-D-glucose transport was decreased to 27%. 
Third, insulin-stimulated GLUT4 translocation was blocked, as determined by
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immunoblotting of subcellular fractions. Thus, the data supports a role for PI 3-K in 
insulin-stimulated GLUT4 translocation.
To show that PI 3-K is required for insulin-stimulated GLUT4 translocation, it is also 
necessary to demonstrate that the activation of the kinase is sufficient for this process. 
Several groups have expressed a constitutively active form of pi 10 in 3T3-L1 
adipocytes: this was either pi 10 with the inter-SH2 region fused to the N-terminus 
(Martin et al., 1996) or pi 10 that was co-expressed with the inter-SH2 region (Frevert 
and Kahn, 1997). For the former, immunofluorescence microscopy of microinjected 
cells showed cell surface GLUT4 that was 75% of that in non-injected insulin- 
stimulated cells. For the latter, immunoblotting of membrane fractions from 
adenovirus-infected cells showed that there was a 3-fold increase in cell surface 
GLUT4 over that in control infected basal cells. However, this increase was less than 
the 4-fold increase upon insulin stimulation of control and experimental cells.
An explanation for the lack of maximal GLUT4 translocation in 3T3-L1 adipocytes 
expressing constitutively active pi 1 0  may be that the construct is not properly targeted 
to a membrane site (Klippel et al., 1996). In their studies, the transient expression of 
constitutively active PI 3-K (pi 10 with an N-terminal inter-SH2 region) in COS-7 
cells stimulated downstream PKB activity by 4-fold. However, the addition of either 
an N-terminal myristoylation sequence or a C-terminal famesylation sequence to the 
constitutively active kinase had two effects. First, the construct was located mainly in 
the membrane fractions. Second, the construct stimulated a greater fold-increase in 
PKB activity (7-20-fold). Thus, it is possible that the expression of membrane- 
localized constitutively active PI 3-K in 3T3-L1 adipocytes could stimulate maximal 
GLUT4 translocation.
The importance of membrane localization of PI 3-K activity was suggested by Ricort 
et al. (1996) and Nave et al. (1996a). Though both platelet-derived growth factor 
(PDGF) and insulin stimulation of 3T3-L1 adipocytes increase PI 3-K activity in anti- 
phosphotyrosine immunoprecipitates (50- and 17-fold respectively), insulin exerts a 
greater effect on glucose uptake (11-fold compared with 2-fold) than PDGF.
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Moreover, PDGF has no effect on GLUT4 translocation. Subcellular fractionation 
reveals that PDGF has a greater effect than insulin on PI 3-K activity in anti- 
phosphotyrosine immunoprecipitates from the plasma membrane (37-fold versus 7- 
fold). However, this situation is reversed for activity determined in the microsomal 
membrane fraction: 4.6-fold versus 2.3-fold. The basis of the different effects of 
insulin and PDGF stimulation was demonstrated by immunoblotting studies. First, 
insulin stimulation leads to the appearance of phosphorylated IRS-1 predominantly in 
the LDM, whereas phosphorylated PDGF receptor is present mainly in the plasma 
membrane. Second, insulin exerts a greater translocation of p85 to the LDM than 
PDGF, whereas the opposite is true for the plasma membrane. Thus, it appears that 
insulin, and not PDGF, is able to induce GLUT4 translocation because it can elevate 
PI 3-K activity in the microsomal membranes. The idea that PI 3-K acts at an 
intracellular membrane site is supported by Heller-Harrison et al. (1996). 
Immunoadsorbed GLUT4 vesicles from the LDM of 3T3-L1 adipocytes were found to 
be associated with IRS-1 immunoprecipitates that demonstrated an increase in PI 3-K 
activity upon insulin stimulation.
Investigations have also been undertaken to determine if IRS-1 is required for the 
regulation of glucose uptake by insulin-activated PI 3-K. One approach has been the 
generation of transgenic mice lacking the gene for IRS-1 (Tamemoto et al. and Araki 
et al., 1994). Insulin resistance is evident, as the injection of insulin does not produce 
as great a drop in blood glucose as that seen in control mice. Also, insulin-stimulated 
glucose uptake is impaired in adipocytes isolated from the transgenic mice. However, 
blood glucose levels are normal and insulin-activated PI 3-K activity can be measured 
in anti-phosphotyrosine immunoprecipitates, later shown to be due to IRS-2 (Patti et 
al., 1995). Thus, IRS-1 independent pathways are capable of regulating insulin- 
stimulated glucose uptake. A role for IRS-2 as the alternative insulin receptor 
substrate was also observed in adipocytes from patients with NIDDM (Rondinone et 
al., 1997). Compared with control subjects, immunoblotting revealed a reduction of 
IRS-1 by 50-90%, with no changes in the level of IRS-2. Again, PI 3-K activity was 
found to be associated with tyrosine-phosphorylated IRS-2. In non-diabetic subjects, 
immunoblotting of IRS-1 and IRS-2 showed that p85 binds preferentially to the
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former. This is reflected in insulin-stimulated PI 3-K activity, where the activity on 
IRS-1 immunoprecipitates was found to be 70% of that in the sum of both IRS 
immunoprecipitates. Thus, IRS-1 appears to be the major docking protein for PI 3-K.
An alternative approach to determine the role of IRS-1 in the regulation of glucose 
uptake has involved the disruption of the interaction between IRS-1 and the insulin 
receptor (Morris et al., 1996). This was achieved by microinjecting the PTB domain 
of IRS-1 or an NPXY phosphopeptide into 3T3-L1 adipocytes (both to block the 
binding of the IRS-1 PTB domain to the NPXY motif of the insulin receptor). 
Immunofluorescence studies revealed that insulin-stimulated GLUT4 translocation 
was not perturbed. Also, submaximal stimulation of translocation was not affected. 
The viability of this technique was demonstrated by the partial inhibition of other 
insulin-stimulated cellular events: membrane ruffling and mitogenesis. Thus, it was 
concluded that an IRS-1 independent pathway can regulate glucose transport. 
Assuming that IRS-2 phosphorylation is perturbed as well, since it also has a PTB 
domain, a possibility is that PI 3-K activation can occur directly via the association of 
p85 with the insulin receptor. In binding studies with GST fusion proteins of the N- 
terminal SH2 domain of p85, interaction with the insulin receptor was disrupted if a 
C-terminal insulin receptor peptide containing the YTHM motif (tyr-1322) was also 
present, indicating interaction via this sequence (Staubs et al., 1994). Further, activity 
in p85 immunoprecipitates could be increased if they were incubated with insulin- 
stimulated partially purified insulin receptor. However, this was not observed if the 
C-terminal (containing the Y(1322)THM motif) was deleted, thus indicating 
activation of PI 3-K via phosphorylated tyr-1322 of the insulin receptor (Van Horn et 
al., 1994).
Taking all these studies into consideration, it appears that PI 3-K is involved in 
insulin-stimulated GLUT4 translocation. Thus, inhibition of the kinase blocks this 
cellular effect. However, the expression of constitutively active PI 3-K leads to 
submaximal GLUT4 translocation. Thus, it is possible that other pathways are also 
involved in this process. However, the role of IRS-1 is unclear. Though PI 3-K 
signalling and increased glucose uptake occur in its absence, a role for IRS-1 under
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normal conditions cannot be ruled out, since other pathways may be able to 
compensate for IRS-1 deficiency. Further, the nature of the IRS-1 independent 
pathway(s) need to be determined. Thus, it would be interesting to investigate the 
effects of IRS-2 deficiency or mutation of the Y(1322)THM motif, or combinations of 
these with IRS-1 deficiency.
1.3.3.2 Ras
The activation of Ras by the insulin receptor initiates a signalling pathway consisting 
of Raf, mitogen-activated-protein kinase kinase (MAPKK), mitogen-activated-protein
r c Vkinase (MAPK) and 90 kDa ribosomal S6  kinase (pp90 ), where each component is 
activated by the preceding one (reviewed by Denton and Tavare, 1995). As insulin 
stimulation leads to activation of these proteins, several groups have investigated their 
roles in the regulation of glucose uptake. The role of Ras in insulin-stimulated 
glucose transport was determined by the microinjection of constitutively active and 
dominant inhibitory forms of the protein into 3T3-L1 adipocytes (Hausdorff et al.,
1994). Cell surface transporters were then quantitated by immunofluorescence 
microscopy. While the former mimics the effects of chronic (20 hour) insulin 
treatment by elevating the expression of cell surface GLUT1, the latter blocks insulin 
stimulation of this response. However, for acute (15 min) insulin treatment, neither 
construct affects basal and insulin-stimulated levels of cell surface GLUT4. Thus, 
Ras appears to be involved in regulating GLUT1 expression, but not GLUT4 
translocation.
An activated form of Raf also appears to have the same effects as those of Ras (Fingar 
and Bimbaum, 1994a). Constitutively active Raf was expressed in 3T3-L1 
adipocytes. While total cellular GLUT1 levels were increased, those of GLUT4 were 
unchanged. Further, immunofluorescence studies of plasma membrane sheets 
revealed elevated cell surface levels of GLUT1 that could not be further increased 
with chronic insulin treatment. However, acute insulin-stimulated GLUT4 
translocation was found to be unaffected. A potential role for MAPK and pp90rsk was 
also determined by Fingar and Bimbaum (1994b). While the treatment of 3T3-L1
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adipocytes with insulin, epidermal growth factor (EGF) or foetal bovine serum (FBS) 
were found to increase MAPK and pp90rsk activity to a similar extent, only insulin 
was capable of stimulating an increase in glucose transport activity. Similar studies 
by Gould et al. (1994) showed that while EGF, PDGF and insulin could activate 
MAPK, only insulin was able to cause GLUT4 translocation in 3T3-L1 adipocytes, as 
determined by ATB-BMPA photolabelling. Thus, neither activated Raf, MAPK or 
pp90rsk appear to be sufficient for stimulation of GLUT4 translocation.
1.3.4 Downstream of Phosphoinositide 3-Kinase
1.3.4.1 Protein Kinase B
A cDNA clone for a novel serine/threonine kinase was isolated by Jones et al. (1991), 
who termed it rac, and by Coffer and Woodgett (1991), who termed it protein kinase 
B (PKB). It was also identified as the cellular homologue of v-akt, and thus is also 
known as Akt (Bellacosa et al., 1991). Human PKB is a polypeptide of 480 residues 
(molecular weight -55.7 kDa) with a C-terminal catalytic domain that is 73% and 
6 8 % similar to those of PKC and cAMP-dependent protein kinase (Jones et al., 1991). 
A PH domain at the N-terminus is also present (Musacchio et al., 1993). PKB was 
later renamed PKBa due to the discovery of two other isoforms, PKBp (Cheng et al., 
1992) and PKBy (Konishi et al., 1995). Human PKBp is 481 residues long and 91% 
homologous to PKBa, whereas PKBy is 454 residues long. Though there are three 
identified isoforms of PKB, most studies have focused on the a-isoform only. The 
insulin stimulation of PKB activity was first described by Kohn et al. (1995). In 
insulin receptor-overexpressing CHO cells that are transiently transfected with PKBa 
cDNA, the insulin-stimulated increase in activity is 12-fold. Further, activation 
appears to occur via PI 3-K: wortmannin inhibits insulin-stimulated activity in vivo, 
but not in vitro (Kohn et al., 1995).
PKB has been implicated in the regulation of two kinases. The first is 70 kDa 
ribosomal S6  kinase (pp70S6k). The expression of a constitutively active form of
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PKBa in Rat-1 fibroblasts was found to increase pp70S6k phosphorylation and activity 
(Burgering and Coffer, 1995). The second PKB-regulated kinase is glycogen synthase 
kinase-3 (GSK-3). Immunoprecipitated PKBa from insulin-stimulated L6  myotubes 
was found to be able to phosphorylate and inactivate GSK-3 in vitro (Cross et al.,
1995). Subsequent PKB assays have utilized a peptide based on the phosphorylation 
sequence from GSK-3, termed Crosstide (GRPRTSSFAEG) (Cross et al., 1995).
A role for PKB in stimulating glucose uptake was indicated by Kohn et al. (1996b), 
using 3T3-L1 adipocytes expressing a constitutively active form of PKBa. The PKBa 
construct was a PH domain deletion mutant with an N-terminal src myristoylation 
signal sequence. As a control, there was a point mutation in the signal sequence. 
Retroviral infection of fibroblasts with the construct allows the cells to spontaneously 
differentiate into adipocytes. Basal glucose transport activity was found to be 70% of 
that in insulin-stimulated cells. The cause of this was attributed to GLUT1 and 
GLUT4. First, immunoblotting revealed increased GLUT1 expression (55%) 
compared with control cells, but no change in GLUT4 levels. Second, cell surface 
GLUT4 (as determined by immunofluorescence microscopy of plasma membrane 
sheets and by anti-myc antibody binding of epitope-tagged GLUT4) was found to be 
indistinguishable between the basal and insulin-stimulated state. However, only the 
long-term effects of PKB activation are represented here: it remains to be seen 
whether PKB is sufficient for acute stimulation of glucose uptake. Further, it needs to 
be established whether PKB is necessary for insulin stimulation of glucose transport.
1.3.4.2 pp70S6k
The identification of pp70S6k as a target for PI 3-K was described by Chung et al.
(1994). In HepG2 cells, the stimulation of PI 3-K and pp70S6k activity by PDGF are 
both inhibited by wortmannin with a similar IC50. Since wortmannin does not inhibit 
pp70S6k activity in vitro, this therefore indicates that the kinase is downstream of PI 3- 
K. Chung et al. (1994) also demonstrated that the activation of pp70S6k can be 
inhibited by the drug rapamycin, which itself does not inhibit PI 3-K activity.
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The elevation of pp70S6k activity in response to insulin stimulation of 3T3-L1 
adipocytes was demonstrated by Fingar et al. (1993). They found that while pre­
incubation of cells with rapamycin before insulin treatment inhibited this rise in 
activity, there was no effect of the inhibitor on the translocation of GLUT1 and 
GLUT4 as determined by immunofluorescence microscopy of plasma membrane 
sheets. Thus, pp70S6k does not appear to be required for insulin-stimulated glucose 
uptake.
1.3.5 Potential Regulators of Glucose Transport
1.3.5.1 Protein Kinase C
The involvement of PKC in the regulation of GLUT4 translocation has been 
investigated using the phorbol ester, phorbol 12-myristate 13-acetate (PMA), a known 
stimulator of PKC activity (Holman et al., 1990). Treatment of rat adipocytes with 
this compound raises cell surface levels of GLUT1 and GLUT4 by 5.7- and 4-fold 
respectively. Though the translocation of GLUT1 is comparable to that seen with 
insulin treatment, the same cannot be said for GLUT4, where the insulin-stimulated 
increase in cell surface levels is 15-20-fold. A similar observation was made in 3T3- 
L1 adipocytes, in which PMA-stimulated cell surface GLUT1 and GLUT4 levels are 
40% and 10% respectively of that following insulin stimulation (Gibbs et al., 1991). 
Further, down-regulation of PKC by chronic treatment of 3T3-L1 adipocytes with 
PMA prevents elevation of glucose transport by acute and chronic PMA stimulation, 
but does not inhibit that by insulin stimulation (Gibbs et al., 1991). Thus, PMA- 
sensitive PKC appears to be neither sufficient nor necessary for insulin-stimulated 
GLUT4 translocation. However, a role for PKC cannot be entirely ruled out, as PMA 
appears to activate PKC differently from insulin stimulation (Farese et al., 1992). In 
immunoblotting studies of cytosolic and total membrane fractions from rat adipocytes, 
PMA and insulin treatment were found to stimulate the translocation of PKC isoforms 
to different extents. For example, while insulin stimulates the rapid tranlocation of 
PKCp to the plasma membrane, PMA does not.
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Nave et al. (1996b) demonstrated that insulin and PMA stimulation are both able to 
increase levels of PI 3 ,4 ,5 -P3 in 3T3-L1 adipocytes. They observed that the fold- 
increase in phospholipid by either compound correlated with the observed fold- 
increase in glucose transport. Further, wortmannin was found to block the stimulatory 
action of both insulin and PMA on PI 3 ,4 ,5 -P3 production and glucose uptake. Gibbs 
et al. (1991) showed that the effects of PMA on glucose transport are not additive 
with maximal stimulatory concentrations of insulin, though an additive effect occurs 
at lower insulin doses. Thus, both studies are consistent with the idea that the PMA- 
stimulated pathway converges with that from the insulin receptor via the production of 
PI 3 ,4 ,5 -P3 . However, factors other than the production of this phospholipid must be 
required for GLUT4 translocation, since PMA stimulation only gives an insulin-like 
response in terms of GLUT1 translocation (Holman et al., 1990).
Phorbol ester-insensitive PKC<^  has been shown to be activated by PI 3 ,4 ,5 -P3 in vitro 
(Nakanishi et al., 1993), thus indicating regulation by PI 3-K. Farese et al. (1992) 
immunoblotted cytosolic and membrane fractions from rat adipocytes and found that 
insulin stimulation decreases cytosolic levels of PKC£, while increasing those in the 
total membrane fraction. Although similar experiments by Frevert and Kahn (1996) 
were unable to show insulin-stimulated translocation of PKC^, they did demonstrate 
that the isoform is present in the LDM fraction, unlike the phorbol ester-sensitive 
isoforms. To determine a role for PKC<£ in the regulation of glucose transport, the 
enzyme was stably transfected into 3T3-L1 adipocytes (Bandyopadhyay et al., 1997). 
Their findings were as follows. Overexpression of wild-type PKC^ by 2-fold also 
doubled basal glucose uptake, but was without an additive effect on the 7-fold 
response seen in insulin-stimulated control transfected cells. Similar overexpression 
of dominant negative PKC£ had no effect on basal glucose uptake, though it did 
attenuate the insulin-stimulated response (a 4-fold maximum response was observed). 
There was no change in the expression of total cellular GLUT1 and GLUT4, while 
immunoblotting of subcellular fractions revealed translocation of both isoforms in 
cells overexpressing PKC£. Thus, PKC£ is a putative component of the insulin 
signalling pathway that regulates glucose transport.
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1.3.5.2 Protein Phosphatases 1 and 2A
A role for PP1 and PP2A in the regulation of glucose transport was first suggested by 
Haystead et al. (1989), from studies with the specific inhibitor okadaic acid. This 
compound was shown to increase the phosphorylation state of many cellular proteins 
in hepatocytes and adipocytes. They observed that the treatment of rat adipocytes 
with 1 pM okadaic acid increased uptake of 2-deoxy-D-glucose, though with a 5 min 
time lag that was not observed with insulin stimulation. The effects of okadaic acid 
on glucose transport were further investigated by Lawrence et al. (1990). Rat 
adipocytes were maximally stimulated with either insulin or okadaic acid prior to the 
measurement of 2-deoxy-D-glucose uptake. The former elicited an 8 -fold response, 
whereas the response induced by the latter was 4-fold. However, treatment with both 
agents led to a submaximal insulin response (5-fold). The cause of this effect was 
investigated by Corvera et al. (1991). They found that while okadaic acid and insulin 
both elevated 3-0-methyl-D-glucose transport and cell surface levels of GLUT4, the 
rate of glucose uptake induced by the former appeared to be lower than expected for 
the number of transporters present. Further, while the addition of okadaic acid to 
insulin-stimulated cells led to a reduction in 3-0-methyl-D-glucose transport, this was 
not associated with a significant decrease in cell surface GLUT4. Thus, it was 
suggested that okadaic acid both stimulates GLUT4 translocation and causes a 
reduction in its intrinsic activity.
PP1 and PP2A are not specific for a particular protein. As such, the sites of action for 
okadaic acid are likely to be located at different points in the insulin signalling 
pathway. The effect of okadaic acid on PI 3-K activity in 3T3-L1 adipocytes and 
muscle was determined by Jullien et al. (1993). While okadaic acid treatment of 3T3- 
L1 adipocyes and muscle has no effect on PI 3-K activity in anti-phosphotyrosine 
immunoprecipitates, it does however attenuate the increase observed with insulin 
stimulation. Further experiments revealed that while okadaic acid does not affect 
insulin-induced receptor autophosphorylation, it does block the subsequent step of 
tyrosine phosphorylation of IRS-1. Thus, inhibition of PI 3-K activation may account, 
at least partly, for the attenuation of insulin-stimulated glucose uptake by okadaic
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acid. Further, okadaic acid stimulation of glucose transport is also likely to occur via 
action at sites downstream of PI 3-K.
1.3.5.3 G Proteins
A role for G proteins in the regulation of glucose uptake can be demonstrated by using 
the non-hydrolyzable GTP analogue, GTPyS (Clarke et al., 1994). Its introduction 
into permeabilized 3T3-L1 adipocytes increases glucose uptake levels. Further, when 
insulin-treated cells are incubated with wortmannin, a stimulated response is observed 
if GTPyS is still present, indicating that G proteins may be acting downstream of PI 3- 
K, or via a different pathway. Further, a role for G proteins in the exocytosis and 
endocytosis of GLUT4 vesicles in rat adipocytes was demonstrated by Shibata et al. 
(1995). If the internalization of GLUT4 is blocked by treatment with a major 
histocompatibility complex class I-derived peptide, GTPyS is still able to stimulate 
translocation of transporters to the plasma membrane, indicating a role for G proteins 
in the exocytosis of GLUT4. The endocytosis of GLUT4 was determined by 
maximally stimulating adipocytes with insulin before ATP-deprivation with 
potassium cyanide and trypsin treatment. The internalization of trypsin-cleaved 
GLUT4 is blocked if GTPyS is present. Also, if insulin stimulation of adipocytes is 
reversed, the rate of decline of transport activity is increased if GTP is present and is 
decreased if GDPpS is present. Thus, it appears that GTP hydrolysis is involved in 
the endocytosis of GLUT4 vesicles.
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1.4 T he PH D om ain and the PTB Dom ain
1.4.1 Structure and Function of the PH Domain
The PH domain is so-called because it was first identified in pleckstrin, a substrate of 
PKC in platelets. It has subsequently been detected in other proteins, including IRS-1 
and PKB (Musacchio et al., 1993). The structures of the PH domains for p-spectrin 
and pleckstrin have been determined (reviewed by Gibson et al., 1994) (Figure 1.4.1). 
The domain consists of an anti-parallel p-sheet made up of seven strands (forming a 
p-barrel), followed by a long a-helix at the C-terminal end. The first four P-strands 
form a sheet that is at an angle to the sheet formed by the last three p-strands. The PH 
domains of different proteins vary in the length of the loops between the strands of the 
p-sheet. A cleft is present in the domain, bounded by P-strands b, c and d (the strands 
are named from a to g). A cluster of positive charges is associated with this cleft (due 
to loops a-b and e-f): this may be of functional importance, as it is conserved in many 
PH domains.
Figure 1.4.1. Structure of the p-spectrin PH Domain (Gibson et al., 1994).
The (3-strands are labelled (from the N-terminus) from a to g.
Three ligands have been shown to bind to the PH domain. The first is PI 4,5-P2 
(Harlan et al., 1994). By using a centrifugation assay, it was found that vesicles
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containing PI 4 ,5 -P2 were able to bind - in a concentration dependent manner - to the 
PH domain of the different proteins tested, which included those of pleckstrin and p- 
adrenergic receptor kinase (p-Ark). NMR studies indicated that PI 4 ,5 -P2 binds to the 
N-terminal half of the PH domain, involving residues found in loop a-b and p-strands 
c and d. As these residues include several positively charged lysines, it was suggested 
that they bind to the negatively charged phosphates of PI 4 ,5 -P2 . However, the 
hydrophobic core of the P-barrel does not appear to be able to bind to the fatty acid 
chains of PI 4 ,5 -P2 . It is likely that the affinity of the PH domain for PI 4 ,5 -P2 will 
vary between proteins. The dissociation constant (K<i) for the binding of PI 4 ,5 -P2 to 
the pleckstrin PH domain is 30 pM (Harlan et al., 1994), whereas it is 1.7 pM for the 
PH domain from phospholipase C (PLC) 8 i (Lemmon et al., 1995). Also, inositol
1.4.5-trisphosphate (Ins 1,4,5-Pa) binds to the PLC 8 i PH domain with a lower K<j of 
210 nM (Lemmon et al., 1995). It is also likely that PH domains from different 
proteins are specific for particular phosphoinositides. Freeh et al. (1997) were able to 
demonstrate the association of PI 3 ,4 -P2 and PI 3 ,4 ,5 -P3 with the PH domain of 
PKBa, with K<j values of 570 and 400 nM respectively. Since PI 4 ,5 -P2 was found to 
bind with a K<j of 2.5 pM, it appears that PKBa has a preference for PI 3 ,4 -P2 and PI
3.4.5-P3.
A second potential ligand for the PH domain is the py subunit of trimeric G proteins 
(Gpy) (Touhara et al., 1994). In their study, GST fusion proteins were produced, with 
sequences for PH domains from several proteins (including IRSI and p-Ark). From 
direct Gpy binding assays, it was found that all of the PH domains tested could bind to 
GPy, but to varying extents. The presence of Ga inhibits this interaction, 
demonstrating that the same site on GPy is responsible for binding the PH domain or 
Ga. By using GST fusion proteins that contained different sections of the PH domain, 
it was found that the portion of the PH domain that binds to Gpy is the C-terminal 
region (corresponding to p-strands d-g and the a-helix) plus sequences distal to it.
The third potential PH domain-binding protein is PKC. The association of the PH 
domain of PKB with three PKC isoforms (a, 8  and Q was identified by Konishi et al. 
(1995). GST fusion proteins of the PKB PH domain were immobilized on glutathione
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sepharose beads and incubated with cell lysate from COS-7 cells expressing one of the 
three PKC isoforms. Binding was detected by immunoblotting with isoform-specific 
antibodies. However, the functional significance of the interaction between the two 
kinases is unclear, as no changes in the enzyme activity of PKB were observed upon 
binding of PKC.
From an examination of the nature of the ligands that bind the PH domain, it is 
possible to suggest that the domain may enable a protein to associate with membranes. 
This has been shown to be the case for PLC §1 (Paterson et al., 1995), which has an 
N-terminal PH domain. Constructs of this enzyme were microinjected into Madin 
Darby canine kidney cells, with the subcellular distribution determined by 
immunofluorescence microscopy. Deletion mutants that lacked the PH domain were 
found to be present only in the cytoplasm, unlike the full length and N-terminal 
constructs, which were membrane-bound. Concomitant studies showed that the 
deletion mutants lacking the the proposed PI 4 ,5 -P2 binding site of the PH domain 
were also unable to bind Ins 1 ,4 ,5 -P3 (the polar head group of PI 4 ,5 -P2), implying that 
membrane interaction is via this phospholipid. Another possible method of 
membrane binding is via GPy (reviewed by Inglese et al., 1995). The enzyme P-Ark 
down-regulates G-protein-coupled receptors (GPCR) by phosphorylating them. 
Association of p-Ark with the plasma membrane occurs when the GPCR effects the 
dissociation of trimeric G proteins into Ga and GPy. The enzyme is then able to bind 
to Gpy, and is thereby localized near its substrate. The region of p-Ark which 
interacts with GPy includes the PH domain.
1.4.2 Structure of the PTB Domain
The crystal structure of the IRS-1 PTB domain is similar to that of the PH domain 
(Eck et al., 1996). Thus, it consists of a seven-stranded p-sandwich (one face formed 
by the first four p-strands in an anti-parallel p-sheet) followed by a C-terminal a- 
helix. Unlike the PH domain, the cluster of positive charges that bind inositol 
phosphates is absent. All nine residues of the insulin receptor peptide LYASSNPAY
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bind to the PTB domain via hydrogen bonds and hydrophobic interactions. The first 
five residues of the peptide form an anti-parallel p-strand with the domain.
1.4.3 Function of the N-terminal Domains of the IRS Proteins
A role for the PH domain of IRS-1 in coupling the protein to the insulin receptor was 
first described by Myers Jr. et al. (1995). Rat IRS-1 was expressed in 32D cells, 
which lack endogenous IRS proteins. The deletion of the PH domain (residues 13- 
115) virtually inhibited insulin-stimulated tyrosine phosphorylation of IRS-1. 
However, overexpression of the insulin receptor prevented this from occurring. The 
nature of the interaction between the IRS-1 PH domain and the insulin receptor is 
unclear, as binding of the latter to a GST fusion protein of the former could not be 
achieved. The findings by Myers Jr. et al. (1995) were supported by Voliovitch et at.
(1995). In their study, the N-terminal 61-residues of the PH domain in IRS-1 were 
deleted. The construct was transiently expressed in COS-7 cells along with the insulin 
receptor. Anti-phosphotyrosine immunoblotting showed that insulin-stimulated 
phosphorylation of the deletion mutant was significantly reduced, compared with that 
observed for full-length IRS-1. The data by Voliovitch et ol. (1995) also suggest that 
the IRS-1 PH domain interacts with a phospholipid, since only the N-terminal residues 
of the PH domain were deleted in their study. This region of the PH domain has been 
shown to be involved in PI 4 ,5 -P2 binding (Harlan et al., 1994).
However, a direct interaction between the insulin receptor and IRS-1 has been located 
at the PTB domain (Wolf et al., 1995). A GST fusion protein of human IRS-1 PTB 
domain (residues 144-316) was able to precipitate phosphorylated purified insulin 
receptor. This interaction was inhibited if tyr-960 of the receptor was mutated to 
phenylalanine, or if an insulin receptor phosphopeptide with the NPXY motif 
(containing tyr-960) was present. Further, phosphopeptide binding studies revealed 
the importance of hydrophobic residues at positions 6 , 7 and 8 , N-terminal to tyr-960. 
For IRS-2, another domain, in addition to the PTB domain, was found to interact with 
the insulin receptor (Sawka-Verhelle et al., 1996). Using the yeast two-hybrid system,
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an association between murine IRS-2 PTB domain (191-350) and the insulin receptor 
was detected, but not if tyr-960 was mutated to phenylalanine. However, an 
interaction between full length IRS-2 and the same mutant insulin receptor was also 
observed. The sequence responsible was located to residues 591-786. Further, it was 
found that tyr-1146, -1150 and -1151 of the insulin receptor were required, as the 
mutation of any of these residues to phenylalanine inhibited binding of the domain.
The role of the PTB domain in receptor-mediated phosphorylation of IRS-1 was 
investigated by Yenush et al. (1996) in 32D cells expressing IRS proteins. Unlike 
IRS-1 constructs lacking the PH domain, the deletion of the PTB domain did not 
affect maximum insulin stimulation of IRS-1 tyrosine phophorylation. However, at 
lower insulin doses, IRS-1 phosphorylation of the construct was affected. When the 
insulin receptor was overexpressed, only the phosphorylation of IRS-1 lacking both 
domains was found to be affected at all insulin concentrations. However, the absence 
of either domain did not perturb IRS-1 phosphorylation. In similar studies (Backer et 
al., 1997), where the insulin receptor and IRS-1 were co-expressed (5:1) in CHO cells, 
mutation of tyr-960 to alanine in the insulin receptor did not affect IRS-1 tyrosine 
phosphorylation. Further, in vitro studies revealed that whilst the solubilized form of 
the same mutant receptor bound similarly to IRS-1 as the wild-type, the deletion of the 
PH domain virtually blocked association of IRS-1 with the insulin receptor.
From the available data, it appears that the PH domain is more sensitive than the PTB 
domain in terms of coupling IRS-1 to the insulin receptor. However, both domains 
are required for full IRS-1 phosphorylation to occur. Despite the greater importance 
of the PH domain, the mechanism of its function has not yet been determined.
1.4.4 Role of the PH Domain in the Activation of PKB
The activation of PKB appears to occur via two mechanisms. The first involves the 
binding of PI 3 ,4 -P2 to the N-terminal PH domain (Franke et al., 1997). In CHO cells 
expressing hemagglutinin epitope-tagged PKBa, the immunoprecipitated activity
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increases if the cells are treated with either PDGF or PI 3 ,4 -P2- This effect is not 
observed if the PKBa constructs have a point or partial deletion mutation of the PH 
domain. The second activation mechanism involves the phosphorylation of PKB 
(Kohn et al., 1995). Kinase activity was measured in insulin receptor-overexpressing 
CHO cells that transiently express PKBa. Alkaline phosphatase treatment of 
immunoprecipitates from stimulated cells was found to reduce PKB activity to basal 
levels. It is likely that the PH domain is responsible for membrane localization of 
PKB in order to facilitate its activation by a regulatory kinase (Kohn et al., 1996a). A 
construct of PKBa lacking the PH domain, but with a src myristoylation signal 
sequence fused to the N-terminus, is constitutively active when expressed in CHO 
cells. This is due to a higher phosphorylated state. A possibility is that the generation 
of PI 3 ,4 -P2 by PI 3-K provides the signal for the membrane association of PKB. This 
idea is consistent with the observation that the expression of constitutively active PI 3- 
K leads to continuous activation of PKB (Didichenko et al., 1996). Also, it is likely 
that phosphorylation is the major mechanism for the direct activation of PKB, as 
dephosphorylation of the constitutively active PKBa construct with phosphatase 
inhibitors reduces activity by 76% (Kohn et al., 1996a). Further, stimulation of 
purified hemagglutinin epitope-tagged PKBa from unstimulated COS-1 cells with PI 
3 ,4 -P2 leads to a 2.5-fold increase in activity, whereas the activity in 
immunoprecipitates from stimulated cells is about 19-fold over basal levels (Freeh et 
al., 1997). Thus, the phospholipid cannot fully activate PKB activity on its own.
The phosphorylation sites on PKBa were identified as two residues: ser-473 and thr- 
308 (Alessi et al., 1996). For hemagglutinin-tagged constructs expressed in 293 cells, 
the mutation of thr-308 to alanine leads to inhibition of the insulin-stimulated increase 
in activity. For a similar mutation of ser-473, 15% of the insulin-induced response 
occurs. This indicates that the phosphorylation of both residues are required for the 
synergistic and full activation of PKB. An upstream kinase for PKB phosphorylation 
was identified by Alessi et al. (1997), and termed PI 3 ,4 ,5 -P3-dependent protein 
kinase-1 (PDK-1) based on its requirement for the phospholipid in in vitro kinase 
assays with PKB as the substrate. Phosphorylation was found to be at only thr-308 of 
PKBa. The dephosphorylation of PKB may occur via PP2A, as immunoprecipitates
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of PKB from stimulated Swiss 3T3 cells can be inactivated by treatment with the 
phosphatase (Andjelkovic et a l 1996).
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1.5 Insulin Resistance
NIDDM is characterized by two defects (Kahn, 1994). The first is insulin resistance, 
where the hormone is unable to fully effect glucose disposal. Thus, there is a defect in 
insulin-stimulated glucose uptake and insulin-inhibited glucose production in the 
liver. The second is relative insulin deficiency, where the pancreas is unable to 
produce enough insulin to compensate for this resistance. The development of 
NIDDM is caused by a combination of genetic and environmental factors (Kahn, 
1994). Studies in subjects of parents with NIDDM demonstrate that low insulin 
sensitivty is inherited, and that this factor precedes and predicts the development of 
NIDDM. A reduction in insulin sensitivity leading to NIDDM can also be caused by 
obesity. Further, this factor has a greater effect on subjects with diabetic parents.
Since insulin resistance is associated with the onset of NIDDM, it is likely that a 
defect (or defects) in the pathway from the insulin receptor to the glucose transporter 
is (or are) responsible for the disease. Though some defective genes have been 
identified, such as that for the insulin receptor, these do not account for the majority of 
cases of NIDDM (Kahn, 1994). Thus, a common defective gene for NIDDM has not 
been discovered. One approach to determine defects in insulin action is in models of 
insulin resistance. One such model is adipocytes made insulin resistant by chronic 
treatment with insulin (see below). This model is useful since it is comparable to the 
pre-diabetic state of NIDDM patients, in which insulin resistance is associated with 
hyper-insulinaemia. Though this model may not represent the genetic cause of 
NIDDM, it does however enable identification of factors that may be involved in 
insulin-regulated glucose uptake.
1.5.1 Insulin Resistance Induced by Chronic Treatment of 
Adipocytes with Insulin
Chronic treatment of 3T3-L1 adipocytes with insulin induces a state of insulin 
resistance (Kozka et al., 1991). Following a 24 h 500 nM insulin treatment, total
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cellular GLUT1 increases 6 -fold, whereas GLUT4 levels rise only 1.4-fold. ATB- 
BMPA photolabelling of cell surface transporters demonstrates that levels of GLUT1 
increase by 4-fold over those in acute (30 min) insulin-stimulated cells, whereas for 
GLUT4, levels are about half of the maximum response. This down-regulation of cell 
surface GLUT4 is associated with resistance to further insulin stimulation. Thus, an 
acute insulin treatment of washed cells (previously chronically insulin-treated) does 
not further increase cell surface GLUT1 and GLUT4.
This state of insulin resistance is not associated with a change in insulin binding 
(Kozka et al., 1991). However, Pryor et al. (1997) have observed a 70% reduction in 
the tyrosine phosphorylation of the insulin receptor following chronic treatment of rat 
adipocytes with insulin, compared with that for acute insulin-stimulated cells. Other 
groups have observed the down-regulation of IRS-1 following chronic treatment of 
3T3-L1 adipocytes with insulin. Immunoblotting studies by Rice et al. (1993) show 
that 24 h 1 pM insulin treatment leads to a virtual absence of IRS-1 (10% of maximum 
levels), while there is a slight increase in p85 (20%). Ricort et al. (1995) determined 
PI 3-K activity in anti-phosphotyrosine immunoprecipitates following 10 h 100 nM 
insulin treatment. They found that activity was 2-fold over basal levels, compared 
with a maximum 60-fold for control acute insulin-stimulated cells. Restimulation 
after washing only produced a maximum response that was 30% of the maximum in 
the control cells. Thus, a factor responsible for the insulin resistance following 
chronic treatment with insulin appears to be down-regulation of IRS-1, which affects 
the downstream signalling of PI 3-K. However, the decreased expression of other 
signalling proteins cannot be ruled out.
The drug metformin has been shown to counteract the insulin resistance that is 
induced by chronic treatment with insulin (Kozka and Holman, 1993). If metformin is 
present during chronic treatment of rat adipocytes with insulin, down-regulation of 
cell surface GLUT4 is prevented. Thus, the proportion of total cellular GLUT4 
present is 60% (compared with 49% for acute insulin-stimulated cells). Further, 
resistance to insulin stimulation is not observed. Thus, if the cells are washed and
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restimulated, resulting levels of cell surface GLUT1 and GLUT4 are comparable to 
those in acute insulin-stimulated cells.
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1.6 Experimental Aims of Work Described in the Thesis
Work has focused on two components of the insulin signalling pathway: the PH 
domain of IRS-1 and PKB. Investigations were undertaken to examine the possibility 
that the PH domain may act to target IRS-1 to a membrane site. IRS-1 PH domain 
was produced using the GST fusion protein system. The construct was introduced 
into permeabilized 3T3-L1 adipocytes to determine if it would affect interactions 
between IRS-1 and the insulin receptor or the LDM. A number of methods have also 
been used to search for a potential protein ligand of the IRS-1 PH domain.
An enzyme assay for PKB was developed. Then, several studies with 3T3-L1 
adipocytes were undertaken to confirm that PKB is downstream of insulin-regulated 
PI 3-K, and also, to determine if PKB may be involved in insulin-stimulated glucose 
uptake. First, the insulin stimulation of PKB activity was measured as a function of 
time and dose. The response observed could then be compared with that for insulin- 
stimulated glucose uptake. Second, the time-course for wortmannin inhibition of 
insulin-stimulated PKB activity was determined, and then compared with that for 
insulin-stimulated glucose uptake. Third, the effects of chronic stimulation of 
adipocytes with insulin on PKB activity was determined, since this treatment regime 
down-regulates cell surface GLUT4. Fourth, the ability of Crosstide to inhibit insulin- 
stimulated glucose uptake was investigated. Studies with 3T3-L1 adipocytes were 
also undertaken to characterize insulin stimulation of PKB activity. First, kinase 
activity was determined in subcellular fractions in order to locate the site of action of 
PKB. Second, okadaic acid was used to determine if PP2A is involved in the 
inactivation of PKB in vivo.
In addition, the ATB-BMPA photolabel was used to quantitate cell surface glucose 
transporters in 3T3-L1 adipocytes expressing constitutively active PKB (Kohn et al., 
1996b). Thus, this would allow an assessment of the relative contributions of GLUT1 






Unless otherwise indicated, general laboratory chemicals and solvents were from
Sigma-Aldrich Company Ltd. (Poole, Dorset), Fisons Scientific UK Ltd.
(Loughborough) or BDH Laboratory Supplies (Merck Ltd., Poole, Dorset).
• Monocomponent porcine insulin was a gift from Dr R. Chance (Lilly Research 
Laboratories, Indianapolis, IN);
• Radiochemicals and ECL Western blotting detection reagents were from 
Amersham International pic (Little Chalfont, Buckinghamshire);
• 2-A-4-(l -azi-2,2,2-trifluoroethyl)benzoyl-1,3-[3H]bis-(D-mannos-4-yloxy)-2- 
propylamine (ATB-[2-3H]BMPA) (« 10 Ci/mmol) was synthesized by 
Professor G.D. Holman (University of Bath, Bath) (Clark and Holman, 1990);
• Crosstide was synthesized by Mrs S. Phillips (University of Bath, Bath) (Cross 
et al., 1995);
• Thesit® (C12E9) was from Boehringer Mannheim UK Ltd. (Lewes, East 
Sussex);
• 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF) was from Calbiochem- 
Novabiochem (UK) Ltd. (Nottingham);
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• Bovine serum albumin (BSA) (Bovuminar Cohn Fraction V) was from 
Intergen Company (Purchase, NY);
• Collagenase was from Worthington Biochemical Corporation (Freehold, NJ);
• Inositol 1,4,5-trisphosphate and okadaic acid were from Alexis Corporation 
(UK) Ltd. (Nottingham).
2.1.2 Antibodies
• Rabbit antisera against GLUT1 and GLUT4 were kindly provided by Dr S.W. 
Cushman (National Institutes of Health, Bethesda, USA); they were raised 
against C-terminal peptides produced in our laboratory (Holman et al., 1990);
• Monoclonal anti-IRS-1 (ID6 ) (Yang et al., 1996) was a gift from Dr M. 
Kasuga (Kobe University School of Medicine, Kobe, Japan);
• Mouse monoclonal anti-phosphotyrosine (clone 4G10) and rabbit polyclonal 
anti-Rac-CT were from Upstate Biotechnology, Inc. (Lake Placid, NY);
• Goat polyclonal anti-Aktl(C-20) was from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA).
2.1.3 Cell Culture
Unless stated otherwise, all cell culture materials were purchased from Sigma.
• The following were purchased from GibcoBRL (Life Technologies, Paisley, 
Renfrewshire): Newborn Calf Serum (NCS); Foetal Bovine Serum (FBS); 
0.25% (w/v) Trypsin (in Gibco solution A - 0.4 g/L KC1, 2.2 g/L NaHCC>3, 6 . 8
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g/L NaCl, 1.0 g/L glucose, 0.005 g/L Phenol Red); Cell Culture Freezing 
Medium (glycerol in DMEM with FBS and NCS); and Nunclon™ A Dishes 
and A Flasks;
• Dulbecco’s Modification of Eagle’s Medium (DMEM) and 0.4% (w/v) Trypan 
Blue solution were from ICN Biomedicals Ltd. (Thame, Oxfordshire);
• Cryogenic vials (2.0 ml) were from Coming Costar Corporation (Cambridge,
MA);
• Universal containers (30 ml) were from Bibby Sterilin Ltd. (Stone,
Staffordshire);
• Phosphate Buffered Saline (PBS) (Dulbecco ‘A’) (0.2 g/L KC1, 0.2 g/L
NaH2P0 4 , 8  g/L NaCl, 1.15 g/L Na2HP0 4 , pH 7.3) was from Oxoid (Unipath 
Ltd., Basingstoke, Hampshire).
2.2 Culture of Adipocyte Cells
2.2.1 Culture of 3T3-L1 Adipocytes
Preparation o f Medium. DMEM (with 4.5 g/1 glucose and without L-glutamine) was 
supplemented with 1% (v/v) L-glutamine (200 mM  in tissue culture grade water), 2% 
(v/v) penicillin-streptomycin solution (5000 units penicillin and 5 mg streptomycin 
per ml in 0.9% (w/v) NaCl), and either 10% (v/v) newborn calf serum or 10% (v/v) 
foetal bovine serum (Myoclone Super Plus) to give DMEM-NCS or DMEM-FBS. 
Sera were heat-inactivated by incubation at 56 °C for 30 min before addition to media.
Culturing Conditions. Media and PBS were pre-warmed to 37 °C before use. Cells 
were grown in an automatic CO2 incubator (LEEC, Nottingham) calibrated for dry
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operation. The temperature was set at 37 °C with CO2 levels at 10%. Dishes of cells 
were stored with 1 0 0  mm dishes of water inside sandwich boxes which were covered 
with a clingfilm lid.
Preparation o f Frozen Stocks o f 3T3-L1 Fibroblasts. 3T3-L1 fibroblasts were 
purchased from American Type Culture Collection (Rockville, MD). Cell number 
was increased by culture in 175 cm flasks (see below) before frozen storage. Pelleted 
cells were resuspended in Cell Culture Freezing Medium (0.5 x 106 cells per 0.5 ml) 
and transferred to cryogenic vials on ice. The cells were slowly cooled above liquid 
nitrogen for 24 h, before eventual storage in liquid nitrogen.
Seeding 3T3-L1 Fibroblasts from Frozen Stocks. The frozen fibroblasts were 
removed from liquid nitrogen storage and rapidly thawed at 37 °C, before addition to 
20 ml DMEM-NCS. The cells were pelleted by spinning at 1500 rpm for 3 min. The 
medium was removed and the cells resuspended in 2 ml DMEM-NCS using a needle 
and syringe (21 g), before transfer to 40 ml DMEM-NCS in a 175 cm2 flask. The 
cells were grown to near-confluence, with medium being replaced every two days.
Harvesting 3T3-L1 Fibroblasts. The subconfluent fibroblasts were washed twice with 
10 ml PBS, before treatment with 4 ml trypsin at 37 °C for 3 min. The cells were 
detached by knocking before dilution with 16 ml DMEM-NCS. The cells were 
pelleted and resuspended as above. Cell number was determined using a 
haemocytometer, where the cells were mixed 1:1 (v/v) with 0.4 % (w/v) Trypan Blue. 
Cells were seeded in 35 mm dishes at a density of 0.05 x 106 cells per 2 ml DMEM- 
NCS per dish. 175 cm2 flasks were seeded with 0.1-0.2 x 106 cells in 40 ml DMEM- 
NCS. Medium was replaced every two days. Cells were passaged 7 times.
Differentiation o f 3T3-L1 Fibroblasts into Adipocytes. Three days after the fibroblasts 
in the 35 mm dishes had grown to confluence, the cells were differentiated into 
adipocytes. DMEM-NCS was replaced with DMEM-FBS containing 0.25 pM 
dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine and 0.2 pM insulin. Two days 
later, the medium was replaced with DMEM-FBS containing 0.2 pM insulin, and
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thereafter every two days with DMEM-FBS. Cells were fully differentiated on day 
nine and were usable until day thirteen.
2.2.2 Isolation and Culture of Rat Adipocytes
Epididymal fat pads were removed from male Wistar rats (180-200 g), washed in rat 
BSA-Krebs-Ringers-HEPES buffer (rat BSA-KRH buffer) (140 mM NaCl, 4.7 mM 
KC1, 2.5 mM CaCl2 .2H20 , 1.25 mM MgS04 .7H20, 2.5 mM NaH2P0 4 .2H20, 10 mM 
HEPES, pH 7.6, 1% (w/v) BSA) and chopped up with scissors. Three fat pads were 
digested in 3.5 ml digestion buffer (rat KRH buffer with 3.5% (w/v) BSA, 0.9 mg/ml 
glucose and 0.7 mg/ml collagenase) for 50 min in a 37 °C shaking water bath. 
Undigested connective material was removed by filtration through a nylon gauze. 
Cells were washed with rat BSA-KRH buffer and made up to 40% cytocrit. Then, the 
cells could either be used immediately, or they could be cultured for 24 h. For the 
former, 40% cytocrit suspensions were treated with or without 20 nM insulin. For the 
latter, 2 ml cells was added to 40 ml DMEM (with 1% (w/v) BSA, 25 mM HEPES, 
pH 7.6, 2 mM L-glutamine, 100 U/ml penicillin and 100 pg/ml streptomycin) in 100 
ml disposable containers (Sarstedt Ltd., Leicester). Incubation was at 37 °C 5% C02 
for 24 h in the absence or presence of 500 nM insulin with or without 1 mM 
metformin.
BSA stocks were prepared as follows. 100 g of powder was dissolved in 500 ml 
double-distilled water and dialyzed for 24 h at 4 °C with two changes of ten volumes 
of double-distilled water. The BSA solution was made up to 10% (w/v) and filtered 
through a Millipore filter (type AA, pore size 0.8 pm) (Millipore Corporation, 
Bedford, MA). The BSA solution was adjusted to pH 7.4 with 10 M NaOH and stored 
in frozen aliquots at -20 °C.
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2.3 Treatment of Adipocytes with Insulin
2.3.1 Insulin Treatment of 3T3-L1 Adipocytes
Two hours prior to insulin stimulation, each dish of 3T3-L1 adipocytes was washed 
twice with 2 ml PBS at 37 °C before incubation in 2 ml DMEM with 2 mM L- 
glutamine, 100 U/ml penicillin and 100 pg/ml streptomycin (serum-free DMEM) for 2 
h at 37 °C 10% CO2. Each dish was then washed 3 times with 2 ml Krebs-Ringers- 
HEPES (KRH) buffer (136 mM NaCl, 4.7 mM KC1, 1.25 mM CaCl2.2H20 , 1.25 mM 
MgS04 .7H20, 10 mM HEPES, pH 7.4) at 37 °C before incubation in 1 ml KRH (0.95 
ml for glucose transport assays) at 37 °C with or without insulin. The usual treatment 
was 100 nM insulin for 20 min.
2.3.2 Insulin Treatment of Permeabilized 3T3-L1 Adipocytes
After incubation in serum-free DMEM, each dish of 3T3-L1 adipocytes was washed 3 
times at 37 °C with 2 ml intracellular (IC) buffer (20 mM HEPES, 5 mM NaCl, 5 mM 
EGTA, 5 mM MgCl2 .6H20 , 140 mM L-glutamate, pH 7.4) before incubation in 0.5 ml 
IC buffer containing 0.4 I.U. streptolysin O (SLO) (Murex Diagnostics Ltd., Dartford) 
for 5 min at 37 °C. Each dish was then washed 3 times at 37 °C with 2 ml IC buffer 
before incubation in 0.95 ml (0.94 ml for insulin-stimulated cells) IC buffer 
supplemented with 10 mM ATP and 3 mM pyruvate (AP-IC); also present was the 
compound to be introduced into the cells. After a period of time (indicated in the 
figure legends - up to 20 min) at 37 °C, cells were further incubated with or without 
10 or 100 nM insulin.
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2.3.3 Chronic Insulin Treatment of 3T3-L1 Adipocytes
Twenty-four hours before an experiment, 2 ml DMEM-FBS with 500 nM insulin was 
added to each dish of 3T3-L1 adipocytes. This concentration of insulin was 
maintained in subsequent incubations with serum-free DMEM and KRH buffer.
2.3.4 Restimulation of 3T3-L1 Adipocytes following Culture with 
Insulin Treatment
After incubation in serum-free DMEM, each dish of 3T3-L1 adipocytes was washed 3 
times at 37 °C with 2 ml Krebs-Ringers-MES (KRM) buffer (salts as for KRH buffer 
plus MES, pH 6.0) before incubation in 1 ml MES with 25 mM D-glucose at 37 °C for 
1 h. Each dish of cells was then washed and insulin-stimulated as before (Methods
2.3.1). Control dishes were maintained in KRH (with 25 mM D-glucose) instead of 
KRM buffer.
2.3.5 Insulin Treatment of Rat Adipocytes Maintained in Primary 
Culture
After 24 h culture, cells were washed with rat BSA-KRH buffer (Methods 2.2.2) 
containing 500 nM insulin in the absence or presence of 1 mM metformin as 
appropriate. After resuspension to 40% cytocrit, cells were incubated with or without 
20 nM insulin, or with 500 nM insulin with or without 1 mM metformin.
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2.4 Glucose Transporter Studies
2.4.1 Assay of 2-deoxy-D-glucose Uptake in 3T3-L1 Adipocytes
To each dish of 3T3-L1 adipocytes containing 0.95 ml KRH buffer was added 50 pi of 
0.3 pCi 2-deoxy-D-[2,6- H]glucose (50 pM final concentration). Cells were incubated 
for 5 min at 37 °C before each dish was washed twice with 3 ml ice-cold KRH buffer. 
Each dish of cells was solubilized in 1 ml 1% (v/v) Triton X-100 before addition of 8  
ml scintillation cocktail. Samples were counted in the 3H channel (0-12 keV) of a 
liquid scintillation counter; standard counts were determined from 50 pi of 0.3 pCi 2- 
deoxy-D-[2,6 -3H]glucose in 1 ml 1% (v/v) Triton X-100. Uptake of 2-deoxy-D- 
glucose was taken to be linear over 5 min and expressed as pmoles transported per 
minute per dish (pmoles/min/dish).
2.4.2 Assay of 2-deoxy-D-glucose Uptake in Permeabilized 3T3-L1 
Adipocytes
Each dish of 3T3-L1 adipocytes containing 0.95 ml AP-IC buffer was given 50 pi of 
radiolabelled sugar (50 nmoles 2-deoxy-D-glucose, 0.6 pCi 2-deoxy-D-[2,6- 
3H]glucose, 0.12 pCi [U-14C]sucrose). Cells were incubated for 5 min at 37 °C before 
each dish was washed twice with 3 ml ice-cold IC buffer. Cells from each dish were 
solubilized in 1 ml 1% (v/v) Triton X-100 before the addition of 8  ml scintillation 
cocktail. Samples were counted in a dual channel program for 3H (0-12 keV) and 14C 
(12-156 keV); standard counts were determined from 50 pi radiolabelled sugar in 1 ml 
1% (v/v) Triton X-100. The uptake of [U-14C]sucrose was used to determine the 
extent of non-specific uptake of 2-deoxy-D-glucose through permeabilized cell 
membrane.
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2.4.3 ATB-BMPA Photolabelling of Cell Surface Glucose 
Transporters in 3T3-L1 Adipocytes
Each dish of 3T3-L1 adipocytes was washed 3 times with 2 ml KRH buffer at 18 °C 
before the addition of 290 pi 18 °C KRH buffer containing 200 pCi ATB-[2- 
3H]BMPA. Following irradiation for 1 min in a Rayonet photochemical reactor, each 
dish was washed 4 times with 2 ml KRH buffer at 18 °C. Cells were solubilized in 1 
ml detergent buffer (2% (w/v) Thesit, 5 mM Na2HP0 4 .1 2 H2 0 , pH 7.2, and 1 pg/ml 
antipain, aprotinin, leupeptin and pepstatin A) on ice for 20 min before centrifugation 
at 20 000 gmax for 20 min at 4 °C. The supernatant was subjected to GLUT1, and then 
GLUT4, immunoprecipitation (50 pi anti-serum conjugated to 5 mg protein A 
sepharose) for 2 h each at 4 °C on a rotating wheel. Immunoprecipitates were washed 
3 times with 1 ml detergent buffer containing 1% (w/v) Thesit and once in 1 ml 
detergent buffer containing 0.1% (w/v) Thesit, before 160 pi sample buffer (Methods
2.7.2) was added for 20 min at room temperature. Samples were resolved on 10% 
SDS-PAGE gels. After staining and destaining, lanes from the gels were cut into 
sixteen 6.5 mm slices and dried individually in open scintillation vials in an 80 °C 
oven. Dried gel slices were solubilized with 500 pi 2% (v/v) NH4OH in 30% (w/w) 
H2O2 in sealed vials at 80 °C, before 3H counts were determined in 8  ml scintillation 
cocktail. A graph of slice number (x-axis) against d.p.m. (y-axis) was constructed. 
Radioactivity associated with the labelled transporter was determined by adding up the 
counts from the slices that formed the peak and subtracting the counts from a same 
number of slices that contained no label (background counts).
2.5 Immunoprecipitation and Assay of Kinase Enzymes
2.5.1 Assay for PI 3-K Activity in 3T3-L1 Adipocytes
Each dish of 3T3-L1 adipocytes was washed twice with 3 ml before solubilization in 1 
ml of 5 mM Na2HP0 4 .1 2 H2 0 , pH 7.2, 0.4 mM Na3V0 4 , 1% (v/v) Triton X-100, and 1
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pg/ml antipain, aprotinin, leupeptin and pepstatin A, for 20 min on ice before 
centrifugation at 20 000 gmax for 20 min. Insoluble fat was removed by passing lysate 
through 0.2 pm Minisart filters (Sartorius). Beforehand, anti-IRS-1 was bound to 
protein G sepharose (200 pi ID6  per 30 pi beads for 3 h at 4 °C). The beads were 
mixed with cell lysate (30 pi beads per sample) for 2 h at 4 °C. The beads were then 
washed twice with 12.5 mM Na2HP0 4 .1 2 H2 0 , pH 7.2, 154 mM NaCl, 1% (v/v) Triton 
X-100, 1 mM DL-dithiothreitol (DTT), then twice with 0.1 M Tris, pH 7.4, 0.5 M LiCl, 
1 mM DTT, and finally twice with 10 mM Tris, pH 7.4, 0.1 M NaCl, 1 mM DTT (1 ml 
volume for each wash). As much buffer as possible was removed before the kinase 
activity was assayed.
For the PI 3-K assay, each sample was resuspended in 50 pi buffer (20 mM HEPES, 
pH 7.1, 0.4 mM EGTA, 0.4 mM Na2HP0 4 .1 2 H2 0 , 10 mM MgCl2 .6 H2 0 , 0.2 mg/ml 
phosphatidylinositol, 40 pM ATP and 5-10 pCi [y-32P]ATP). The samples were 
incubated with the phospholipid for 5 min at room temperature before the Mg2+ and 
ATP were added. After 20 min, 30 pi 4 M HC1 was added to stop the reaction; 130 pi 
1 :1  (v/v) chloroform/methanol was then added, before the samples were vortexed and 
spun at 13 000 rpm for 10 min to separate the phases.
TLC polyester plates coated with silica gel (layer thickness 250 pm, particle size 5 to 
17 pm, pore size 60 A) were pre-treated with 0.91% (w/v) trans-1,2- 
diaminocyclohexane-N,N,N’,N’-tetraacetic acid (CDTA) in 0.6% (v/v) 10 M NaOH, 
6 6 % (v/v) ethanol. Plates were soaked for 10 s and left to air-dry before baking in an 
80 °C oven for 1 h. Samples from the lower phase (see above) were spotted onto the 
TLC plate. Lipids were then separated using the following solvent: 7.5 ml water, 3 ml 
8 8 % (v/v) formic acid, 0.375 g 2,6-di-ter/-butyl-4-methylphenol (BHT), and 75 pi 
ethoxyquin mixed with 75 ml methanol, 60 ml chloroform, 45 ml pyridine and 12 g 
dissolved boric acid. After separation, the plates were dried before exposure to 
autoradiography film. Labelled phosphatidylinositol was then cut out and counted in 
8  ml scintillation cocktail in the P channel (5-1700 keV) of a liquid scintillation 
counter.
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2.5.2 Assay for PKB Activity in 3T3-L1 Adipocytes
Each dish of 3T3-L1 adipocytes was washed twice with 3 ml ice-cold lysis buffer (50 
mM HEPES, pH 7.6, 1% (v/v) Triton X-100, 1 mM Na3VC>4 , 10 mM NaF, 30 mM 
Na4P2C>7, 150 mM NaCl, 1 mM EDTA, 100 pM AEBSF, and 1 pg/ml antipain, 
aprotinin, leupeptin and pepstatin A) before solubilization in 1 ml. Samples were 
transferred to eppendorf tubes and left on ice for 10 min, before centrifugation at 14 
000 rpm for 5 min at 4 °C. Insoluble fat was removed by passing lysate through 0.2 
pm Minisart filters (Sartorius). PKB from each dish was immunoprecipitated by 
mixing lysate with 2 pg anti-Aktl(C-20) conjugated to 10 pi protein G sepharose for 2 
h at 4 °C. Immunoprecipitates were washed 3 times with 1 ml lysis buffer and 3 times 
with 1 ml kinase assay buffer (50 mM Tris, pH 7.5, 10 mM MgCl2.6 H2 0 ). As much 
buffer as possible was removed before assaying for kinase activity.
Immunoprecipitates were incubated in 50 pi kinase assay buffer containing 1 mM 
DTT, 100 ng protein kinase A (PKA) inhibitor peptide, 25 pg protamine sulphate, 5 
pM ATP and 2 pCi [y- PJATP for 5 min. The reaction was started by the addition of 
the radiolabelled ATP. Samples were incubated for 20 min at 30 °C, after which 50 pi 
supernatant was removed. To the remaining beads, 40 pi 2% (w/v) sodium dodecyl 
sulphate (SDS) was added for 10 min. The two supernatants were combined and from 
this, 20 pi was spotted onto a 2 cm x 2 cm area of P81 phosphocellulose paper 
(Whatman International Ltd., Maidstone, Kent). After the spots had dried, the 
phosphocellulose was washed 5 times with 500 ml 75 mM phosphoric acid in a 
sandwich box on a shaking table. The phosphocellulose was then rinsed once in water 
and once in acetone. Once dried, the phosphocellulose was put into scintillation vials 
containing 8  ml scintillation cocktail. Counts were determined using the P channel 
(5-1700 keV) of a liquid scintillation counter. Background counts were determined 
from 10 pi protein G sepharose that was treated in the same way as the 
immunoprecipitates.
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2.6 Subcellular Fractionation of Adipocytes
2.6.1 Subfractionation of 3T3-L1 Adipocytes
Each dish of 3T3-L1 adipocytes was washed twice with 3 ml ice-cold TES (10 mM 
Tris, pH 7.2, 5 mM EDTA, 250 mM sucrose, 100 pM AEBSF, and 1 pg/ml antipain, 
aprotinin, leupeptin and pepstatin A) before the cells were removed in 1 ml TES with 
a cell scrapper. Phosphatase inhibitors were included in TES for those studies in 
which PKB was assayed (1 mM Na3V0 4 , 10 mM NaF and 30 mM Na4P2C>7). 
Following 15 strokes in a 5 ml homogenizer, the homogenate was subjected to 
sequential centrifugation with a TLA-100.3 fixed angle rotor (Beckman TL-100 
ultracentrifuge) at 4 °C. The first spin was at 15 000 rpm (12 000 gmax) for 15 min to 
obtain the crude plasma membrane pellet. The supernatant was then spun at 17 000 
rpm (16 000 gmax) for 15 min to pellet the high density microsomes (HDM). The 
supernatant from this was spun at 100 000 rpm (541 000 gmax) for 17 min to obtain the 
low density microsomes (LDM). The crude plasma membrane pellet was resuspended 
in 300 pi TES and spun at 35 000 rpm (105 000 gmax) for 20 min (TLS-55 swinging 
bucket rotor, Beckman TL-100) on 600 pi of a 38% sucrose cushion (1.12 M sucrose, 
10 mM Tris, pH 7.2, 10 mM EDTA). The sucrose layer was then spun with 2 ml TES 
at 37 000 rpm (74 000 gmax) for 9 min (TLA-100.3 rotor) to obtain the plasma 
membrane fraction (PM). Membrane fractions were resuspended in 5 mM 
Na2HP0 4 .1 2 H2 0 , pH 7.2, and assayed for protein content.
2.6.2 Subfractionation of Rat Adipocytes
After washing 2 ml 40% cells once in TES at 20 °C, they were resuspended in 2 ml 
TES at 18 °C. Following 10 strokes in a 55 ml homogenizer, the homogenate was 
spun at 1000 rpm for 1 min. From this, the infranatant was removed with a syringe 
and needle (21 g) before it was subjected to sequential centrifugation with a TLA-
100.3 rotor (Beckman TL-100). The first spin at 18 000 rpm (18 000 gmax) for 20 min
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gave the crude plasma membrane pellet. The supernatant was taken and spun at 30
000 rpm (49 000 gmax) for 30 min to obtain the HDM fraction. The remaining 
supernatant was spun at 100 000 rpm (541 000 gmax) for 17 min to obtain the LDM 
fraction. The crude plasma membrane pellet was homogenized in 2 ml TES with 5 
strokes in a 10 ml homogenizer before recentrifugation at 18 000 rpm for 20 min. The 
PM fraction was then obtained as above (.Methods 2.6.1). Membrane fractions were 
resuspended in TES and assayed for protein content.
2.7 Protein Biochemistry Techniques
2.7.1 Bio-Rad Protein Assay
The Bio-Rad Protein Assay (Bio-Rad Laboratories Ltd., Hemel Hempstead, 
Hertfordshire) was used to quantitate the protein content of samples. Samples were 
made up to 160 pi with 5 mM Na2HP0 4 .1 2 H2 0 , pH 7.2, and mixed with 40 pi Dye 
Reagent Concentrate (Bio-Rad) in the wells of Microplates (Labsystems, Helsinki, 
Finland). A calibration curve was constructed using 1-5 pg BSA. Absorption at 595 
nm was measured in a spectrophotometer.
2.7.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Protein samples were mixed with sample buffer (2% (w/v) SDS, 115 mM Tris, pH 6 .8 ,
1 mM EDTA, 10% (v/v) glycerol, 400 pg/ml bromophenol blue and 10% (v/v) 2- 
mercaptoethanol) such that the volume of the latter was at least 75% of the total 
volume, before heating at 95 °C for 5 min. Four-times and two-times concentrates of 
sample buffer were used for larger volumes of protein samples.
Discontinuous polyacrylamide gels (lower resolving gel and upper stacking gel) were 
set up on either the Mini-PROTEAN II electrophoresis cell or the PROTEAN II xi 
slab cell (both Bio-Rad). Gels were prepared according to the manuals with the
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following solutions: acrylamide/bis (30% T, 2.7% C) (National Diagnostics, Flowgen, 
Lichfield, Staffordshire), resolving gel buffer (1.5 M Tris, pH 8 .8 , 0.4% (w/v) SDS), 
stacking gel buffer (0.5 M Tris, pH 6 .8 , 0.4% (w/v) SDS), 10% (w/v) ammonium 
persulfate (Bio-Rad) and N,N,N’,N’-tetramethylethylenediamine (TEMED) (Bio- 
Rad). For the Mini-PROTEAN II cell, the resolving gel was made to 0.375 M Tris 
and 0.1% (w/v) SDS with acrylamide concentrations of 7-13%, while the stacking gel 
was made to 0.125 M Tris and 0.1% (w/v) SDS with 5% acrylamide. For the 
PROTEAN II cell, the method was modified to give 0.5 M Tris and 0.133% (w/v) 
SDS for the resolving gel, and 0.156 M Tris, 0.125% (w/v) SDS and 6.375% 
acrylamide for the stacking gel.
After the upper and lower buffer chambers were filled with electrode buffer (0.025 M 
Tris, 0.1% (w/v) SDS, 0.192 M glycine, pH 8.3), protein samples were loaded using 
either a Gilson pipetter or a Hamilton syringe. Gels were run until the dye front had 
reached the bottom. After electrophoresis, protein bands were detected by staining for 
30 min with 0.2% (w/v) Coomassie Blue R-250 in fixative (30% (v/v) methanol, 10% 
(v/v) glacial acetic acid) and destaining for a few hours with fixative only.
2.7.3 Electrotransfer of Protein from SDS-PAGE Gels to 
Nitrocellulose
After SDS-PAGE, the 1.5 mm gel was soaked in transfer buffer (0.0375% (w/v) SDS, 
48 mM Tris, 39 mM glycine, pH 8 .8 ) for 5 min. The gel was laid on top of a piece of 
BioTrace® nitrocellulose blotting membrane (Gelman Sciences Ltd., Northampton) 
and sandwiched between two layers (nine sheets thick) of electrode paper (Pharmacia 
Biotech, St. Albans, Hertfordshire). The nitrocellulose and electrode paper were 
soaked in transfer buffer beforehand with air bubbles smoothed out. The assembly 
was placed between the pre-wet electrode plates of a Multiphor II NovaBlot 
electrophoretic transfer unit (Pharmacia). Current was run at 0.8 mA/cm2 for 105 
min. After electrotransfer, the nitrocellulose was rinsed in water before staining with
0.1% (w/v) Ponceau S in 3% (w/v) trichloroacetic acid.
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2.7.4 Western Blotting
The nitrocellulose was rinsed briefly in TBS-T (10 mM  Tris, pH 7.4, 0.9% (w/v) 
NaCl, 0.1% (v/v) Tween 20) before blocking with 5% (w/v) Marvel dried skimmed 
milk (Premier Beverages, Stafford) in TBS-T for 30 min. After a brief wash, the 
nitrocellulose was incubated with the primary antibody (1:1000 or 1:4000) in TBS-T 
with 3% (w/v) Marvel for 90 min. After 6 x 3 min washes with TBS-T, the 
nitrocellulose was incubated with the secondary antibody (1:4000 anti-rabbit (Sigma), 
anti-goat (Sigma) or anti-mouse (Amersham) IgG conjugated to horseradish 
peroxidase) in TBS-T with 3% (w/v) Marvel for 30 min. After 6 x 3 min washes with 
TBS-T, the nitrocellulose was incubated for 1 min with ECL detection reagent 
(Amersham). The nitrocellulose was placed between two transparency sheets before 
exposure to autoradiography film.
All incubations were carried out at room temperature on a shaking table. For 
phosphotyrosine immunoblotting, 3% (w/v) and 1% (w/v) BSA were used in the 
blocking and antibody incubations respectively.
2.8 Expression and Purification of a GST Fusion Protein
2.8.1 PH Domain/GST Fusion Protein Construct
The vector pGEX-2T (Smith and Johnson, 1988) encoding the fusion protein of 
glutathione ^-transferase and PH domain (with a thrombin cleavage site) was a gift 
from Dr Kamran Salim (Ludwig Institute for Cancer Research, UCL, London). The 
PH domain was amplified from rat IRS-1 cDNA and extended at the C-terminal end 
from residue 120. The sequence is as follows:
1 MASPPDTDGF SDVRKVGYLR KPKSMHKRFF VLRAASEAGG PARLEYYENE 
51 KKWRHKSSAP KRSIPLESCF NINKRADSKN KHLVALYTRD EHFAIAADSE
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101 AEQDSWYQAL LQLHNRAKAH HDGAGGG
2.8.2 Transformation of Bacterial Cells
Epicurian Coli® SURE® competent cells (Stratagene, La Jolla, California) were 
transformed with the pGEX-2T vector. The cells were thawed before 100 pi was 
aliquoted into a 1.9 ml eppendorf and mixed with 1.7 pi of 1.42 M P-mercaptoethanol. 
The cells were incubated on ice for 10 min with gentle swirling every 2 min, before 10 
ng plasmid was added for 30 min on ice. The cells were then heated at 42 °C for 45 s 
before incubation for 2 min on ice. Pre-heated (42 °C) 0.9 ml SOC medium (20 g/1 
tryptone, 5 g/1 yeast extract, 0.5 g/1 NaCl, 10 mM MgCk.btfeO, 10 mM MgSC>4 and 20 
mM glucose) was added before the cells were shaken at 37 °C for 1 h. The cells (5 pi 
in 200 pi SOC medium) were spread on 100 mm LB-ampicillin agar (10 g/1 NaCl, 10 
g/1 tryptone, 5 g/1 yeast extract, 20 g/1 agar, pH to 7.0 with 5 M NaOH, 50 mg/1 
ampicillin) plates and incubated at 37 °C overnight.
2.8.3 Culture and Lysis of Bacterial Cells
An aliquot of 5 ml LB Broth (50 pg/ml ampicillin) was inoculated and shaken at 37 
°C overnight. The culture was then transferred to 500 ml LB Broth (100 pg/ml 
ampicillin) before shaking at 37 °C during the day (about 7 h). From this culture, 100 
ml was added to 1000 ml LB Broth (100 pg/ml ampicillin), which was then shaken at 
37 °C until absorbance at 600 nm was 0.6-1.0. Fusion protein production was induced 
by incubation with 0.1 mM isopropyl P-D-thiogalactopyranoside (IPTG) at 25 °C 
overnight. The cells were pelleted by spinning at 6000 rpm for 10 min at 4 °C before 
resuspension in 12.5 ml ice-cold lysis buffer (50 mM Tris, 50 mM NaCl, 5 mM 
MgCl2 .6 H2 0 , 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.5). The 
cells were sonicated on ice with 8 x 10 s pulses, using a 19 mm diameter probe. The 
lysed cells were spun at 30 000 rpm for 30 min at 4 °C and the supernatant saved.
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2.8.4 Purification and Cleavage of GST Fusion Protein
The supernatant from lysed cells was mixed with 1 ml glutathione sepharose 4B beads 
(Pharmacia) (equilibrated with several bed volumes of lysis buffer) for 30 min at 4 °C 
in 2 x 12 ml polystyrene conical test tubes (Sarstedt). The beads were then washed 3 
or 4 times with 10 ml lysis buffer (minus PMSF) per tube. The beads were then 
equilibrated with one bed volume of thrombin resuspension buffer (TRB) (50 mM 
Tris, 150 mM NaCl, 5 mM MgCl2 .6 H2 0 , 2.5 mM CaCl2.2 H2 0 , 1 mM DTT, pH 8 ). 
The fusion protein was cleaved with 1.5 units thrombin per ml beads at 4 °C 
overnight. The supernatant was collected and mixed with 10 pi p-aminobenzamidine 
agarose beads at 4 °C for 30 min (to bind thrombin); the supernatant from this was 
saved. The glutathione sepharose beads were washed 2 or 3 times with TRB to 
remove any remaining unbound cleaved protein. The washes were combined with the 
supernatant and concentrated with Microsep™ centrifugal concentrators (Flowgen). 
PD-10 columns (Pharmacia) were used to replace TRB with the buffer of choice. The 
purity of the final product was determined by SDS-PAGE.
2.9 Analysis of Data
Data was plotted on GraphPad PRISM™ (Version 2.0) (GraphPad Software, Inc., San 
Diego, CA). Statistical analysis was carried out using the PRISM™ program with 
unpaired t tests (two-tail P values).
Autoradiograms were scanned with a Bio-Rad GS-670 Imaging Densitometer. The 
density of protein bands were determined using Molecular Analyst™ Software (Bio- 
Rad).
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3.0 RESULTS AND DISCUSSION
3.1 Studies with the PH Domain of IRS-1
3.1.1 Searching for the Binding-protein of the IRS-1 PH Domain
So far, the only protein found to associate with the PH domain of IRS-1 is Gfy 
(Touhara et al., 1994). However, the functional significance of this interaction has not 
been demonstrated in vivo. Further, though the tyrosine-phosphorylated residues of 
IRS-1 are known to activate multiple signalling proteins - including PI 3-K, which 
appears to be involved in insulin-regulated glucose uptake - the purpose of the PH 
domain is not as clear (reviewed by Keller and Lienhard, 1994). Thus, in an attempt 
to further understand the role of the IRS-1 PH domain in insulin signalling and in 
relation to stimulation of glucose transport, cell lysate from 3T3-L1 adipocytes was 
screened for a binding-protein for this domain. The identification of such a protein 
may help determine the function of the IRS-1 PH domain. The probe used was an 
IRS-1 PH domain construct, produced using the GST fusion protein system {Methods 
2.8). Separate experiments had demonstrated that the protein was functional, as it was 
able to attenuate the tyrosine phosphorylation of IRS-1 by the insulin receptor in 
permeabilized 3T3-L1 adipocytes {Results and Discussion 3.1.3). Thus, these 
experiments indicate that the bacterially-expressed IRS-1 PH domain has a similar 
conformation to that in vivo. Two techniques were used to attempt to identify a PH 
domain-binding protein. The first involved a modification of the Western blotting 
procedure, where biotinylated IRS-1 PH domain was used to detect binding-proteins 
on nitrocellulose. The second involved affinity chromatography with the GST fusion 
protein of the IRS-1 PH domain immobilized on glutathione sepharose beads.
A probe for proteins that bind the IRS-1 PH domain was made by covalently linking 
biotin to the IRS-1 PH domain protein from purified GST-PH domain. The 
biotinylation reagent was ImmunoPure® NHS-LC-Biotin (sulfosuccinimidyl-6 -
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(biotinamido)-hexanoate) (Pierce & Warriner (UK) Ltd., Chester). It was linked by 
incubating a 100-fold excess with IRS-1 PH domain in 0.1 M Na2B4O7.10H2O, pH 
8.5, at 4 °C for 24 h. Unreacted biotin was removed by the addition of Tris and 
dialysis with PBS. Biotinylated IRS-1 PH domain was detected with streptavidin 
linked to horseradish peroxidase (streptavidin-HRP) (Figure 3.1.1).
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Figure 3.1.1. Detection of Biotinylated IRS-1 PH Domain with Streptavidin 
Linked to Horseradish Peroxidase.
Biotinylated IRS-1 PH domain (10, 100, 250, 500 and 1000 ng) was resolved on a 13% SDS-PAGE 
gel, transferred to nitrocellulose and incubated with streptavidin-HRP (1:4000) in TBS, before 
detection with ECL Western blotting detection reagent (.Methods 2.7).
To identify proteins that may bind to the IRS-1 PH domain, lysate from 3T3-L1 
adipocytes was run on a SDS-PAGE gel and transferred to nitrocellulose, before 
incubation with biotinylated IRS-1 PH domain and then streptavidin-HRP (Figure
3.1.2). For the controls, samples on nitrocellulose were either incubated with 
streptavidin-HRP only, or they were incubated with an excess of unbiotinylated IRS-1 
PH domain before incubation with the biotinylated probe. No difference was 
observed between the control and experimental samples. As streptavidin-HRP was 
able to detect protein on its own, attempts were made to block any biotin-containing 
proteins on the nitrocellulose prior to incubation with biotinylated IRS-1 PH domain, 
using either anti-biotin antibody (Sigma) or streptavidin (Pierce) (both 1:4000). 
Neither method prevented the bands from appearing (data not shown).
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Figure 3.1.2. Western Blotting of Lysate from 3T3-L1 Adipocytes with 
Biotinylated IRS-1 PH Domain.
Each dish o f  3T3-L1 adipocytes was solubilized in 500 pi sample buffer, o f  which 50 pi was run on a 
10% SDS-PAGE gel before transfer to nitrocellulose (Methods 2.7.2 and 2.7.3). Three duplicate lanes 
were prepared and blocked with 5% (w/v) Marvel in TBS (no Tween 20) for 30 min before the 
following incubations: (A) Incubation with streptavidin-HRP only; (B) Incubation with 1:100 IRS-1 PH 
domain for 30 min and then 1:1000 biotinylated IRS-1 PH domain for 90 min; (C) As for B, except pre­
incubation with 1:45 IRS-1 PH domain; (D) Incubation with 1:1000 biotinylated IRS-1 PH domain for 
90 min. After extensive washing with TBS, samples were incubated with 1:4000 streptavidin-HRP for 
30 min before detection with ECL Western blotting detection reagent (.Methods 2.7.4). All incubations 
were in 1% (w/v) BSA/TBS. Markers show molecular weights in kDa.
An advantage of this modified Western blotting technique is that a signal from the 
biotinylated probe can be amplified using streptavidin linked to horseradish 
peroxidase. However, a PH domain-binding protein was not detected with this 
method. It is difficult to determine whether failure was due to a fault with the 
technique, as the ability to identify Gpy as a control was not examined. Since the
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IRS-1 PH domain has been shown to be functional, then the cause of the failure to 
detect a binding-protein is probably not due to the probe itself. Using a similar 
method, Wang et al (1994) resolved purified G protein p-subunit (Gp) on SDS- 
PAGE before transfer to nitrocellulose and detection with a PH domain construct. 
Thus, the use of purified protein instead of cell extract may aid detection as more of 
the desired protein is present. Further, in this study, the inability to detect Gp itself in 
the cell extract may reflect the low specificity of the interaction between this protein 
and the IRS-1 PH domain. Thus, the binding of Gpy with the GST fusion protein of 
the IRS-1 PH domain is weaker than with that of the P-Ark PH domain (Touhara et 
al., 1994). Another possible reason for the failure to detect novel proteins in the cell 
extract may be the disruption of protein conformation caused by denaturation with 
SDS treatment. Thus, a way to overcome this problem may be to run proteins on 
polyacrylamide gels under non-denaturing conditions prior to transfer to 
nitrocellulose.
An alternative method to identify proteins that bind the PH domain was to mix 
immobilized IRS-1 PH domain with cell lysate, before elution with sample buffer and 
detection by Coomassie Blue stain following SDS-PAGE. GST or GST-PH domain 
were bound to glutathione sepharose beads before incubation with lysate from 3T3-L1 
adipocytes. Originally, a band between 29 and 36 kDa and another two between 24 
and 29 kDa were detected in GST-PH domain beads, but not in GST beads. To 
examine the possibility that these bands were degradation products of GST-PH 
domain, the experiment was repeated again, in which a 1 0 0 -fold excess of unbound 
PH domain was present during the incubation of bound GST-PH domain with cell 
lysate (Figure 3.1.3). This procedure did not eliminate the additional bands, indicating 
that they were indeed likely to be degradation products of the GST-PH domain.
This method of searching for a binding-protein for the IRS-1 PH domain - where a 
GST fusion protein of the IRS-1 PH domain was immobilized on glutathione 
sepharose beads - was advantageous over the previous method in that it did not 
require the denaturation of cellular proteins. Also, it had the potential to allow the 
mixing of a relatively large amount of cell lysate with the IRS-1 PH domain construct.
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Thus, this feature was also an advantage over the earlier method, in which there is a 
limit to the volume of protein that can be loaded onto a SDS-PAGE gel.
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Figure 3.1.3. Incubation of GST-PH Domain Immobilized on Glutathione 
Sepharose Beads with Lysate from 3T3-L1 Adipocytes.
GST-PH domain was produced from a litre culture and immobilized on 500 pi glutathione sepharose 
beads (Methods 2.8). Lysate was produced by solubilizing each dish o f  3T3-L1 adipocytes in 1 ml lysis 
buffer (20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 1 mM PMSF, 1 mM Na3V 0 4, 
and 1 pg/ml antipain, aprotinin, leupeptin and pepstatin A) for 30 min on ice before centrifugation at 49 
000 gmax for 30 min. To 2.5 pi beads was added 10 ml lysate; incubation was at 4 °C for 24 h on a 
rotating wheel. The beads were then washed 5 times with the lysis buffer. Protein was eluted with 30 
pi sample buffer and resolved on a 13% SDS-PAGE gel (Methods 2.7.2). GST-PH domain was either: 
(A and C) Untreated with cell lysate; (B) Mixed with cell lysate; (D) Mixed with cell lysate in the 
presence o f  a 100-fold excess o f  unbound PH domain protein. Molecular weight (M W ) markers (from 
the top) are: 66, 45, 36, 29, 24, 20 and 14 kDa.
However, no binding-proteins for the IRS-1 PH domain were detected with this 
technique. A possible reason is that the detection of proteins with Coomassie Blue 
stain is less sensitive than by Western blotting. Indeed, Konishi et al. (1995) were 
able to find an association between PKC and a GST fusion protein of the PH domain 
of PKB by both using cell lysate from cells overexpressing PKC and by detection with 
PKC antibodies. Thus, a way of overcoming the problem may be to use even more 
cell lysate from 3T3-L1 adipocytes. However, with the quantities used in this study, a
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faint background of non-specifically bound protein was already observed, though this 
may be eliminated by pre-incubation of lysate with glutathione sepharose beads bound 
to GST only. As a potential control, any proteins bound to the IRS-1 PH domain 
could be immunoblotted with antibodies against PKC or GPy.
Despite the lack of success in finding a binding-protein for the IRS-1 PH domain, the 
absence of such a protein cannot be ruled out. One of the reasons for why it cannot be 
said that a PH domain-binding protein does not exist, is that the techniques used did 
not have a positive control to check their feasibility. Also, further modifications of 
the described protocols can be made. Given that the binding of phosphoinositides and 
inositol phosphates to the PH domain have been observed (Harlan et al., 1994, and 
Lemmon et al., 1995), it would also be worth investigating if this interaction occurs 
for the IRS-1 PH domain.
3.1.2 Investigating the Role of the IRS-1 PH Domain in Insulin- 
stimulated Glucose Uptake
A proposed role of the IRS-1 PH domain in insulin signalling is the targeting of 
activated PI 3-K - bound to IRS-1 - to an intracellular membrane site so that it can 
enhance GLUT4 exocytosis. This idea is supported by two observations. First, 
insulin-activated PI 3-K is present mainly at an intracellular membrane location - the 
LDM - in 3T3-L1 adipocytes (Yang et al., 1996). Second, insulin stimulation of 3T3- 
L1 adipocytes leads to the appearance of tyrosine-phosphorylated IRS-1 in the LDM, 
together with translocation of p85 to the same compartment (Ricort et al., 1996). To 
investigate the possibility that the IRS-1 PH domain acts to target IRS-1 to the LDM 
fraction, a method of blocking the function of the PH domain of endogenous IRS-1 in 
3T3-L1 adipocytes was required. In this study, one of two compounds were 
introduced into permeabilized 3T3-L1 adipoyctes. The first was the IRS-1 PH 
domain, which could compete with endogenous IRS-1 for endogenous binding sites. 
The second was Ins 1 ,4 ,5 -P3, which could bind to the PH domain of endogenous IRS-
1. This inositol phosphate is known to bind the PH domain of PLC 5i (Lemmon et
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al., 1995). The insulin-stimulated cellular responses that were measured following 
treatment with these compounds were glucose uptake and PI 3-K activity in the LDM.
If the PH domain does target the IRS-1/PI 3-K complex to the LDM where it may act 
to cause GLUT4 translocation, then the presence of exogenous IRS-1 PH domain - 
which may compete for endogenous binding sites - could result in a reduction in 
insulin-stimulated glucose transport. Permeabilized 3T3-L1 adipocytes were pre- 
incubated with 3.5 pM IRS-1 PH domain for 15 min prior to a 10 nM insulin 
stimulation for 20 min (Figure 3.1.4). Insulin-stimulated 2-deoxy-D-glucose transport 
was the same regardless of whether the permeabilized cells were pre-treated with IRS- 
1 PH domain or not.
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Figure 3.1.4. Insulin-stimulated 2-deoxy-D-Glucose Uptake in Permeabilized 
3T3-L1 Adipocytes Following Incubation with IRS-1 PH Domain.
Each dish o f  3T3-L1 adipocytes was permeabilized and pre-incubated for 15 min before treatment 
without (B) or with (I) 10 nM insulin for 20 min (.Methods 2.3.2)’, one group was pre-incubated with 3.5 
pM IRS-1 PH domain prior to insulin stimulation (P). Uptake o f  2-deoxy-D-glucose was measured as in 
Methods 2.4.2. Values are the means ± S.E.M. from three independent experiments done in duplicate
(n = 6).
A possible alternative method of blocking the function of the IRS-1 PH domain, and 
perhaps insulin-stimulated glucose uptake, is the introduction of Ins 1,4 ,5-P3 into the 
cell. Insulin-stimulated 2-deoxy-D-glucose transport was measured in permeabilized 
3T3-L1 adipocytes following pre-incubation with Ins 1,4 ,5-P3 (45 pg per dish of cells)
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(Figure 3.1.5). Again, attenuation of the insulin-stimulated (10 nM for 20 min) 
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Figure 3.1.5. Insulin-stimulated 2-deoxy-D-Glucose Uptake in Permeabilized 
3T3-L1 Adipocytes Following Incubation with Inositol 1,4,5-trisphosphate.
3T3-L1 adipocytes were treated as in Figure 3.1.4, except that the pre-incubation was with 45 pg 
inositol 1,4,5-trisphosphate per dish (S). Values are the means ± S.E.M. from two independent 
experiments done in duplicate (n = 4).
Thus, the pre-incubation of permeabilized 3T3-L1 adipocytes with either IRS-1 PH 
domain or Ins 1,4 ,5-P3 does not appear to affect subsequent insulin-stimulated 2- 
deoxy-D-glucose uptake. The failure to see an effect was not likely to be due to an 
inadequacy of the cell permeabilization procedure, as the IRS-1 PH domain was able 
to attenuate insulin-stimulated IRS-1 phosphorylation in similarly permeabilized 3T3- 
L1 adipocytes (Results and Discussion 3.1.3). A possibility is that either compound 
was not sufficient in quantity to have an effect on the insulin-stimulated response. 
Though a submaximal stimulation with 10 nM insulin was used in the experiments, 
the use of even lower insulin doses may be beneficial. Also, although the binding of 
PI 4 ,5-P2 and Ins 1,4 ,5-P3 to the PH domain have been identified (Harlan et al., 1994, 
and Lemmon et a l, 1995), the binding of these compounds to the IRS-1 PH domain 
has not been described. Thus, it is possible that Ins 1,4 ,5-P3 may not interact with the 
IRS-1 PH domain in vivo.
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Another approach to determine if the PH domain targets IRS-1/PI 3-K to the LDM 
was to measure the PI 3-K activity in that fraction from insulin-stimulated 
permeabilized 3T3-L1 adipocytes pre-incubated with IRS-1 PH domain (Figure 3.1.6). 
An insulin treatment at 10 nM for 10 min was determined to cause maximal 
recruitment of p85a to the microsomal fraction (Nave et al., 1996a). This level of 
stimulation led to activity in the LDM which was the same regardless of whether the 
insulin-stimulated cells were pre-treated with IRS-1 PH domain or not.




>. 5  io- 
> =
S|
Figure 3.1.6. PI 3-K Activity in the LDM Fraction from Insulin-stimulated 
Permeabilized 3T3-L1 Adipocytes Following Incubation with IRS-1 PH Domain.
Each dish o f  permeabilized 3T3-L1 adipocytes was pre-incubated for 20 min before treatment without 
(B) or with (I) 10 nM insulin for 10 min (.Methods 2.3.2)-, one group was pre-incubated with 17 pM IRS- 
1 PH domain prior to insulin stimulation (P). The cells were homogenized and subfractionated to 
obtain the LDM (Methods 2.6.1). Protein samples o f  0.8 pg were assayed for PI 3-K activity {Methods 
2.5.1). Values are the means from a single experiment done in duplicate. Error bars show Min and 
Max values.
Though the translocation of p85 to the microsomal membranes upon insulin 
stimulation of 3T3-L1 adipocytes has been identified, the mechanism involved was 
not investigated (Nave et al., 1996a, and Ricort et a l, 1996). However, consistent 
with the role of IRS-1 in targeting PI 3-K to an intracellular membrane site is the 
appearance of tyrosine-phosphorylated IRS-1 in the LDM fraction upon stimulation of 
3T3-L1 adipocytes with insulin, but not with PDGF (Ricort et al., 1996). In this study 
however, the presence of exogenous IRS-1 PH domain did not attenuate insulin-
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stimulated PI 3-K activity in the LDM fraction of permeabilized 3T3-L1 adipocytes. 
It is difficult to interpret the cause of this effect. First, it is not known if the quantity 
of IRS-1 PH domain was sufficient to affect p85 translocation. Second, and most 
importantly, it needs to be established that the IRS-1 PH domain can associate with 
the LDM. This could be achieved by introducing biotinylated IRS-1 PH domain or 
the IRS-1 PH domain as a GST fusion protein into permeabilized 3T3-L1 adipocytes 
prior to detection in subcellular fractions with streptavidin or a GST antibody. 
Further, p85 exists in the LDM of basal 3T3-L1 adipocytes, where tyrosine 
phosphorylated IRS-1 is absent (Ricort et al., 1996). Thus, this observation argues 
against membrane-association via IRS-1, since p85 can only interact with IRS-1 in the 
tyrosine-phosphorylated state. Nevertheless, another possibility is that the PH domain 
targets IRS-1 to the LDM so that it can activate p85 already present there. If this idea 
is correct, exogenous IRS-1 PH domain should also inhibit this process.
Thus, using the methods described in this study, a role for the IRS-1 PH domain in 
enabling insulin-stimulated PI 3-K activity to occur in the LDM of 3T3-L1 adipocytes 
was not established. However, it is necessary to determine if the IRS-1 PH domain is 
able to interact with the LDM fraction at all, and if so, if it could compete for binding 
sites with IRS-1. Further, the nature of p85 is such that it has several N-terminal 
domains that are not involved in the interaction with pi 10 (Kapeller and Cantley, 
1994). These regions could be important for membrane-association.
3.1.3 Attenuation of Insulin-stimulated Tyrosine Phosphorylation of 
IRS-1
Another proposed role for the PH domain is to target IRS-1 to the plasma membrane. 
This is based on two observations. First, an interaction between a PH domain and PI 
4 ,5 -P2 has been described (Harlan et al., 1994). Second, deletion of the PLC 5i PH 
domain prevents the protein from associating with the plasma membrane (Paterson et 
al., 1995). Further, studies by other groups indicate that the PH domain of IRS-1 is 
important for its phosphorylation by the insulin receptor (Myers Jr. et al, 1995, and
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Voliovitch, et al., 1995). Thus, these findings have important implications for insulin- 
regulated glucose uptake. If IRS-1 is unable to localize at the plasma membrane near 
the insulin receptor due to the absence or disruption of its PH domain, then this defect 
may affect insulin-stimulated glucose transport. However, it has been shown earlier in 
this study (Results and Discussion 3.1.2) that the presence of exogenous IRS-1 PH 
domain was unable to perturb insulin-stimulated glucose uptake in permeabilized 
3T3-L1 adipocytes. Thus, further experiments were undertaken to eliminate the 
possibility that the result was due to a fault with the IRS-1 PH domain protein. If the 
bacterially-expressed protein is found to be able to affect insulin-stimulated 
phosphorylation of IRS-1 in permeabilized 3T3-L1 adipocytes, then the result would 
indicate that the IRS-1 PH domain is functional.
By introducing excess IRS-1 PH domain into permeabilized 3T3-L1 adipocytes prior 
to insulin stimulation, one might expect to see a reduction in IRS-1 phosphorylation, 
as endogenous IRS-1 would compete with exogenous PH domain for binding sites at 
the plasma membrane. Initial experiments (Figure 3.1.7) in which permeabilized cells 
were pre-incubated with 3.5 pM IRS-1 PH domain prior to stimulation with 100 nM 
insulin for 10 min demonstrated no attenuation of IRS-1 tyrosine phosphorylation by 
the insulin receptor. However, by shortening the duration of insulin treatment, 
disruption of insulin-stimulated IRS-1 phosphorylation by the IRS-1 PH domain could 
be observed (Figure 3.1.8). Pre-treatment with 10 pM IRS-1 PH domain prior to 
stimulation with 100 nM insulin for 2 min led to a phosphorylated IRS-1 band with an 
intensity that was 43.1% of that from control insulin-stimulated cells (after subtraction 
of the value for the band from basal cells). A similar experiment was carried out, in 
which permeabilized cells were pre-incubated with 3.5 pM IRS-1 PH domain (Figure 
3.1.9). Attenuation of IRS-1 phosphorylation was also seen, confirming that it was 
the duration of insulin treatment in the initial experiments that was responsible for the 
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Figure 3.1.7. Insulin-stimulated Tyrosine Phosphorylation of IRS-1 Following 
the Introduction of IRS-1 PH Domain into Permeabilized 3T3-L1 Adipocytes.
Each dish o f 3T3-L1 adipocytes was permeabilized and pre-incubated for 15 min before a further 10 
min incubation without (B) or with (I) 100 nM insulin (Methods 2.3.2)\ one group was pre-incubated 
with 3.5 pM IRS-1 PH domain prior to insulin stimulation (P). Each dish o f  cells was immediately 
solubilized in 200 pi boiling-hot sample buffer (with 1 mM Na3V 0 4) before heating at 100 °C for 5 min 
and sonication. Samples were resolved on a 7% SDS-PAGE gel, transferred to nitrocellulose and 
immunblotted with anti-phosphotyrosine (<Methods 2 .7). Markers show molecular weights in kDa.
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Figure 3.1.9. Attenuation of Insulin-stimulated Tyrosine Phosphorylation of 
IRS-1 Following the Introduction of 3.5 pM IRS-1 PH Domain into 
Permeabilized 3T3-L1 Adipocytes.
3T3-L1 adipocytes were treated as in Figure 3.1.8, except that pre-incubation was for 20 min with 3.5 
pM IRS-1 PH domain before stimulation with 100 nM insulin for 2 min. A densitometric scan was 
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Figure 3.1.8. Attenuation of Insulin-stimulated Tyrosine Phosphorylation of 
IRS-1 Following the Introduction of IRS-1 PH Domain into Permeabilized 3T3- 
L1 Adipocytes.
3T3-L1 adipocytes were treated as in Figure 3.1.7, except that the pre-incubation was for 20 min with 
10 pM IRS-1 PH domain before stimulation with 100 nM insulin for 2 min. (a) Immunoblot with anti- 
phosophotyrosine. (b) Densitometric scan o f  tyrosine-phosphorylated bands for IRS-1 and the insulin 
receptor (IR). Values are the means from two independent experiments. Error bars show Min and Max 
values.
As the IRS-1 PH domain is able to affect phosphorylation of IRS-1 by the insulin 
receptor, then this may perturb downstream events in this signalling pathway. PI 3-K 
is activated upon binding to phosphorylated IRS-1, so its activity on
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immunoprecipitated IRS-1 was measured following insulin stimulation of 
permeabilized 3T3-L1 adipocytes pre-treated with IRS-1 PH domain (Figure 3.1.10): 
however, no reduction in activity was observed. The activation of PI 3-K leads 
ultimately to an increase in glucose uptake, so this was also measured under the same 
conditions that affect insulin-stimulated phosphorylation of IRS-1 (Figure 3.1.11): 















Figure 3.1.10. PI 3-K Activity on IRS-1 Immunoprecipitates Following Insulin 
Stimulation of Permeabilized 3T3-L1 Adipocytes Pre-incubated with IRS-1 PH 
Domain.
3T3-L1 adipocytes were treated as in Figure 3.1.8. IRS-1 was immunoprecipitated and assayed for PI 
3-K activity as in Methods 2.5.1. Values are the means from single experiments (one with 3.5 pM and 
the other with 10 pM PH domain) done in duplicate. Error bars show Min and Max values.
Earlier studies by Myers Jr. et al. (1995) and Voliovitch et al. (1995) had suggested a 
role for the PH domain in coupling IRS-1 to the insulin receptor. In this study, the 
presence of exogenous IRS-1 PH domain in permeabilized 3T3-L1 adipocytes was 
sufficient to attenuate insulin-stimulated tyrosine phosphorylation of IRS-1, but only 
at shorter insulin stimulation times. However, a control protein should have also been 
tested for its ability to affect receptor-mediated IRS-1 phosphorylation: this could be a 
protein with a similar molecular weight to the IRS-1 PH domain, or a PH domain 
mutant. Nevertheless, the results are consistent with Myers Jr. et al. (1995), who
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demonstrated that the absence of a PH domain impaired insulin-stimulated 
phosphorylation of IRS-1, but not if the insulin receptor was overexpressed. Thus, 
both investigations indicate a role, though not essential, of the PH domain in allowing 
IRS-1 phosphorylation by the insulin receptor. So far, the nature of the interaction of 
the IRS-1 PH domain with the insulin receptor has not been identified, though it does 
not appear to involve direct binding to the receptor (Myers Jr. et al., 1995). In further 
investigations, it would be interesting to repeat the experiments again, but in a cell- 
free system. Thus, the purified insulin receptor could be reconstituted into a varied 
lipid environment before determining the phosphorylation of recombinant IRS-1 in the 
absence or presence of IRS-1 PH domain. Thus, it may suggest a role for certain 
phospholipids in this process. Further, it may help to assess whether an intermediate 
protein is required for the interaction of IRS-1 with the insulin receptor.
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Figure 3.1.11. Uptake of 2-deoxy-D-Glucose Following Insulin Stimulation of 
Permeabilized 3T3-L1 Adipocytes Pre-incubated with IRS-1 PH Domain.
3T3-L1 adipocytes were treated as in Figure 3.1.8. Uptake o f  2-deoxy-D-glucose was measured as in 
Methods 2.4.2. Values are the means from a single experiment done in duplicate. Error bars show Min 
and Max values.
However, under the same conditions that led to impaired insulin-stimulated IRS-1 
phosphorylation, there was no effect on the insulin-stimulation of PI 3-K activity in 
IRS-1 immunoprecipitates or of 2-deoxy-D-glucose uptake. In contrast, Myers Jr. et 
al. (1995) found that the deletion of the IRS-1 PH domain led to complete inhibition 
of insulin-stimulated PI 3-K activity in IRS-1 immunoprecipitates. However, in their
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cell system, insulin-stimulated IRS-1 phosphorylation was virtually blocked. Thus, a 
possible explanation for the failure in this study to observe inhibition by the IRS-1 PH 
domain of insulin-stimulated events downstream of IRS-1 phosphorylation could be 
that, under normal conditions, only a fraction of phosphorylated IRS-1 is required for 
activation of downstream processes. Thus, partial inhibition of insulin-stimulated 
IRS-1 phosphorylation would not be sufficient to have an effect on downstream 
signalling. Also, in measurements of 2-deoxy-D-glucose uptake following insulin 
stimulation in the presence of exogenous IRS-1 PH domain, the 5 min assay time may 
see the full tyrosine phosphorylation of IRS-1 occurring. Thus, this may also explain 
the failure to see attenuation of insulin-stimulated transport activity.
Though the methods described in this study were unable to completely block insulin- 
stimulated tyrosine phosphorylation of IRS-1 and resultant downstream processes, 
they do however point to a role for the PH domain in coupling IRS-1 to its receptor. 
In view of the recognition of a role for the IRS-1 PTB domain in coupling IRS-1 to the 
insulin receptor (Yenush et al., 1996), it would be interesting to determine insulin- 
stimulated IRS-1 phosphorylation following the introduction of both the PH and PTB 
domains into permeabilized 3T3-L1 adipocytes: it is possible that both domains may 
be more effective in inhibiting this process than the PH domain alone.
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3.2 Development of an Assay for PKB
Before studies could be undertaken to investigate the role of PKB in insulin-regulated 
glucose uptake, an assay for the kinase had to be developed. The following 
experiments describe how the eventual method (.Methods 2.5.2) was arrived at. 
Initially, the possibility of measuring PKB activity in plasma membrane-free cell 
extracts from 3T3-L1 adipocytes was investigated (Figure 3.2.1), using Crosstide as 
the enzyme substrate, since the peptide is from a sequence in GSK-3 that is 
phosphorylated by PKB in vitro (Cross et al., 1995).














Figure 3.2.1. Measurement of Crosstide-phosphorylating activity in Post-Crude- 
Plasma-Membrane Fractions from 3T3-L1 Adipocytes.
3T3-L1 adipocytes were insulin-stimulated as in Methods 2.3.1, except that a 30 min pre-incubation in 
1 ml KRH buffer was included before a further 10 min incubation without (B) or with (I) 100 nM 
insulin; one pre-incubation included 1 pM wortmannin before insulin treatment (W). Cells were 
homogenized and the crude plasma membrane fraction removed (Methods 2.6.1). Kinase activity in 10 
pi aliquots o f  cell extract was measured as in Methods 2.5.2, using 25 pg Crosstide per assay. Samples 
were incubated for 10, 20 or 30 min, after which 10 pi aliquots were spotted onto phosphocellulose. 
Background counts were determined from an aliquot o f radiolabelled ATP with activity equivalent to 
that in 10 pi o f reaction mixture (containing cell extract).
Insulin stimulation (100 nM for 10 min) was found to raise kinase activity by about 4- 
fold over basal levels. Pre-treatment of cells with 1 pM wortmannin - to block 
activation of PKB by upstream PI 3-K activation (Kohn et al., 1995) - prior to insulin
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treatment did not completely prevent the increase in kinase activity. This observation 
indicates that kinases other than PKB in the 3T3-L1 adipocyte homogenates may have 
also been catalyzing the phosphorylation of Crosstide. Taking into consideration that 
the insulin-stimulated response was low, it was decided that PKB activity should be 
measured in PKB immunoprecipitates.
Using anti-Rac-CT to immunoprecipitate PKB from cell lysate, kinase activity from 
basal and insulin-stimulated 3T3-L1 adipocytes was measured. However, 
phosphorylated Crosstide was not detected in the reaction mixture supernatant after 






Figure 3.2.2. Crosstide-phosphorylating Activity in Rac-CT Immunoprecipitates 
from Basal and Insulin-stimulated 3T3-L1 Adipocytes.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated without (B) or with (I) 100 nM insulin for 
20 min. PKB was immunoprecipitated from each dish (5 pg anti-Rac-CT conjugated to 50 pi protein A 
sepharose) and activity assayed as in Methods 2.5.2, using 25 pg Crosstide per assay in 30 min 
incubations. Aliquots o f 10 pi o f reaction mixture supernatant were spotted onto phosphocellulose. 
Background (BG) counts were determined from 50 pi protein A sepharose that had been treated in the 
same way as the immunoprecipitates.
To investigate the possibility that the Crosstide substrate may have been binding to or 
become trapped in the immunoprecipitates, another assay was carried out using 
protamine sulphate, a non-physiological protein substrate (Jones et al., 1991) (Figure
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3.2.3). It was found that phosphorylated protein - not present in the supernatant - 
could be released from the immunoprecipitates with electrophoresis sample buffer.
10.On
Figure 3.2.3. Phosphorylated Protamine Sulphate Binds to Rac-CT Immuno­
precipitates.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated without (B) or with (I) 100 nM insulin for 
20 min. PKB was immunoprecipitated from each dish (2.5 pg anti-Rac-CT conjugated to 25 pi protein 
A sepharose) and activity assayed as in Methods 2.5.2, using 25 pg protamine sulphate per assay in 30 
min incubations. Reaction mixture supernatant was removed and protein was eluted from the beads 
with 40 pi 2x sample buffer before separation on a 13% SDS-PAGE gel (.Methods 2.7.2). Radioactive 
bands were then cut out and counted. Background counts were determined from an empty lane on the 
gel and subtracted from the other counts.
Thus, it was concluded that a way to overcome the problem of Crosstide binding to 
the Rac-CT immunoprecipitates might be to use a detergent solution to elute the 
peptide, which could then be spotted onto phosphocellulose. To determine if the 
presence of SDS affects the binding of phosphorylated Crosstide to phosphocellulose, 
kinase activity was measured again in plasma membrane-free cell extract from 3T3-L1 
adipocytes. Aliquots from the reaction mixture were then either spotted directly onto 
phosphocellulose, or mixed with SDS solution first before spotting (Figure 3.2.4). 
The counts detected on phosphocellulose were similar regardless of whether the 
aliquots added contained SDS or not.
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Figure 3.2.4. Binding of Phosphorylated Crosstide to Phosphocellulose in the 
Absence and Presence of SDS.
3T3-L1 adipocytes were treated without (B) or with (I) insulin, homogenized, fractionated and assayed 
for kinase activity as in Figure 3.2.1. At the end o f  a 30 min incubation, 10 pi reaction mixture was 
mixed with 10 pi 0.5% (w/v) or 2% (w/v) SDS before spotting onto phosphocellulose. For the 
control, 10 pi reaction mixture (with cell extract) was spotted directly onto phosphocellulose.
Another measurement of kinase activity in immunoprecipitates of PKB from 3T3-L1 
adipocytes was made using anti-Aktl(C-20) (the Rac-CT antibody was discontinued 
by the supplier) to immunoprecipitate the kinase (Figure 3.2.5). This time, at the end 
of the assay, aliquots of the supernatant were spotted onto phosphocellulose separately 
from aliquots of 2% (w/v) SDS that had been mixed with the beads. Unexpectedly, 
little or no phosphorylated Crosstide was detected on the immunoprecipitates, perhaps 
because a different antibody was used, or because protein G sepharose was used 
instead of protein A. PKB activity was found to be 5-6 times higher in insulin- 
stimulated cells than in basal cells.
83
Beads Sup. Combined
Figure 3.2.5. Crosstide-phosphorylating Activity in Aktl(C-20) Immunoprecip­
itates from 3T3-L1 Adipocytes.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated without (B) or with (I) 100 nM insulin for 
20 min. PKB was immunoprecipitated from each dish (2.5 pg anti-Aktl(C-20) conjugated to 25 pi 
protein G sepharose) and assayed for kinase activity as in Methods 2.5.2, using either 25, 50 or 100 pg 
Crosstide per assay in 30 min incubations. Supernatant was removed and 10 pi spotted onto 
phosphocellulose (Sup.); beads were mixed with 40 pi 2% (w/v) SDS for 10 min before 10 pi was 
spotted (Beads). Counts from both samples were combined to give total activity (Combined). For the 
background, 25 pi protein G sepharose was treated in the same way as the immunoprecipitates.
In order to determine the time range where incorporation of phosphate into Crosstide 
is linear, subsequent measurements of PKB activity in immunoprecipitates from 3T3- 
L1 adipocytes were carried out in which different incubation times were studied. 
However, an insulin-stimulated rise in PKB activity could no longer be observed (data 
not shown). In order to assess if there was a problem with the stock of Crosstide, an 
assay of PKB activity in rat adipocytes was carried out using either the peptide or 
protamine sulphate as the enzyme substrate (Figure 3.2.6). An increase in PKB 
activity upon insulin stimulation was observed if the protein was used as the substrate 
in the assay instead of the peptide. Thus, protamine sulphate was used in all 
subsequent assays for PKB.
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Figure 3.2.6. Comparison between Crosstide and Protamine Sulphate as the 
Substrate for Measurement of PKB Activity in Rat Adipocytes.
Freshly-isolated rat adipocytes prepared as in Methods 2.2.2 were treated without (B) or with (I) 20 nM 
insulin for 20 min, before immunoprecipitation o f PKB (from 0.5 ml o f 40% (v/v) cells) and 
measurement o f kinase activity as in Methods 2.5.2, using either 25 pg Crosstide or 25 pg Protamine 
Sulphate per assay in 20 min incubations. Aliquots o f  10 pi o f  supernatant were spotted onto 
phosphocellulose. For the background, lOpl protein G sepharose was treated as for the 
immunoprecipitates, with either Crosstide or protamine sulphate in the reaction mixture.
As protamine sulphate was to be used for all further assays, it was necessary to assess 
its characteristics as a PKB substrate. Measurements of PKB activity in 3T3-L1 
adipocytes were carried out using different incubation times in the assay, in order to 
determine if phosphorylation of protamine sulphate was linear over 20 min (Figure 
3.2.7b); in the same experiment, it was determined whether or not the phosphorylated 
protein binds to the immunoprecipitates (Figure 3.2.7a). As the rate of 
phosphorylation was linear for assay times of 10, 15 and 20  min, it was decided that a 
reaction time of 20 min would be used in all further PKB assays. As phosphorylated 
protamine sulphate was detected on the immunoprecipitates, various ways of eluting 
and spotting the phosphorylated protein were investigated (Figure 3.2.8). The method 
of mixing the removed supernatant and eluted protein before spotting onto 
phosphocellulose gave similar levels of PKB activity to that determined using the 
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Figure 3.2.7. Measurement of PKB Activity with Protamine Sulphate as 
Substrate in 3T3-L1 Adipocytes Using Different Incubation Times in the Assay.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated without (B or Basal) or with (I or 
Insulin) 100 nM insulin for 20 min, before immunoprecipitation o f PKB and measurement o f kinase 
activity as in Methods 2.5.2, using 25 pg protamine sulphate per assay in 10, 15 or 20 min incubations. 
At the end o f the assay, 10 pi o f  removed supernatant was spotted onto phosphocellulose, as was 10 pi 
of 40 pi 2% (w/v) SDS that had been mixed with the beads for 10 min. (a) Phosphorylated protamine 
sulphate found on the Beads and in the Supernatant are plotted separately, (b) Phosphorylated 











Figure 3.2.8. Different Methods of Eluting and Spotting Phosphorylated 
Protamine Sulphate at the End of a PKB Assay.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated without (B) or with (I) 100 nM insulin for 
20 min, before immunoprecipitation o f  PKB and measurement o f kinase activity as in Methods 2.5.2. 
Samples were assayed for 20 min, before: (X) spotting 10 pi removed supernatant separately from 10 pi 
o f 40 pi 2% (w/v) SDS that had been mixed with the beads for 10 min; (Y) spotting 20 pi from a 
combined solution o f 50 pi removed supernatant and 40 pi 2% (w/v) SDS that had been mixed with the 
beads for 10 min; (Z) spotting 20 pi o f  a combined solution where 40 pi 2% (w/v) SDS had been mixed 
with beads and supernatant for 10 min.
The appropriate amount of Aktl(C-20) antibody required to immunoprecipitate PKB 
from a dish of 3T3-L1 adipocytes was determined. Cell lysates that had been 
subjected to immunoprecipitation with different quantities of the antibody were 
subsequently immunoblotted with anti-Rac-CT. Thus, any non-immunoprecipitated 
PKB could be detected (Figure 3.2.9). It was found that at least 1 pg antibody was 
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Figure 3.2.9. Western Blotting with Anti-Rac-CT of Cell Lysate from 3T3-L1 
Adipocytes that was Subjected to Immunoprecipitation with Different Quantities 
of anti-Aktl(C-20).
Basal (B) and insulin-stimulated (I) 3T3-L1 adipocytes were prepared, lysed and immunoprecipitated 
{Methods 2.3.1 and 2.5.2). Immunoprecipitation was with 0.25, 0.5, 1 or 2.5 pg Aktl(C-20) antibody 
conjugated to 25 pi protein G sepharose. Samples o f 25 pi cell lysate were then boiled with 25 pi 2x  
sample buffer. Samples were resolved on a 10% SDS-PAGE gel, transferred and immunoblotted 
{Methods 2 .7). The control was cell lysate not subjected to immunoprecipitation o f  PKB. Bands were 
analyzed by densitometry and expressed as a percentage o f the control band.
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3.3 Studies with PKB in 3T3-L1 and Rat Adipocytes
Several experiments were undertaken in order to provide circumstantial evidence for 
or against the involvement of PKB in insulin-stimulated glucose uptake. First, the 
insulin stimulation of PKB activity in 3T3-L1 adipocytes was measured as a function 
of dose and time. The insulin-stimulated response could then be compared with that 
for glucose transport. Second, the effects of wortmannin on insulin-activated PKB 
and insulin-stimulated glucose uptake in 3T3-L1 adipocytes were compared, since 
both processes appear to be regulated by PI 3-K (Kohn et al., 1995, and Clarke et al.,
1994). If PKB stimulates glucose transport, then wortmannin should reduce the 
activity of the former more rapidly than that of the latter. Further, PP2A is a putative 
inactivator of PKB; the phosphatase can be inhibited by okadaic acid (Andjelkovic et 
al., 1996). Thus, the effects of okadaic acid on wortmannin inhibition of insulin- 
stimulated activities for PKB and glucose transport were also compared. Third, 
measurements of PKB activity in subcellular fractions of adipocytes were made in 
order to determine the location of PKB action. The detection of insulin-stimulated 
activity in membrane fractions would support a role for the kinase in regulating 
GLUT4 trafficking. Fourth, the putative regulation of glucose uptake by PKB was 
investigated by using Crosstide as a competitive inhibitor of PKB in permeabilized 
3T3-L1 adipocytes. Inhibition of insulin-stimulated glucose uptake by this peptide 
would suggest the involvement of PKB in this process.
3.3.1 Insulin Stimulation of PKB Activity and Glucose Uptake in 
3T3-L1 Adipocytes
The stimulation of endogenous PKB activity by insulin has already been demonstrated 
in L6 myotubes (Cross et al., 1995), in skeletal muscle and adipose tissue (Cross et 
al, 1997), and in 3T3-L1 adipocytes (Tanti et al., 1997). PKB activity in 3T3-L1 
adipocytes under basal and insulin-stimulated conditions was further characterized in 
the study described here. Cells were stimulated for 20 min with a range of insulin 
concentrations (from 1 pM to 1 pM) prior to measurement of PKB activity (Figure
89
3.3.1a). A sigmoidal dose-response curve was obtained: activity began to rise above 
insulin doses of 100 pM before reaching a plateau at doses above 1 pM. The EC50 (the 
dose that gives the response between the top and bottom plateau) was 21 .8 nM insulin.
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Figure 3.3.1. PKB Activity in 3T3-L1 Adipocytes Following Insulin Stimulation 
with Different Doses.
(a) 3T3-L1 adipocytes prepared as in Methods 2.3.1 were stimulated for 20 min with 0.001, 0.01, 0.1, 
1, 10, 100 and 1000 nM insulin. PKB was immunoprecipitated and assayed for activity as in Methods 
2.5.2. (b) PKB activity in 3T3-L1 adipocytes stimulated without (B) or with (I) 100 nM insulin for 20 
min. Values are the means ± S.E.M. from three independent experiments.
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The PKB activity in 3T3-L1 adipocytes following 100 nM insulin stimulation was 
nearly 23-fold over that in basal cells (Figure 3.3.1b). This response is greater than 
that observed by other groups. Cross et al (1997) found a maximal insulin-stimulated 
rise in PKB activity of 14-fold in freshly-isolated rat adipocytes, whereas Tanti et al 
(1997) determined an 8-fold increase in 3T3-L1 adipocytes following 100 nM insulin 
stimulation for 5 min. It is difficult to determine whether this discrepancy was due to 
low basal activity and/or high insulin-stimulated activity in this thesis, as the other 
groups have only described PKB activity as a percentage of the maximum. A possible 
reason may be that protamine sulphate was used as the substrate instead of Crosstide, 
which was preferred by the other groups. However, it has been shown earlier in this 
thesis (Results and Discussion 3.2) that the phosphorylation of protamine sulphate by 
immunoprecipitated PKB from basal and insulin-stimulated 3T3-L1 adipocytes is 
linear over a 20 min assay period. A more likely reason is that, in this thesis, PKB 
immunoprecipitates were treated with detergent at the end of an assay in order to 
remove any non-specifically bound phosphorylated substrate. As shown earlier 
(Figure 3.2.7a), phosphorylated protamine sulphate is distributed similarly between 
the supernatant and PKB immunoprecipitates from insulin-stimulated cells. However, 
for PKB immunoprecipitates from basal cells, the phosphorylated substrate is located 
mainly in the supernatant. Thus, the detergent extracts would have a greater effect on 
measured insulin-stimulated activity than on measured basal activity, giving a greater 
basal/insulin difference. Species difference could be another possible explanation for 
why the fold-increase for insulin-stimulated PKB activity was determined to be 
greater than that found by Cross et al. (1997). Thus, they measured PKB activity in 
freshly-isolated rat adipocytes, which may give a different response to 3T3-L1 
adipocytes.
To determine the time-course of activation of PKB by insulin in 3T3-L1 adipocytes, 
cells were stimulated with 100 nM insulin for different times, from 2 min to 1 h 
(Figure 3.3.2). PKB activity was similar whether the cells were stimulated for 2 min 
or for 1 h. Thus, activation of PKB by insulin in 3T3-L1 adipocytes is rapid and is 
maintained despite prolonged acute stimulation. This time-course data for insulin 
stimulation of PKB activity is consistent with Cross et al (1997). In freshly-isolated
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rat adipocytes, they found that half-maximal activity occurred at 2 min, with maximal 
activity at 5 min; activity was maintained for at least 1 h. The rapid and sustained rise 
in PKB activity following insulin stimulation is consistent with its putative role in 
insulin-stimulated glucose uptake, as stimulation of 2-deoxy-D-glucose uptake in 3T3- 
L1 adipocytes is not maximal until after 10-15 min treatment with 100 nM insulin 
(Fingar and Bimbaum, 1994b). Thus, in 3T3-L1 adipocytes, insulin stimulation 
maximally activates PKB before there is a maximal level of glucose transport.
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Figure 3.3.2. PKB Activity in 3T3-L1 Adipocytes Following Stimulation with 
Insulin for Different Lengths of Time.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were stimulated with 100 nM insulin for 2 min to 1 h. 
PKB was immunoprecipitated and assayed for activity as in Methods 2.5.2. Values are from a single 
experiment.
To compare the insulin stimulation of glucose uptake with that of PKB activity in 
3T3-L1 adipocytes, measurements of 2-deoxy-D-glucose uptake were made at the 
insulin concentrations that were used in Figure 3.3.1a (Figure 3.3.3a). The sigmoidal 
dose-response curve observed was to the left of that for insulin-stimulated PKB 
activity (Figure 3.3.3b). Uptake of 2-deoxy-D-glucose began to increase at doses 
above 10 pM before reaching a plateau above doses of 100 nM. The EC50 was 1.19 nM 
insulin. Also, while 100 nM insulin stimulation for 20 min produced a maximal 
response in terms of glucose uptake, the same could not be said for PKB activity.
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Thus, glucose transport is more sensitive to insulin stimulation than PKB activity in 
3T3-L1 adipocytes.
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Figure 3.3.3. Uptake of 2-deoxy-D-glucose in 3T3-L1 Adipocytes Following 
Insulin Stimulation with Different Doses.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were stimulated for 20 min with 0.001, 0.01, 0.1, 1, 
10, 100 and 1000 nM insulin, (a )  Uptake of 2-deoxy-D-glucose was measured as in Methods 2.4.1. 
Values are the means ± S.E.M. from three independent experiments, (b) Data from Figures 3.3.1a 
(PKB) and 3.3.3a (2-deoxy-D-glucose) are expressed as a percentage of the response at 1 pM insulin 
stimulation.
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Similarly, the dose-response curve for insulin-stimulated insulin receptor p-subunit 
phosphorylation in 3T3-L1 adipocytes is also to the right of that for insulin-stimulated 
glucose uptake (Kohanski et a l , 1986). They determined an EC50 value of 8 nM for 
the former, which is less than that for insulin stimulation of PKB activity (21.8 nM). 
Kohanski et al. (1986) also determined an EC50 of 2 nM for insulin-stimulated glucose 
transport, which is similar to that determined here (1.19 nM). The greater sensitivity 
of glucose transport to insulin stimulation than P-subunit phosphorylation or 
activation of PKB may be a result of amplification of the signal from the insulin 
receptor.
3.3.2 Inhibition of Insulin Stimulation of PKB Activity and Glucose 
Uptake in 3T3-L1 Adipocytes
The pre-treatment of CHO cells overexpressing the insulin receptor with wortmannin 
(which blocks PI 3-K activity) inhibits insulin activation of PKB (Kohn et al., 1995). 
Experiments were undertaken to determine if this was also the case in 3T3-L1 
adipocytes. Thus, cells were stimulated with 100 nM insulin for 20 min to activate 
PKB, before treatment with 1 pM wortmannin for different lengths of time; 
measurements of PKB activity were subsequently made (Figure 3.3.4a). This insulin 
and wortmannin treatment regime was the same as that used to demonstrate maximal 
inhibition of insulin-stimulated PI 3-K activity by wortmannin in 3T3-L1 adipocytes 
(Yang et al., 1996). PKB activity declined rapidly following wortmannin treatment 
with a half-time of 52.8 s, before reaching a plateau of 4.35 finoles Pi/min/dish. Thus, 
the addition of wortmannin to insulin-stimulated 3T3-L1 adipocytes causes a rapid 
decline in PKB activity to basal levels. As wortmannin does not inhibit PKB in vitro 
(Kohn et a l , 1995), then this result suggests that insulin stimulation of PKB activity 
occurs via PI 3-K only, without contributions from convergent signalling pathways. 
Further evidence for PI 3-K regulation of PKB in 3T3-L1 adipocytes could be 
provided by the use of the other PI 3-K inhibitor, LY294002. Alternatively, a 
dominant negative form of PI 3-K could be expressed in 3T3-L1 adipocytes. The 
virtual inhibition of insulin-stimulated PKB activity by wortmannin is consistent with
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previous studies in CHO cells co-expressing the insulin receptor and PKBa (Kohn et 
al., 1995) and in L6 myotubes (Cross et al., 1995). In these studies, the addition of 
wortmannin prior to insulin stimulation blocked the rise in PKB activity.
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Figure 3.3.4. Inhibition of Insulin-stimulated PKB Activity and 2-deoxy-D- 
glucose Uptake by Wortmannin in 3T3-L1 Adipocytes.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were stimulated with 100 nM insulin for 20 min before 
1 pM wortmannin was added for a further 2 to 30 min. (a) PKB was immunoprecipitated and assayed 
for activity as in Methods 2.5.2. (b) Uptake of 2-deoxy-D-glucose was measured as in Methods 2.4.1, 
using assay times o f 2 min. Values are the means ± S.E.M. from three independent experiments.
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As a comparison, the inhibition of insulin-stimulated glucose uptake in 3T3-L1 
adipocytes by wortmannin was also determined (Figure 3.3.4b). Cells were stimulated 
with 100 nM insulin for 20 min prior to 1 pM wortmannin treatment and measurement 
of 2-deoxy-D-glucose uptake. Transport of 2-deoxy-D-glucose declined less rapidly 
than PKB activity following wortmannin treatment, with a half-time of 5 min. 
Transport did not begin to plateau at the lower level until after 30 min treatment with 
wortmannin, whereas for PKB activity, the plateau occurred after 10 min. Thus, 
insulin-activated PKB activity is more sensitive to wortmannin inhibition than insulin- 
stimulated glucose uptake in 3T3-L1 adipocytes. Further, the data from Figure 3.3.4 
is consistent with the idea that PKB is an upstream regulator of glucose transport, 
since the virtual inactivation of PKB occurs more quickly than the reduction in 
transport activity to basal levels.
PP2A can dephosphorylate and inactivate immunoprecipitated PKB from vanadate- 
stimulated Swiss 3T3 cells (Andjelkovic et al., 1996). As stimulated kinase activity is 
reduced by 92%, this suggests PP2A may inactivate PKB in vivo. Further, the 
presence of okadaic acid during PP2 A treatment prevents inhibition of kinase activity 
in PKB immunoprecipitates. Thus, studies were carried out in 3T3-L1 adipocytes to 
determine if okadaic acid could affect the inhibition of insulin-stimulated PKB 
activity by wortmannin (Figure 3.3.5a). During treatment with 100 nM insulin for 20 
min, 1 pM okadaic acid was also present. Cells were then further incubated with 1 pM 
wortmannin before measurement of PKB activity. Following the addition of the PI 3- 
K inhibitor, PKB activity declined with a half-time of 224.8 s before reaching a 
plateau of 12.19 fmoles Pj/min/dish. It was shown above (Results and Discussion
3.3.2) that the inhibition of insulin-stimulated PKB activity by wortmannin occurs 
with a half-time of 52.8 s before reaching a plateau of 4.35 fmoles Pi/min/dish (Figure 
3.3.4a). Thus, okadaic acid treatment reduces the rate at which wortmannin treatment 
leads to inhibition of insulin-stimulated PKB activity. Also, okadaic acid reduces the 
extent of wortmannin inhibition of insulin activation of PKB. These two observations 
indicate that okadaic acid can partially counteract the block of insulin activation of 
PKB by wortmannin in 3T3-L1 adipocytes. Thus, the results suggest that PP2A has 
only a partial role to play in the dephosphorylation and subsequent inactivation of
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PKB. If it is the major inactivator of PKB, as suggested by in vitro studies 
(Andjelkovic et a l , 1996), then okadaic acid should have prevented the huge 
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Figure 3.3.5. Inhibition of PKB Activity and 2-deoxy-D-glucose Uptake by 
Wortmannin in 3T3-L1 Adipocytes Following Treatment with Insulin and 
Okadaic Acid.
3T3-L1 adipocytes prepared as in Methods 2.3.1 were treated with 100 nM insulin and 1 pM okadaic 
acid for 20 min before 1 pM wortmannin was added for a further 2 to 60 min. (a) PKB was 
immunoprecipitated and assayed for activity as in Methods 2.5.2. (b) Uptake of 2-deoxy-D-glucose was 
measured as in Methods 2.4.1, using assay times of 2 min. Values are the means ± S.E.M. from three 
independent experiments.
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Earlier studies in 3T3-L1 adipocytes had shown that pre-treatment with 1 pM okadaic 
acid attenuates insulin-stimulated PI 3-K activity in anti-phosphotyrosine 
immunoprecipitates by 65% (Jullien et a l, 1993). However, their results are 
inconsistent with the study described here. The activity of downstream PKB in 
insulin-stimulated 3T3-L1 adipocytes is 74.6 ±2.13 fmoles Pi/min/dish, whereas it is
69.5 ± 7.81 fmoles Pi/min/dish in the presence of okadaic acid (Figures 3.3.4a and 
3.3.5a). The two values are not significantly different (P > 0.05). Thus, okadaic acid 
treatment appears to have no effect on insulin stimulation of PKB activity (though it 
may activate PKB in the absence of insulin stimulation - compare the plateau in 
Figure 3.3.4a with that in Figure 3.3.5a). The reason for the discrepancy is not clear. 
A possibility is that Jullien et al. (1993) treated their cells with okadaic acid before 
stimulating with insulin, whereas in the study described here, both compounds were 
added at the same time to the dishes of cells. Thus, the inhibitory effects of okadaic 
acid on the insulin stimulation of PI 3-K may be reduced in the latter method.
If PKB does regulate glucose transport, then okadaic acid should also partially block 
the wortmannin inhibition of insulin-stimulated glucose uptake. Thus, 3T3-L1 
adipocytes were treated with 100 nM insulin and 1 pM okadaic acid for 20 min, before 
1 pM wortmannin was added for various lengths of time prior to measurement of 2- 
deoxy-D-glucose uptake (Figure 3.3.5b). Compared with cells that were insulin- 
stimulated in the absence of okadaic acid (Figure 3.3.4b), the decline in 2-deoxy-D- 
glucose uptake following wortmannin treatment was slower and linear over the time- 
points up to 60 min. Even after 60 min incubation with wortmannin, the transport rate 
was greater than 200 pmoles/min/dish (Figure 3.3.5b), compared with 33 
pmoles/min/dish at 30 min in cells which were untreated with okadaic acid (Figure 
3.3.4b).
From the data in Figures 3.3.4a and 3.3.5a, it can be calculated that okadaic acid 
increases the half-time for wortmannin inhibition of insulin-stimulated PKB activity 
by a factor of 4.26. If okadaic acid affects the half-time for wortmannin inhibition of 
insulin-stimulated glucose uptake by the same factor, then its value should be 21.3 
min. However, the results show that the half-time is greater than 60 min (Figure
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3.3.5b). Thus, the ability of okadaic acid to attenuate the wortmannin inhibition of 
insulin-stimulated glucose uptake may not be solely due to action at the level of PKB. 
A possibility is that okadaic acid may also act at another target to counteract 
wortmannin inhibition of insulin-stimulated glucose uptake. In future experiments, it 
would be interesting to determine the rate of loss of ATB-BMPA-labelled cell surface 
GLUT4 following the addition of wortmannin to adipocytes insulin-stimulated in the 
presence of okadaic acid. This would allow an estimation of the rates of endocytosis 
and exocytosis of GLUT4 (Yang and Holman, 1993): these values could then be 
compared with those for 3T3-L1 adipocytes expressing constitutively active PKB.
3.3.3 Insulin Stimulation of PKB Activity in Subcellular Fractions of 
Adipocytes
The addition of a src myristoylation sequence to the N-terminus of PKB lacking its 
PH domain has been shown to cause constitutive activation of the kinase when this is 
expressed in 3T3-L1 cells (Kohn et al., 1996b). This indicates that the site of 
activation and action of insulin-activated PKB in the cell may be at a membrane 
location, since the myristoylation sequence enables a protein to attach to a membrane. 
In order to determine the effect of insulin on the subcellular location of PKB activity, 
3T3-L1 adipocytes were subfractionated into cytoplasmic, PM and LDM fractions 
prior to measurement of kinase activity. PKB activity was found to be present in all 
three fractions (Figure 3.3.6a). An insulin-stimulated increase in activity occurred 
only in the cytoplasmic fraction, where a 3-fold response was observed. A similar 
result was obtained when the experiment was repeated using freshly-isolated rat 
adipocytes, instead of 3T3-L1 adipocytes (Figure 3.3.6b).
The insulin-stimulated increase in cytosolic PKB activity does not appear to be due to 
translocation from either the plasma membrane or the LDM fractions, as activity in 
those compartments are similar in the basal and insulin-stimulated states. A 
possibility is that cytosolic PKB is activated at a membrane site, but then returns to
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the cytoplasm. Thus, determination of PKB activity in subcellular fractions at 
different insulin stimulation times may show this.























Figure 3.3.6. PKB Activity in Subcellular Fractions of 3T3-L1 and Rat 
Adipocytes.
3T3-L1 adipocytes (a ) and freshly-isolated rat adipocytes (b) prepared as in Methods 2.3.1 and 2.2.2 
were treated without (B) or with (I) insulin for 20 min (100 nM for the former and 20 nM for the latter). 
Cells were homogenized and subfractionated into cytoplasmic (C), plasma membrane (PM) and low 
density microsome (LDM) fractions as in Methods 2.6. Aliquots o f  50 pg protein were subjected to 
PKB immunoprecipitation (2 pg anti-Aktl(C-20) conjugated to 10 pi protein G sepharose in 1 ml lysis 
buffer) and assayed for activity as in Methods 2.5.2. Values are from a single experiment in each case.
The increase in activity of cytosolic PKB is consistent with its role as a regulator of 
the cytosolic proteins GSK-3 (Cross et al., 1995) and pp70S6k (Burgering and Coffer,
1995), but not with its role as a regulator of GLUT4 translocation, since insulin-
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stimulated PI 3-K appears to act at an intracellular membrane compartment (Nave et 
al., 1996a, and Ricort et a l, 1996). A possibility may be that, instead of acting at an 
intracellular compartment to initiate GLUT4 exocytosis, PKB may regulate signalling 
molecules involved in the fusion of GLUT4 vesicles with the plasma membrane.
3,3.4 Insulin Stimulation of Glucose Uptake in Permeabilized 3T3-L1 
Adipocytes Pre-treated with Crosstide
Crosstide is a peptide that corresponds to a sequence from GSK-3 that is 
phosphorylated by PKB upon insulin stimulation of L6 myotubes (Cross et al., 1995). 
If this peptide is present inside a cell, it may compete with endogenous substrates for 
phosphorylation by PKB, thereby attenuating the cellular responses regulated by the 
kinase. Thus, Crosstide was introduced into permeabilized 3T3-L1 adipocytes to 
determine if it would perturb insulin-stimulated glucose uptake. Permeabilized cells 
were pre-incubated with Crosstide (50 pg per dish) for 15 min prior to stimulation 
with 100 nM insulin for 20 min and subsequent measurement of 2-deoxy-D-glucose 
uptake (Figure 3.3.7). However, insulin-stimulated transport was the same regardless 
of whether the cells were pre-incubated with Crosstide or not. Increasing the amount 
of Crosstide per dish to 100 pg and reducing the insulin stimulation time to 5 min had 
no effect.
Thus, the use of Crosstide as a competitive inhibitor of PKB (at concentrations greater 
than 80 pM) does not appear to perturb submaximal insulin stimulation (100 nM for 5 
min) of 2-deoxy-D-glucose uptake in 3T3-L1 adipocytes. A problem with interpreting 
this result is that it is not known whether PKB activity towards endogenous substrates 
was sufficiently blocked. As a control, the phosphorylation of endogenous GSK-3 or
Of t *
the activation of pp70 could be measured in response to insulin stimulation in the 
presence of Crosstide: attenuation of these PKB-regulated events would indicate 
competitive inhibition of PKB. These experiments were performed before it was 
discovered that it was no longer possible to assay PKB activity in immunoprecipitates 
with Crosstide as the substrate (Results and Discussion 3.2). Thus, the possibility that
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there is a fault with the Crosstide peptide can be ruled out. An alternative method to 
inhibition of PKB activity in 3T3-L1 adipocytes might be to block its activation. Two 
residues in PKBa (ser-473 and thr-308) are phosphorylated in response to insulin 
stimulation (Alessi et al., 1996). Thus, the introduction into 3T3-L1 adipocytes of 
two peptides corresponding to these phosphorylation sites of PKB may block insulin- 
activation of this kinase.
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Figure 3.3.7. Introduction of Crosstide into Permeabilized 3T3-LI Adipocytes 
prior to Measurement of Basal and Insulin-stimulated 2-deoxy-D-glucose Uptake.
Permeabilized 3T3-L1 adipocytes prepared as in Methods 2.3.2 were pre-incubated for 15 min prior to 
treatment without (B) or with (I) 100 nM insulin; one group o f  cells were pre-incubated with Crosstide 
prior to insulin stimulation (C). Uptake o f  2-deoxy-D-glucose was measured as in Methods 2.4.2. 
(Experiment 1) Pre-incubation with 50 pg Crosstide per dish and insulin stimulation for 20 min. 
(Experiment 2) Pre-incubation with 100 pg Crosstide per dish and insulin stimulation for 5 min. 
Values are the means from a single duplicate experiment. Error bars show Min and Max values.
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3.4 Studies with 3T3-L1 Adipocytes Expressing a Constit- 
utively Active Form of PKB
The expression of a constitutively active form of PKB in 3T3-L1 adipocytes has 
previously been shown to raise basal glucose uptake (Kohn et al., 1996b). The ATB- 
BMPA photolabel was used to determine the effect of this constitutively active kinase 
on cell surface levels of GLUT1 and GLUT4. Thus, an assessment of the relative 
contributions of both transporter isoforms to the elevated glucose transport activity 
could be made.
3T3-L1 adipocytes expressing constitutively active PKB were supplied by Professor 
R.A. Roth. Fibroblasts were infected with a murine retrovirus encoding a variant of 
PKB known as myrAkt A4-129, which has the PH domain (amino acids 4-129) 
deleted and a src myristoylation sequence added onto the N-terminus. Control cells 
express wild-type PKB (wtAkt). Both PKB constructs have a hemagglutinin epitope 
tag at the C-terminus. Previous studies (Kohn et al., 1996b) have shown that 
constitutively active PKB causes an increase in glucose uptake in basal cells by 
elevating GLUT1 expression and GLUT4 translocation. Total cellular GLUT1 was 
determined by Western blotting. GLUT4 translocation was measured by the group 
with two different methods. The first was a plasma membrane sheet assay. Cells 
grown on glass coverslips were sonicated to remove the cytoplasm. GLUT4 on the 
remaining plasma membrane was then detected by immunofluorescence microscopy. 
The second approach involved use of an anti-myc antibody binding assay. GLUT4 
containing the c-myc epitope was detected on the cell surface with an anti-myc 
antibody. However, these techniques did not show a large increase in GLUT4 
translocation upon insulin stimulation of control cells (these were 3T3-L1 adipocytes 
expressing either an empty vector or constitutively active PKB with a point mutation 
in the src myristoylation sequence). Also, cell surface GLUT1 was not quantitated. 
Thus, the ATB-BMPA photolabel was used to clarify matters.
To check that the 3T3-L1 adipocytes were expressing functional myrAkt A4-129, 
glucose transport was measured in the basal and insulin-stimulated state (Figure
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3.4.1). For 3T3-L1 adipocytes expressing wtAkt (wtAkt cells), insulin stimulation 
increased 2-deoxy-D-glucose uptake by 21.6-fold over basal levels. For 3T3-L1 
adipocytes expressing myrAkt A4-129 (myrAkt A4-129 cells), basal 2-deoxy-D- 
glucose transport was 38.9% of the insulin-stimulated value, and 9.6-fold greater than 
basal uptake in control wtAkt cells. These figures for the myrAkt A4-129 cells are 
different from those previously determined by Kohn et al. (1996b). They found that 
basal glucose uptake was 70% of the insulin-stimulated value, and 5-fold greater than 
in basal control 3T3-L1 adipocytes infected with an empty vector. Their method was 
slightly different, as they subtracted background counts (assessed by cytochalasin B 
binding) from all transport counts. However, this procedure would increase the 
basal/stimulated fold-increase determined in the study described here. Nevertheless, it 
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Figure 3.4.1. Uptake of 2-deoxy-D-glucose under Basal and Insulin-stimulated 
Conditions in 3T3-L1 Adipocytes Expressing wtAkt and myrAkt A4-129.
3T3-L1 adipocytes expressing wtAkt or myrAkt A4-129 were treated without (wtB and myrB, 
respectively) or with (w tl and m yrl, respectively) 100 nM insulin for 20 min as in Methods 2.3A. 
Uptake o f  2-deoxy-D-glucose was measured as in Methods 2.4.1. Values are the means ± S.E.M. from 
four independent experiments, o f  which three were done in duplicate (n = 7).
Cell surface GLUT1 and GLUT4 in 3T3-L1 adipocytes expressing wtAkt and myrAkt 
A4-129 were quantitated by photolabelling with ATB-BMPA (Figures 3.4.2 and
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3.4.3). For wtAkt cells, insulin treatment resulted in a 4.2-fold and a 10.5-fold 
increase in GLUT1 and GLUT4 respectively at the plasma membrane. These values 
are similar to those determined for non-transfected 3T3-L1 adipocytes (Calderhead et 
al., 1990). In basal myrAkt A4-129 cells, cell surface GLUT1 was 6 -fold greater than 
in basal wtAkt cells. Further, insulin stimulation of myrAkt A4-129 cells led to a 1.8- 
fold increase in GLUT1 at the cell surface. GLUT4 cell surface levels were similar in 
the insulin-stimulated state for both groups of cells. However, in the basal state, 
myrAkt A4-129 cells had 3.9-times more cell surface GLUT4 than wtAkt cells. Thus, 
the data reveals that the expression of constitutively active PKB in 3T3-L1 adipocytes 
leads to higher cell surface levels of GLUT1 and GLUT4 in the basal state. It also 
appears that total cellular GLUT1 (but not total cellular GLUT4) is increased, as 
determined by measurements of cell surface transporters in the insulin-stimulated 
state.
From the experiments described in this study, it is possible that the constitutively 
active PKB was not expressed to a similar level as that by Kohn et al. (1996b). This 
may explain the lower than expected basal glucose uptake in the myrAkt A4-129 cells 
(38.9% of the insulin-stimulated response, rather than 70%). Unfortunately, a 
hemagglutinin epitope antibody was not available at the time to allow 
immunoprecipitation of PKB, and thus a comparison of PKB activity between the two 
studies. However, an indicator of constitutive PKB activity is GLUT1 expression. 
Though total cellular GLUT1 was not quantitated in this study, a figure can be 
determined from the values obtained for cell surface GLUT1. It has been shown 
previously in 3T3-L1 adipocytes that half the total cellular transporters are present in 
the plasma membrane in the insulin-stimulated state (Yang and Holman, 1993). 
Assuming that this phenomenon also applies to 3T3-L1 adipocytes expressing wtAkt 
and myrAkt A4-129, then there is a 252% increase in GLUT1 expression in the latter 
compared with the former. This figure is greater than that of 55% determined by 
Kohn et al (1996b) in their immunoblotting studies. Thus, in this regard, levels of 
constitutively active PKB appear to be comparable to those obtained by Kohn et al 
(1996b).
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Figure 3.4.2. ATB-BMPA Photolabelling of Cell Surface GLUT1 and GLUT4 in 
Basal and Insulin-stimulated 3T3-L1 Adipocytes Expressing wtAkt and myrAkt 
A4-129.
3T3-L1 adipocytes expressing wtAkt or myrAkt A4-129 were treated without (wtB and myrB, 
respectively) or with (wtl and myrl, respectively) 100 nM insulin for 20 min, as in Methods 2.3.1. Cell 
surface transporters GLUT1 (a) and GLUT4 (b) were photolabelled with ATB-BMPA and processed, 
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Figure 3.4.3. ATB-BMPA Photolabelling of Cell Surface GLUT1 and GLUT4 in 
Basal and Insulin-stimulated 3T3-L1 Adipocytes Expressing wtAkt and myrAkt 
A4-129.
3T3-L1 adipocytes expressing wtAkt or myrAkt A4-129 were treated without (wtB and myrB) or with 
(wtl and myrl) insulin before photolabelling o f  cell surface transporters with ATB-BMPA (as in Figure 
3.4.2). Radioactivity counts associated with the transporters GLUT1 (a) and GLUT4 (b) were 
determined as in Methods 2.4.3. Values are the means ± S.E.M. from three (for GLUT1) and five (for 
GLUT4) independent experiments.
From the experiments described in this thesis, the basal level of cell surface GLUT4 in 
myrAkt A4-129 cells was 37% of that in the insulin-stimulated state. This figure is in 
contrast to Kohn et al. (1996b), who found maximal GLUT4 translocation in the basal 
state. The reason for this discrepancy does not appear to be due to reduced GLUT4 
expression in the experiments described in this thesis, since insulin-stimulated levels 
of cell surface GLUT4 in 3T3-L1 adipocytes expressing wtAkt and myrAkt A4-129
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were found to be similar. Further, the extent of GLUT4 translocation and 2-deoxy-D- 
glucose uptake in basal myrAkt A4-129 cells are similar (37% and 38.9% respectively 
of the insulin-stimulated response). These figures are consistent with the role of 
GLUT4 as the dominant isoform that contributes to glucose transport (Calderhead et 
a l , 1990). Thus, ATB-BMPA photolabelling has not underestimated cell surface 
levels of GLUT4. It is possible that Kohn et al (1996b) may have overestimated the 
extent of GLUT4 translocation. First, ATB-BMPA photolabelling is a more 
quantitative method of determining levels of cell surface transporters. Second, though 
Kohn et al (1996b) observed similar levels of cell surface GLUT4 in basal and 
insulin-stimulated myrAkt A4-129 cells, this does not correlate with their transport 
studies, where the basal response was 70% of the insulin-stimulated response. 
Nevertheless, taking glucose uptake as an indicator of GLUT4 translocation, the data 
from Kohn et a l (1996b) would indicate cell surface GLUT4 in basal myrAkt A4-129 
cells that is around 70% of the insulin-stimulated response. Thus, Kohn et al. (1996b) 
would still observe greater GLUT4 translocation in basal myrAkt A4-129 cells than in 
the study described here. The reason for this discrepancy is unclear, especially as the 
expression of GLUT1 in myrAkt A4-129 cells reported here is comparable, if not 
greater, than that observed by Kohn et al (1996b). In any case, constitutively active 
PKB does not appear to cause maximal GLUT4 translocation.
The ATB-BMPA photolabelling studies show that increased GLUT1 expression in 
myrAkt A4-129 cells is associated with an increase in cell surface levels in the basal 
and insulin-stimulated states. Though insulin-stimulated cell surface levels of GLUT1 
are 2.5-fold greater in myrAkt A4-129 cells than in wtAkt cells, a similar difference 
was not observed in terms of 2-deoxy-D-glucose uptake. Thus, insulin-stimulated 2- 
deoxy-D-glucose transport in wtAkt cells was 8 8 % of that in myrAkt A4-129 cells. 
Taken together with the observation that insulin-stimulated cell surface levels of 
GLUT4 were unchanged by the expression of myrAkt A4-129, it appears that 
increased GLUT1 expression does not contribute to the elevated glucose uptake in 
basal myrAkt A4-129 cells.
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To determine the mechanism of action of PKB in the elevation of cell surface GLUT4, 
it would be interesting to examine the recycling of GLUT4. Basal myrAkt A4-129 
cells would be labelled with ATB-BMPA and incubated for different lengths of time, 
such that labelled transporters are internalized. Then, the plasma membrane can 
subsequently be isolated, so that cell surface GLUT4 can be quantitated. Thus, the 
rate of internalization of GLUT4 can be determined, and rates of endocytosis and 
exocytosis estimated (Yang and Holman, 1993). This would allow an assessment of 
the relative contributions of both constants to GLUT4 translocation.
The low translocation of GLUT4 in basal myrAkt A4-129 cells compared with that in 
insulin-stimulated cells may represent a mechanism downstream of PKB that down- 
regulates cell surface GLUT4 in response to continuous stimulation. Thus, it is 
necessary to examine the effects of acute stimulation of PKB activity, as this would be 
a closer representation of normal physiological conditions. A possibility is treatment 
of 3T3-L1 adipocytes with PI 3 ,4 -P2. However, it does not fully activate PKB in vitro 
(Freeh et a l , 1997), though the scenario may be different in vivo, as PI 3 ,4 -P2 was 
found to increase PKB activity in NIH 3T3 cells comparably to PDGF stimulation 
(Franke et a l , 1997). The availability of a compound that specifically inhibits PKB 
would also be useful in determining its role in insulin-stimulated GLUT4 
translocation. An alternative to stable expression of myrAkt A4-129 in 3T3-L1 
adipocytes would be to transiently express wild-type and dominant negative PKB. 
This method of expression has already been used by Dudek et al (1997) to implicate a 
role for PKB in apoptosis in neural cells.
In summary, the data shows that the expression of constitutively active PKB in 3T3- 
L1 adipocytes leads to an increase in basal glucose uptake, but not to maximal insulin- 
stimulated levels. Though there is an increase in GLUT1 expression, the cause of the 
elevated basal glucose uptake appears to be due mainly to increased cell surface 
GLUT4. Thus, constitutively active PKB appears to stimulate submaximal glucose 
transport activity via GLUT4 translocation.
109
3.5 Studies w ith PKB in 3T3-L1 and R at A dipocytes  
C hronically Treated w ith Insulin
Chronic treatment of 3T3-L1 adipocytes with insulin (500 nM for 24 h) leads to down- 
regulation of cell surface GLUT4, though there is no change in total cellular GLUT4 
(Kozka et al., 1991). This transporter isoform can no longer be recruited to the 
plasma membrane when the cells are washed and restimulated with insulin. Further, 
there is no change in the binding of insulin to its receptor following chronic treatment 
with insulin. Thus, the observed insulin resistance implies a defect in the insulin 
signalling pathway. The identification of the component(s) involved may help in 
understanding the mechanism underlying insulin-stimulated GLUT4 translocation. 
Down-regulation of PKB activity following chronic treatment of adipocytes with 




Figure 3.5.1. PKB Activity Following Chronic Treatment of 3T3-L1 Adipocytes 
with Insulin.
3T3-L1 adipocytes were either: acutely treated without (B) or with (I) 100 nM insulin for 20 min 
{Methods 2.3.1); chronically treated with 500 nM insulin for 24 h (IC) {Methods 2.3.3); chronically 
treated with 500 nM insulin for 24 h and incubated in KRM for 1 h prior to 100 nM insulin stimulation 
for 20 min (ICA) {Methods 2.3.4). PKB was immunoprecipitated and assayed for activity as in 
Methods 2.5.2. Values are the means ± S.E.M. from two independent experiments done in duplicate {n 
= 4).
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In this thesis, experiments were undertaken in 3T3-L1 adipocytes to determine if 
insulin resistance induced by chronic treatment with insulin was associated with a 
down-regulation of PKB activity (Figure 3.5.1). A 24 h treatment with 500 nM insulin 
led to PKB activity that was 40.1% of that in cells acutely stimulated with 100 nM 
insulin for 20 min. When 3T3-L1 adipocytes chronically treated with insulin were 
incubated in Krebs-Ringers-MES buffer to remove bound insulin before an acute 
insulin stimulation was given, no further increase in PKB activity was observed. 
Thus, chronic treatment of 3T3-L1 adipocytes with insulin appears to down-regulate 
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Figure 3.5.2. PKB Activity in Rat Adipocytes Maintained in Culture in the 
Presence of Insulin with or without Metformin.
Freshly-isolated rat adipocytes were either cultured for 24 h before acute treatment without (B) or with 
(I) 20 nM insulin for 30 min, or they were chronically treated with 500 nM insulin in a 24 h culture 
without (IC) or with (ICM ) 1 mM metformin (Methods 2.2.2 and 2.3.5). PKB was immunoprecipitated 
from 0.5 ml 40% (v/v) cells and assayed for activity as in Methods 2.5.2. Values are the means ± 
S.E.M. from four independent experiments. P < 0.05 for B vs. I A, IA vs. IC, and IC vs. ICM; P > 
0.05 (ns) for IA vs. ICM.
For rat adipocytes maintained in a 24 h culture with 500 nM insulin, the presence of 1 
mM metformin prevents down-regulation of cell surface GLUT4 (Kozka and Holman, 
1993). Thus, experiments were undertaken to determine if metformin could also 
prevent the down-regulation of PKB activity following chronic treatment of rat 
adipocytes with insulin (Figure 3.5.2). Acute stimulation with 20 nM insulin of rat
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adipocytes cultured under basal conditions produced a 4.7-fold increase in PKB 
activity over unstimulated basal levels. For rat adipocytes cultured with 500 nM 
insulin for 24 h, PKB activity was 40% of that in adipocytes cultured under basal 
conditions before acute stimulation with 20 nM insulin. The presence of 1 mM 
metformin during the 24 h culture with 500 nM insulin resulted in PKB activity that 
was not significantly different from that in rat adipocytes cultured under basal 
conditions before acute stimulation with 20 nM insulin (P < 0.05). Thus, metformin 
appears to block the down-regulation of PKB activity that is associated with chronic 
treatment of rat adipocytes with insulin.
Insulin stimulation of freshly-isolated rat adipocytes results in the migration of PKB to 
higher molecular weight regions on SDS-PAGE gels (Kohn et al., 1995). This effect 
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Figure 3.5.3. The Phosphorylation State of PKB in Rat Adipocytes Maintained 
in Culture in the Presence of Insulin with or without Metformin.
Rat adipocytes were prepared and treated as in Figure 3.5.2. Protein in cell lysates were resolved on 
10% SDS-PAGE gels, transferred to nitrocellulose and immunoblotted with anti-Aktl(C-20) {Methods 
2.7).
Acute stimulation with 20 nM insulin of rat adipocytes cultured under basal conditions 
produced multiple bands for PKB that were of higher molecular weight than those in 
cells cultured without insulin. The presence of 500 nM insulin during the 24 h culture 
of rat adipocytes prevented this migration, but did not if 1 mM metformin was also 
present during the chronic treatment. Thus, the results confirm that PKB activity is
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down-regulated following chronic treatment of rat adipocytes with insulin, and that 
this down-regulation is prevented if metformin is present during the chronic treatment.
In the study described here, chronic treatment of 3T3-L1 adipocytes with insulin led to 
PKB activity that was less than half that seen with acute stimulation. In addition, the 
activity could not be further raised following a washing procedure and acute 
restimulation with insulin. No changes in the expression of PKB were detected in rat 
adipocytes chronically treated with insulin. Thus, chronic treatment with insulin 
down-regulates PKB activity without affecting expression, as well as rendering 
adipocytes resistant to restimulation of its activity. This observation is comparable to 
the effects of prolonged insulin stimulation on cell surface GLUT4 (Kozka et al, 
1991).
Chronic treatment of rat adipocytes with insulin decreases tyrosine phosphorylation of 
the insulin receptor by 70% compared with an acute insulin stimulation (Pryor et al, 
1997). Also, some groups have observed a reduction in IRS-1 expression with 
prolonged insulin treatment of 3T3-L1 adipocytes (Rice et a l, 1993, and Ricort et al, 
1995), though others have not for rat adipocytes (Pryor et a l, 1997). Thus, down- 
regulation of PKB activity due to chronic treatment of adipocytes with insulin is likely 
to be a consequence of the perturbation of these upstream components of the insulin 
signalling pathway. Consistent with this idea is the absence of reduced PKB 
expression with prolonged insulin stimulation: instead, PKB is present in a lower 
phosphorylated state. However, it cannot be ruled out that other factors may be 
directly down-regulating PKB activity, perhaps by covalent modification. To 
investigate this possibility, it would be necessary to be able to activate PKB via a 
mechanism independent of the insulin signalling pathway. One potential method 
would be treatment of adipocytes with PI 3 ,4 -P2, as this phospholipid has been shown 
to directly increase PKB activity in NIH 3T3 cells (Franke et a l, 1997). Another 
possibility would be to stimulate adipocytes with isoproterenol, as this drug has been 
shown to stimulate PKB activity via a wortmannin-insensitive pathway in rat 
adipocytes (Moule et a l, 1997). Thus, if either or both compounds are able to 
stimulate PKB activity in adipocytes chronically treated with insulin, then it would
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indicate that PKB has not been directly down-regulated (that is, it has not been 
rendered inactivatable by prolonged insulin stimulation).
In the study described here, the inclusion of metformin during chronic treatment of rat 
adipocytes with insulin alleviated the down-regulation of PKB activity. Thus, as for 
cell surface GLUT4 (Kozka and Holman, 1993), metformin counteracts the effects of 
prolonged insulin treatment. Though the mechanism of action of metformin is 
unknown, Pryor et al (1997) have shown that the reduction of the tyrosine 
phosphorylation of the insulin receptor of rat adipocytes chronically treated with 
insulin is prevented by concomitant metformin treatment. Thus, action at the level of 
the insulin receptor may explain the counteractive effect of metformin on the down- 
regulation of PKB. Consistent with this idea is the unchanged expression of PKB 
when rat adipocytes are chronically treated with insulin and metformin. Instead, PKB 
remains in a higher phosphorylated state, similar to that seen with acute stimulation of 
adipocytes with insulin. However, the action of metformin at other points in the 
insulin signalling pathway cannot be ruled out. To examine this possibility, two 
further experiments could be undertaken. The first would be to incubate 
immunoprecipitated PKB from basal cells (or from cells chronically treated with 
insulin) with metformin to determine if it directly activates the kinase. The second 
would be as for the first suggestion, but in the presence of cell lysate minus the insulin 
receptor, as metformin may act indirectly via a cytosolic factor on PKB activity.
In summary, the defects in the insulin signalling pathway following chronic treatment 
of adipocytes with insulin include down-regulation of PKB activity. Thus, the 
involvement of the kinase in the regulation of glucose transport cannot be ruled out. 
However, further studies are required to determine if the down-regulation of PKB 




The aim of this study was to investigate the role of two components of the insulin 
signalling pathway in the regulation of glucose uptake: the IRS-1 PH domain and 
PKB. The IRS-1 PH domain does not appear to be required for IRS-1-mediated 
activation of PI 3-K, an enzyme implicated to be involved in insulin-stimulated 
glucose uptake. Thus, the role of the PH domain for the normal functioning of IRS-1 
needs to be established, and in particular, its role in relation to insulin-regulated 
glucose uptake. PKB is an insulin-activated kinase that is downstream of PI 3-K. 
Thus, PKB may be a link between insulin stimulation of PI 3-K activity and the 
subsequent elevation of glucose transport activity.
Previous studies have indicated that the PH domain acts as a membrane-targeting 
signal. First, the PH domain can bind to GPy and PI 4 ,5 -P2 (Touhara et al., 1994, and 
Harlan et al., 1994): both are membrane-localized. Second, the deletion of the PLC 5i 
PH domain abolishes the ability of the enzyme to associate with the plasma membrane 
(Paterson et al., 1995). Thus, it is possible that the PH domain may perform the same 
function for IRS-1. From this thesis, indirect evidence is consistent with the PH 
domain targeting IRS-1 to the plasma membrane: the introduction of exogenous IRS-1 
PH domain into permeabilized 3T3-L1 adipocytes partially blocks insulin-stimulated 
IRS-1 phosphorylation. The additional requirement of the PTB domain for the 
targeting of IRS-1 to the insulin receptor (Yenush et al., 1996) may explain why total 
inhibition of IRS-1 phosphorylation was not observed. However, it needs to be 
demonstrated that the IRS-1 PH domain can directly associate with the plasma 
membrane. Further, if there is an interaction between the two, it needs to be 
determined if the PH domain binds via a protein or a lipid. In the study described in 
this thesis, the lack of success in identifying an IRS-1 PH domain-binding protein 
does not eliminate the possibility that such a molecule exists, given that other groups 
have found protein-protein interactions involving the PH domain of other proteins 
(Touhara et al., 1994, and Konishi et al., 1995). However, the ability of 
phospholipids to bind the IRS-1 PH domain needs to be explored, given that other
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groups have observed such interactions with other PH domains (Harlan et al., 1994, 
and Lemmon et al., 1995).
Since the PH domain appears to target IRS-1 to the plasma membrane, it is entirely 
possible that it may target the same protein to the LDM fraction of 3T3-L1 adipocytes. 
Support for this idea is provided by observations that tyrosine-phosphorylated IRS-1 
appears in this membrane fraction following insulin stimulation of 3T3-L1 adipocytes 
(Ricort et al., 1996). However, indirect evidence from this thesis suggest otherwise. 
Thus, in permeabilized 3T3-L1 adipocytes, exogenous IRS-1 PH domain does not 
block insulin-stimulated glucose transport or PI 3-K activity in the LDM. However, 
and importantly, it needs to be shown that the IRS-1 PH domain can interact with the 
LDM.
To demonstrate a role for PKB in insulin-stimulated glucose uptake, it would be 
preferable to use a specific inhibitor and activator of the enzyme. The availability of 
these compounds would help determine if PKB is both essential and sufficient for 
insulin stimulation of GLUT4 translocation. The phospholipid PI 3 ,4 -P2 has been 
shown to stimulate PKB activity in vivo in NIH 3T3 cells (Franke et al., 1997). 
However, this compound may also activate other PH domain-containing proteins, so it 
may not be an appropriate choice of PKB activator. In this thesis, the use of Crosstide 
as a competitive inhibitor of insulin-stimulated PKB action in permeabilized 3T3-L1 
adipocytes was not successful. However, the subsequent response that was measured 
was glucose uptake. It needs to be determined if Crosstide can affect insulin- 
stimulated cellular events that have been established as downstream of PKB, such as 
the activation of pp70S6k and the inactivation of GSK-3. Thus, due to the 
unavailability of activators and inhibitors of PKB, alternative experiments have to be 
undertaken instead.
From the experiments described in this thesis, circumstantial evidence is consistent 
with the idea that PKB is involved in insulin-stimulated glucose uptake in 3T3-L1 
adipocytes. First, maximum insulin activation of PKB activity precedes maximum 
insulin stimulation of glucose transport in 3T3-L1 adipocytes. Thus, PKB activity
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reaches near-maximal levels following 2  min insulin stimulation, whereas glucose 
uptake is maximal after 10-15 min insulin stimulation (Fingar and Bimbaum, 1994b). 
Similarly, following wortmannin treatment of insulin-stimulated 3T3-L1 adipocytes, 
the inactivation of PKB occurs more rapidly than the decline of glucose transport. 
The half-times for the reduction of the insulin-stimulated response are 52.8 s for the 
former and 5 min for the latter. Further, okadaic acid can counteract wortmannin 
inhibition of insulin-stimulated PKB activity and glucose transport activity. However, 
the site of action of okadaic acid is not fully understood. Thus, okadaic acid may 
affect glucose transport at another site other than that at the level of PKB. Second, the 
dose-response curve for insulin-stimulated PKB activity is to the right of that for 
insulin-stimulated glucose uptake. This observation is consistent with the concept of 
amplification of the signal from an upstream component of the signalling pathway.
Further circumstantial evidence for a role for PKB in insulin-stimulated glucose 
transport was obtained using adipocytes made insulin-resistant by chronic treatment 
with insulin. PKB activity is down-regulated following this treatment and cannot be 
elevated following washing of the cells and restimulation with insulin. Further, the 
inclusion of metformin during chronic treatment with insulin prevents the down- 
regulation of PKB activity. Thus, the data indicate that PKB may be involved in the 
signalling pathway linking the insulin receptor to GLUT4 translocation. However, 
chronic treatment with insulin affects signalling at the level of the insulin receptor and 
IRS-1 (Pryor et al., 1997, Rice et al., 1993, and Ricort et al., 1995). Thus, since 
multiple pathways emanating from the receptor are likely to be perturbed, other 
aspects of insulin action not involved in glucose transport may be affected.
A method of investigating the effects of PKB activity on glucose uptake and GLUT4 
translocation has involved the expression of a constitutively active form of PKB in 
3T3-L1 adipocytes (Kohn et al., 1996b). In this thesis, it was observed that the 
expression of this form of PKB leads to an elevation of glucose transport activity that 
is 38.9% of that in the insulin-stimulated state. This value is less than the 70% 
determined by Kohn et al. (1996b). Even so, they did not observe maximal glucose 
uptake in basal 3T3-L1 adipocytes expressing constitutively active PKB. The
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increased basal glucose uptake appears to be the result of increased GLUT4 
translocation, rather than increased GLUT1 expression. First, the extent of GLUT4 
translocation is similar to that of increased glucose transport activity. Second, 
compared with control cells, there is an increase in cell surface levels of GLUT1, but 
not of GLUT4, in the insulin-stimulated state. However, there is no corresponding 
increase in maximal insulin-stimulated glucose uptake. Thus, the data show that 
constitutively active PKB is capable of increasing glucose uptake via GLUT4 
translocation, but not to maximal levels. A potential caveat with this method is that 
the long-term effects of elevated PKB activity are manifested. Thus, it would be 
preferable to observe the effects of acute activation of PKB.
PKB becomes constitutively active in 3T3-L1 adipocytes if it is membrane-localized 
via the addition of an N-terminal myristoylation signal sequence to a PH domain 
deletion mutant of the kinase (Kohn et al., 1996b). However, from the experiments 
described in this thesis, insulin stimulation only increases endogenous PKB activity in 
the cytoplasmic fraction of 3T3-L1 adipocytes. Possibly, PKB is activated at a 
membrane site before it migrates to the cytoplasm. However, the site of action for 
endogenous PKB would be different to that for constitutively active PKB. Thus, for 
the 3T3-L1 adipocytes expressing the constitutively active kinase, the elevated basal 
glucose uptake may be occurring via a mechanism that does not operate under normal 
physiological conditions. However, it could be equally argued that the constitutively 
active form of PKB is unable to cause maximal GLUT4 translocation because it is not 
able to act in the cytosol like endogenous PKB. The expression of alternative 
constitutively active forms of PKB in 3T3-L1 adipocytes would help to clarify 
matters.
In summary, there is an argument for and against a role for PKB in insulin-stimulated 
glucose uptake in adipocytes. The argument for the case is as follows. First, maximal 
insulin stimulation of PKB activity occurs before that of glucose transport activity. 
Second, wortmannin inhibits insulin-stimulated PKB activity more rapidly than 
insulin-stimulated glucose uptake. Third, activation of PKB is less sensitive to insulin 
stimulation than elevation of glucose uptake. Fourth, PKB activity, like cell surface
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GLUT4, can be down-regulated by chronic treatment of adipocytes with insulin. 
Fifth, constitutively active PKB can raise basal glucose uptake via GLUT4 
translocation. The argument against the case is as follows. First, the evidence from 
all the experiments undertaken with non-transfected adipocytes is only circumstantial. 
Thus, the evidence does not demonstrate a direct link between PKB activity and 
glucose uptake. Second, constitutively active PKB does not appear to maximally 
increase the levels of GLUT4 at the plasma membrane, since insulin stimulation can 
cause further translocation of the transporter isoform. Finally, since the constitutively 
active form of PKB is membrane-localized, then it may not be acting in a similar 
manner to insulin-stimulated PKB. This observation can be used to argue for or 
against a role for PKB in insulin-stimulated glucose uptake.
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